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Polyketides are a class of small molecules synthesized by a broad spectrum of 
bacteria, plants, and fungi, and many exhibit powerful bioactive properties. The number 
of clinically-relevant compounds adapted from polyketide scaffolds is growing, eliciting 
attempts from synthetic organic chemists to construct polyketide-related compounds in 
the laboratory from simple chemical building blocks. Unfortunately, the current 
efficiency by which a skilled artisan can synthesize even small quantities of a polyketide 
is severely limited by the functional and stereochemical complexity of these compounds. 
Conceptually, it would be much simpler to genetically reprogram the enzymes 
responsible for polyketide biosynthesis to produce designer molecules; however, the 
massive size of polyketide synthase enzymes has hindered efforts towards understanding 
critical features of their structures and mechanisms. Only very recently has structural 
information become available for enzymes involved in polyketide biosynthesis, providing 
an initial glimpse into the inner workings of these subcellular pharmaceutical factories. It 
will not be possible for mankind to fully realize the potential of engineered polyketide 
synthases without understanding how their architectures govern the molecules they have 
evolved to produce. 
 viii 
In this work, the structure and mechanism of several enzymes involved in 
polyketide biosynthesis is investigated. An unprecedented architecture for the 
ketoreductase-enoylreductase didomain from the second module of the spinosyn 
polyketide synthase reveals structural divergence from the related mammalian fatty acid 
synthase, and reconstituted in vitro activity of the enoylreductase domain indicates the 
isolated enzyme retains activity apart from its parent polyketide synthase module. The 
dehydratase domain isolated from the tenth module of the rifamycin polyketide synthase, 
previously hypothesized to only form double bonds with (Z) geometry, was found to have 
altered stereoselectivity dependent on the carrier handle bound to the substrate. The 
enoyl-isomerase domain, isolated from the fourteenth module of the bacillaene 
polyketide synthase, utilizes a catalytic mechanism that relies only on a single active site 
histidine. A series of ketosynthase domains from trans-acyltransferase polyketide 
synthases reveal how polyketides bind covalently to the active site of the ketosynthase, 
and how the flanking subdomain of the ketosynthase is used as an anchor point for the 
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Chapter 1. Introduction 
During the fall of 1928, the Scottish scientist Alexander Fleming noticed 
something strange in one of his petri dishes. A blue-green mold had occupied a region of 
the culture plate that should have been inhabited by a species of Staphylococcus. Upon 
closer inspection, he noticed that the growth of Staphylococcus was inhibited when in 
close proximity to the mold, indicating that the mold was producing a substance that 
prevented the bacteria from encroaching upon its space. If the mold was producing a 
compound that is toxic to Staphylococcus yet harmless to humans, perhaps this substance 
could be isolated and used as an antibiotic? Unknowingly, Dr. Fleming had made one of 
the most critical findings responsible for ushering in the modern era of natural product 
discovery; penicillin was scheduled for mass production in the United States just 12 years 
later. It was not until 1945 that scientists began to understand penicillin’s mechanism of 
action, when Dorothy Hodgkin used X-ray crystallography to determine the atomic 
structure of this small molecule. It is astounding that just within the last one-hundred 
years man has come to the realization that there is an arsenal of molecular weapons under 
our feet that have been rigorously developed by natural selection for billions of years. We 
have adopted some of these weapons for our own uses, to augment our immune systems 
against infection, lower cholesterol, and even fight cancer. We have discovered that X-
ray crystallography allows us to visualize the location of every atom in these natural 
products, permitting scientific inquiry of the mechanism of action, and form hypotheses 
concerning potential chemical modifications to increase efficacy. We are currently 
embarking on a new frontier of reengineering the biological machinery that has evolved 
to construct these molecules, as discovering natural products gives way to designing 




Polyketides are a class of natural products that have shown tremendous bioactive 
potential (Figure 1-1). For example, the Buruli ulcer afflicts thousands in developing 
countries with painful skin lesions, resulting from an infection by Mycobacterium 
ulcerans (Nakanaga et al., 2013). This pathogenic mycobacterium produces the 
polyketide mycolactone, inhibiting the host’s immune response and causing severe 
dermal ulcers. Ironically, a common treatment for the Buruli ulcer is rifamycin, a 
polyketide antibiotic produced by the soil-dwelling bacterium Amycolatopsis 
mediterranei, also used as a first line of defense against tuberculosis (World Health 
Organization, 2010). Perhaps the most comprehensively studied polyketide is the 
antibiotic erythromycin, generally prescribed for bacterial infections for those who have 
an allergy to penicillin (Figure 1-2) (Khosla et al., 2007). Although a powerful antibiotic, 
erythromycin also causes abdominal disturbances in some patients. Conceivably, one of 
the functional groups of erythromycin could be altered, and the new analog may retain 
antibiotic properties without adverse side effects. This hypothesis would be very 
challenging to test; erythromycin is a 14-membered macrolide containing 10 chiral 
centers and decorated with two sugar moieties. The synthesis of erythromycin was 
eventually completed by the Nobel laureate Robert Woodward, a heroic effort that was 
not accomplished until thirty years after its discovery (Woodward et al., 1981). If organic 
chemists were to develop a modification to erythromycin that revealed enhanced 
medicinal properties in humans, it would not be economically possible to synthetically 
generate the kilograms of analog required for distribution as a prescription antibiotic. A 
solution to this problem potentially lies in genetic engineering: rewiring and 
reprogramming the polyketide biosynthetic machinery from the host organism to produce 
natural product analogs that can be isolated by fermentation and extraction. If scientists 




of polyketide compounds that would become accessible for research and production 
would be virtually unlimited. 
Type I PKSs are multienzyme polypeptide complexes that represent some of the 
largest proteins discovered, and provide an exceptional opportunity to examine enzyme 
catalysis, molecular recognition and protein-protein docking (Shen, 2003; Keatinge-Clay, 
2012). The enzymatic domains employed by PKSs are similar to those found in fatty acid 
biosynthesis, and the set of domains required for a single round of polyketide extension 
and processing is called a module (Figure 1-3). The domains present in a module with a 
complete set of processing enzymes include the ketosynthase (KS) that catalyzes a thio-
Claisen condensation of the polyketide intermediate with an α-carboxylated extender 
unit, the acyltransferase (AT) that selects the α-carboxylated extender unit from the 
cellular pool of available acyl-CoAs, the ketoreductase (KR) that stereospecifically 
reduces the newly incorporated β-carbonyl and sets the chirality of the α-substituent, the 
dehydratase (DH) that eliminates an α-proton and β-hydroxyl as water, the 
enoylreductase (ER) that stereospecifically reduces the resulting enone to generate a fully 
saturated intermediate, and the acyl carrier protein (ACP) that shuttles the growing 
polyketide between all the domains within its cognate module, as well as transfer to the 
subsequent module. A thioesterase (TE) appended to the terminal module of the synthase 
releases the polyketide via thioester hydrolysis or macrocyclization. The mammalian 
fatty acid synthase (FAS) can be thought of as an iterative single-module polyketide 
synthase, equipped with a complete set of processing domains (Maier et al., 2008). Type 
I PKSs diverged into two distinct classes early in evolution: cis-AT and trans-AT (Piel, 
2010). The cis-AT class was discovered earlier and is better studied than the trans-AT 
class, and is so named because this class harbors an AT domain integrated into the PKS 




architecture for a complete module. Trans-AT PKSs do not include an AT domain 
integral to the module, and AT activity is supplied by a discretely-encoded AT domain 
that docks to the synthase. Trans-AT PKSs have also been observed to form membrane-
bound megacomplexes, in which many copies of the megasynthase aggregate to form an 
organelle-sized structure with the purpose of producing and exporting polyketides 
(Straight et al., 2007).  
PKSs are able to generate such an incredibly diverse array of natural product 
metabolites utilizing only these core enzymatic domains by taking advantage of two key 
features: domain deletions and modularity. If a module lacks one of the processing 
domains (or if it is a null mutant), the α- and β-positions of the polyketide substrate 
cannot be reduced to a completely saturated acyl intermediate. For example, if a module 
has the architecture KS-AT-DH-KR-ACP (lacking an ER domain), the resulting 
polyketide will be transferred to the subsequent module as the enone intermediate. In a 
similar manner, if the modular architecture was KS-AT-KR-ACP, the polyketide will be 
transferred as a β-hydroxyl intermediate. The advantage of PKS modularity is related to 
the concept of assembly line construction: the intermediate generated by module 1 is 
always passed to module 2 and then to module 3, until the polyketide encounters a 
module harboring a TE and is released from the synthase. This allows for the relatively 
rapid reorganization of a PKS by genetic recombination, producing an entirely distinct 
polyketide from the same set of core enzymatic domains.  
With such an elegant yet simple design for natural product evolution, it would 
seem that man would have the capacity to construct any polyketide imaginable by 
building a custom PKS through genetic engineering. Instead of the daunting task of 
synthetically reversing one of the ten asymmetric centers of erythromycin, the KR 




generates the opposite stereochemistry, and the new analog collected by fermentation. 
Although this endeavor has been successful in some cases, attempts to modify PKSs by 
domain- or module-swapping generally only produce nonfunctional synthases (Kao et al., 
1998; Tsuji et al., 2001; Kumar et al., 2003). Several problems may contribute to this 
observation: downstream modules may refuse to accept the altered substituent of the 
polyketide intermediate, or the protein-protein interactions between modules (or within 
modules) may be disrupted and lead to misfolded domains. The crystal structure of a 
complete module would undoubtedly solve many problems associated with rational PKS 
engineering, but no such structure has been published to date. Instead, the domains that 
compose the PKS module have been isolated and structurally investigated to provide a 
mosaic body of information about the synthase. The following chapters describes several 
of these studies, in which domains or didomains dissected from PKS modules are 
isolated, crystallized, and biochemically interrogated to determine their contribution to 
PKS enzymology.  
In Chapter 2, the crystal structure and reconstituted in vitro activity of a KR+ER 
didomain from the second module of the spinosyn PKS (Spn(KR+ER)2) is presented. 
Despite the similarities in domain architecture between Type I PKSs and the FAS, the 
structure reveals that the interface shared by the KR and ER domains in Spn(KR+ER)2 is 
remarkably different than observed in the FAS. The structure indicates ER domains of 
Type I PKSs are not dimeric, unlike the closely related FAS. It is hypothesized that this 
architecture is necessary to accommodate the assembly line nature of the megasynthase, 
permitting the ACP from one module to access the KS of the subsequent module. To 
confirm that the crystal structure of Spn(KR+ER)2 is representative of the native 
orientation of the didomain in solution, small angle X-ray scattering (SAXS) analysis was 




structure of Spn(KR+ER)2, but does not fit the isolated KR+ER didomain of the FAS, 
indicating the crystal structure of Spn(KR+ER)2 is not a crystallographic artifact. The 
active site residues of the ER domain directly responsible for catalysis were interrogated 
by designing an in vitro activity assay coupled with site-directed mutagenesis. It was 
found that an active site lysine contributes most to catalysis, although the lysine to 
alanine mutant was able to reduce enoyl substrate mimics to a lesser degree.  
In Chapter 3, the crystal structure and reconstituted in vitro activity of a DH 
domain from the tenth module of the rifamycin PKS (RifDH10) is presented. Double 
bonds are installed by PKS modules lacking an ER domain, and are frequently 
encountered polyketide functional groups. The vast majority of polyketide double bonds 
have (E) geometry, but the macrolactam polyketide antibiotic rifamycin contains a double 
bond with (Z) geometry. The atypical geometry of this double bond was hypothesized to 
result from a cis-dehydration event catalyzed by RifDH10, as this DH domain resides in 
the module responsible for tailoring the propionyl-derived extender unit that harbors the 
(Z) double bond in rifamycin. To better understand polyketide (Z) double bond formation, 
RifDH10 was isolated, purified, and crystallized. The active site of RifDH10 is 
structurally homologous to other PKS DH domains that have been solved, and the 
catalytic dyad (composed of histidine and aspartate residues) is positioned identically to 
what has been observed in DHs that generate (E) double bonds. Despite the structural 
homology of the RifDH10 active site to trans-dehydrating DHs, in vitro activity assays 
were conducted with substrate mimics to further establish the geometry of the 
dehydration product. RifDH10 is specific for substrate mimics harboring a (3R)-hydroxyl 
if the thioester handle is N-acetyl-cysteamine, pantetheine, or a non-cognate ACP 
(EryACP6). In contrast, RifDH10 is specific for (3S)-hydroxyl substrates if the thioester 




assayed, RifDH10 only catalyzed the formation of double bond products with (E) 
geometry, indicating the (Z) double bond characteristic of rifamycin is likely formed 
during the subsequent macrolactamization step catalyzed by RifF.  
In Chapter 4, a modification to the popular expression vector pET-28 is 
presented, describing how the multiple-cloning region of this vector was replaced with a 
ligation independent cloning cassette. pET-28 is a commonly employed expression vector 
for the overproduction of protein in E. coli, however the requisite use of restriction 
enzymes to introduce genes of interest increases costs and reduces yield relative to 
ligation independent cloning techniques. Homologous recombination in Saccharomyces 
cerevisiae was employed to exchange the multiple-cloning region of pET-28 with a 
customized ligation independent cloning cassette, generating pGAY-28. The cloning 
efficiency of this vector is much higher than pET-28, and the protocol used to introduce a 
gene of interest does not require restriction enzymes. To demonstrate the increased 
efficiency, a 10.3 kb insert (coding for a complete PKS polypeptide) was successfully 
incorporated into the ligation independent cloning cassette of pGAY-28, while methods 
employing restriction enzymes to incorporate an identical insert into pET-28 were 
unsuccessful. The strategy employed to accomplish plasmid modification via 
homologous recombination is uniquely versatile, and can be utilized to reconstruct large 
or small regions of expression vectors easily and quickly.  
In Chapter 5, the crystal structure and reconstituted in vitro activity of an enoyl-
isomerase domain (EI) from the fourteenth module of the bacillaene PKS (PksEI14) is 
presented. EIs are relatively rare PKS processing domains, currently only discovered in 
four trans-AT PKS pathways. They catalyze the reversible isomerization of double bonds 
from the classical α,β-position to the β,γ-position (relative to the thioester handle of the 




revealing a histidine and tyrosine in the active site cavity. To determine the mechanism of 
isomerization, substrate mimics were synthesized and enzymatic assays were carried out 
in either H2O or D2O. A tyrosine mutant reveals that the active site histidine catalyzes 
isomerization unaided, and assays conducted in deuterated solvent show that water is not 
activated by the enzyme as an acid-base catalyst. PksEI14 represents the first example of 
an enzyme employing a single histidine to independently shuttle a substrate proton to 
catalyze α,β → β,γ double bond isomerization.  
 In Chapter 6, the crystal structure of a KS from the second module of the 
bacillaene PKS (PksKS2) is presented. KSs from trans-AT PKS pathways act as 
gatekeepers, being specific for the substituents and geometry of the α- and β-positions of 
the polyketide intermediate. Understanding how this specificity is conferred is imperative 
if trans-AT KSs are to be engineered into unnatural biosynthetic pathways for the 
production of novel metabolites. The 1.95 Å crystal structure of PksKS2 provides the 
highest resolution available for a Type I PKS KS, and a cysteine-to-serine active site 
mutant acylated by the natural polyketide intermediate for PksKS2 reveals key residues 
that confer substrate specificity. A hexanoyl group was also crystallographically captured 
in the active site, revealing that both the natural substrate and a tolerable substrate mimic 
bind in the same orientation. The structure also reveals that trans-AT KSs harbor a 
flanking subdomain homologous to the ordered linker that stabilizes the integrated AT 
domain of cis-AT PKSs. It has been previously hypothesized that this region likely forms 
the docking site for a trans-AT, so that the architecture of a complete module for both the 
cis-AT and trans-AT PKS systems would be structurally similar. However, in silico 
docking of a trans-AT with the flanking subdomain of PksKS2 indicates significant 




accommodate the KS:AT orientation observed in cis-AT systems. The role of the trans-
AT KS flanking subdomain is further investigated in Chapter 7.  
In Chapter 7, seven crystal structures of trans-AT PKS KS domains are 
presented, and their role in stabilizing the trans-AT PKS megacomplex is analyzed. The 
flanking subdomain for each of the seven structures harbors a three-helix motif that self-
associates in each of the available crystalline states. Analysis of several trans-AT KS 
structures previously deposited into the Protein Data Bank (PDB) reveals that this three-
helix motif also self-associates, forming crystal contacts that stabilize one dimension of 
the protein crystal. In total, ten distinct crystal structures exhibiting the same well-defined 
interaction indicate that this crystal contact is likely not an arbitrary artifact of 
crystallization, but instead serves the role of stabilizing the trans-AT PKS megacomplex 
observed by others with cryo-EM. Even though the amino acid sequences of the three-
helix LINKS (Localization INducing Ketosynthase Sequence) motifs are not conserved 
in multiple sequence alignments, each crystallographic example demonstrates that 
LINKS bind to spatially-reversed copies of themselves through ionic and hydrophobic 
interactions. The lack of LINKS sequence conservation imparts a code that promotes the 














Figure 1-1. Polyketide warfare. Mycobacterium ulcerans contains a large plasmid 
harboring the 110-kilobase gene cluster responsible for the biosynthesis of the toxic 
polyketide mycolactone. Infection results in severe skin lesions and dermal necrosis. The 
bacterium Amycolatopsis mediterranei produces the polyketide rifamycin, used in the 
treatment of both the Buruli ulcer and tuberculosis due to its ability to inhibit DNA-






Figure 1-2. The erythromycin PKS. In an assembly-line fashion, 6-deoxyerythronolide B 
(the aglycone of erythromycin) is constructed stepwise by six PKS modules on three 
polypeptides. The black line that connects the polyketide to the PKS represents the ~18 Å 
phosphopantetheinyl arm of the ACP, responsible for shuttling the growing polyketide to 
all of the domains within the module, as well as transfer to the subsequent module. A TE 
domain appended to the end of the synthase releases 6-deoxyerythronolide B by 













Figure 1-3. Polyketide functional groups depend on module type. The four general 
classes of PKS modules: α-modules have domain architecture KS+AT+ACP, and 
generate β-keto products, β-modules include a KR domain and generate β-hydroxy 
products, γ-modules include a DH domain and generate α,β-olefin products, and δ-





Chapter 2. Divergence of multimodular polyketide synthases revealed 
by a didomain structure 
 
ABSTRACT 
  The enoylreductase (ER) is the final common enzyme from modular polyketide 
synthases (PKSs) to be structurally characterized. The 3.0 Å–resolution structure of the 
didomain comprising the ketoreductase (KR) and ER from the second module of the 
spinosyn PKS reveals that ER shares an ~600-Å
2 
interface with KR distinct from that of 
the related mammalian fatty acid synthase (FAS). In contrast to the ER domains of the 
mammalian FAS, the ER domains of the second module of the spinosyn PKS do not 
make contact across the two-fold axis of the synthase. This monomeric organization may 
have been necessary in the evolution of multimodular PKSs to enable acyl carrier 
proteins to access each of their cognate enzymes. The isolated ER domain showed 
activity toward a substrate analog, enabling us to determine the contributions of its active 
site residues.  
INTRODUCTION 
 Modular PKSs are megasynthases that synthesize biologically active polyketides 
such as the antibacterial erythromycin, the antifungal amphotericin and the insecticide 
spinosyn (Khosla et al., 2007; Smith & Tsai, 2007). Each module along the PKS 
assembly line harbors a set of enzymes responsible for extending the polyketide chain 
and setting the chemistries and configurations of the newly added α- and β-carbons. 
Chapter 2 was adapted from the following published work: Zheng J, Gay DC, Demeler B, White MA, and 
Keatinge-Clay AT. (2012) Divergence of multimodular polyketide synthases revealed by a didomain 





Although studying enzymes that naturally operate within a megasynthase is inherently 
challenging, these component enzymes must be more thoroughly characterized to 
decipher the mechanisms by which polyketides are synthesized. Our efforts have focused 
on the processing enzymes: a KR that stereoselectively reduces the β-keto group, a 
dehydratase (DH) that performs an elimination reaction to generate a double bond and an 
ER that stereoselectively reduces that double bond (Keatinge-Clay, 2007; Keatinge-Clay, 
2008; Zheng & Keatinge-Clay, 2011; Zheng et al., 2010; Keatinge-Clay & Stroud, 2006). 
 Relatively little structural and functional information exists for ER, even though 
the atomic-resolution structures of the other common PKS domains have been 
determined and in vitro studies have been conducted with those isolated domains 
(Keatinge-Clay, 2008; Keatinge-Clay & Stroud, 2006; Tsai et al., 2001; Tang et al., 
2006; Alekseyev et al., 2007). The crystal structure of the nucleotide-binding subdomain 
of the ER from the phthiocerol polyketide synthase (PpsC) reveals little about the active 
site or the overall architecture of ER11. Experiments to identify the key ER residues 
through mutagenesis of engineered triketide lactone synthases have been performed, and, 
though residues mediating stereoselectivity were found, a point mutation that abolished 
activity was not identified (Kwan et al., 2008; Kwan & Leadlay, 2010). 
The processing enzymes from the second module of the spinosyn PKS—SpnKR2, 
SpnDH2 and SpnER2 (named according to their PKS and module of origin)—
sequentially process a triketide intermediate during the synthesis of spinosyn (Figure 2-
1) (Kirst, 2010). Although the SpnER2 domain was not amenable to crystallization, we 




loop connecting the KR subdomains and shares an interface with KR within the 
mammalian FAS (Maier et al., 2008). Indeed, crystals were obtained that diffracted to 3.0 
Å. The structure shows that SpnKR2 and SpnER2 both fold similarly to their mammalian 
FAS counterparts (Maier et al., 2008; Oppermann et al., 2003; Persson et al., 2008). To 
our surprise, however, the domains form a completely different interface. The 
conformation adopted by helix αF from SpnER2 precludes the dimerization mode 
observed for the ER of the mammalian FAS. The three-dimensional organization of the 
KR and ER domains, confirmed by small-angle X-ray scattering (SAXS), reveals that the 
complete modules of multimodular PKSs have a different architecture than the 
mammalian FAS. The first in vitro biochemical studies of an ER domain isolated from its 
PKS show that SpnER2 retains activity on the substrate analog crotonyl-pantetheine and 
that a lysine contributes most to catalysis. 
RESULTS 
The overall architecture of Spn(KR+ER)2 
 The structure of the Spn(KR+ER)2 didomain (SpnB residues 1216–1989; Figure 
2-1a) was solved to 3.0-Å resolution through selenomethionine incorporation and 
multiwavelength anomalous dispersion phasing (Figure 2-2 and Table 2-1). The two 
Spn(KR+ER)2 didomains in the asymmetric unit adopt the same conformation with 0.6-
Å Cα r.m.s. deviation (Figure 2-3a). Although the SpnKR2 domains have similar 
average B-factors (49 Å
2
 versus 56 Å
2
), the average B-factor of one SpnER2 domain is 
highly elevated compared to the other (96 Å
2
 versus 62 Å
2




terminal residues of each Spn(KR+ER)2 molecule in the asymmetric unit fold onto the 
other molecule (that is, it is domain swapped), resulting in the close association of 
SpnKR2 catalytic subdomains and the occlusion of the SpnKR2 NADPH-binding sites 
(Figure 2-4). Nonphysiological domain swapping is sometimes observed in crystals of 
truncated proteins (Liu & Eisenberg, 2002; Kishan et al., 1997). Aside from the four 
residues spanning the domains, the swapped C-terminal residues are folded as expected 
from related KR structures and have B-factors equivalent to the surrounding protein 
(Keatinge-Clay, 2007; Zheng & Keatinge-Clay, 2011; Zheng et al., 2010; Keatinge-Clay 
& Stroud, 2006). 
 The interface between SpnER2 and SpnKR2 is very different from and ~50% 
larger (~600 Å
2
) than the KR-ER interface of the mammalian FAS (Figures 2-2a,b, 2-5 
and 2-6) (Kirst, 2010). Contacts between the catalytic subdomain of SpnKR2 and the 
substrate-binding subdomain of SpnER2 form the majority of the interface, which is 
primarily composed of nonconserved, hydrophilic residues (Figures 2-5, 2-6, and 2-7). 
SpnER2 inserts into a loop between the catalytic and structural subdomains of SpnKR2; 
the N- and C-terminal ends of the insertion loop, referred to here as the N- and C-
terminal linkers, help mediate the interface between SpnKR2 and SpnER2. The N-
terminal linker (residues 176–189, numbering based on first residue visible in the 
electron density maps) spans from the C-terminal end of the SpnKR2 structural 
subdomain to β-strand 1 (β1) of the SpnER2 substrate-binding domain via unconserved 
residues; the C-terminal linker (residues 503–510) connects β9 of the SpnER2 substrate-




served residues. Although the N-terminal linker is comparable in length to that of the 
mammalian FAS (~13 residues), the C-terminal linker is much shorter than its 
mammalian FAS counterpart (8 versus ~29 residues) and is constrained by a conserved 
hydrophobic interaction with the KR catalytic subdomain (mediated by Trp506 in 
Spn(KR+ER)2; Figures 2-2a,b, 2-6, 2-7, and 2-8) (Maier et al., 2008). Within the 
mammalian FAS, the separation between the C-terminal end of β9 of ER (residue 1855) 
and the N-terminal end of the KR catalytic subdomain (residue 1886) is 36 Å. The short 
C-terminal linker of multimodular PKSs cannot span this distance, preventing KR and 
ER from forming the orientation observed in the mammalian FAS. 
 To investigate whether the conformation of the Spn(KR+ER)2 didomain in 
solution is similar to that observed in the crystal structure (corrected for domain 
swapping), we performed SAXS (Figures 2-2c and 2-9) (Putnam et al., 2007). The 
experimental scattering curve closely matched the scattering curve predicted by the pro-
gram CRYSOL for the Spn(KR+ER)2 monomer from the crystal structure (Svergun et 
al., 1995). The scattering curve predicted from a model generated through the 
superposition of SpnKR2 and SpnER2 on the KR and ER domains of the porcine FAS 
did not match the experimentally obtained scattering curve. The radius of gyration (Rg) 
determined from the SAXS data through the Guinier approximation (29.5 Å) matches 
that calculated from the Spn(KR+ER)2 crystal structure (30.2 Å) but not that calculated 
from the model generated through the superposition of SpnKR2 and SpnER2 on the KR 
and ER domains of the porcine FAS (36.7 Å). The ab initio molecular envelope 




domain structure that is consistent with the Spn(KR+ER)2 crystal structure but not with 
the model generated using the orientations of KR and ER in the porcine FAS (Figures 2-
2d and 2-9) (Svergun et al., 1995; Franke & Svergun, 2009). 
Oligomerization state 
 The architecture of PKS modules as determined by limited-proteolysis and size-
exclusion experiments and through structural biology techniques has generally correlated 
well with the architecture of the mammalian FAS: the ketosynthase and DH are dimeric, 
and the acyltransferase, KR and acyl carrier protein (ACP) are monomeric (Keatinge-
Clay, 2008; Keatinge-Clay & Stroud, 2006; Tang et al., 2006; Alekseyev et al., 2007; 
Maier et al., 2008; Staunton et al., 1996). However, studies of the oligomerization state 
of the ERs of modular PKSs have been seemingly contradictory: though the crystal 
structures of the mammalian FAS and the nucleotide-binding subdomain of the ER from 
PpsC show these ERs making dimeric contacts via the interface anticipated for medium-
chain dehydrogenase/reductase (MDR) enzymes, limited proteolysis of DEBS2 (the 
second polypeptide of the erythromycin PKS) produced a monomeric EryER4 (Staunton 
et al., 1996). A size-exclusion study of Ery(DH+KR+ER)4 suggests that this tridomain is 
dimeric; however, this result may not address the oligomerization state of EryER4 as it is 
possible that EryDH4 alone mediates dimerization (Keatinge-Clay, 2008; Keatinge-Clay 
& Stroud, 2006). 
 Spn(KR+ER)2, SpnER2 and SpnKR2 were analyzed by size-exclusion 




predicted values 83 kDa, 36 kDa and 50 kDa, respectively; Figure 2-10). The oligomer-
ization states of these proteins were also examined through sedimentation velocity 
experiments (Figure 2-11) (Demeler & van Holde, 2004). For each Spn(KR+ER)2, 
SpnER2 and SpnKR2, the van Holde–Weischet integral distribution plots show 
essentially identical sedimentation coefficient distributions for three different 
concentrations examined, indicating the absence of any mass-action–based 
oligomerization effects. A global genetic algorithm–Monte Carlo analysis was performed 
to confirm the composition of and identify the molecular weights and anisotropies for 
each protein. The molecular weights determined from the genetic algorithm–Monte Carlo 
analysis are in excellent agreement with the known monomeric molecular weights of 
Spn(KR+ER)2, SpnER2 and SpnKR2. The molecular weight of Spn(KR+ER)2 was also 
estimated to be 81 kDa from the SAXS data26, providing further confirmation that 
Spn(KR+ER)2 is a monomer in solution. 
SpnKR2 structure 
 SpnKR2 consists of a structural and a catalytic subdomain (residues 1–175 and 
511–753, respectively; both subdomains have a Rossmann-like fold, and the KR domain 
belongs to the ‘complex’ subfamily of the short-chain dehydrogenase/reductase (SDR) 
superfamily), aligning well with TylKR1, AmpKR2 and EryKR1 (1.8 Å, 1.8 Å and 1.9 Å 
Cα r.m.s. deviation, respectively; Figure 2-12a) (Keatinge-Clay, 2007; Zheng & 
Keatinge-Clay, 2011; Keatinge-Clay & Stroud, 2006; Oppermann et al., 2003). 




helix and is ~30 residues shorter (Keatinge-Clay & Stroud, 2006). Within the catalytic 
subdomain, the active site residues Lys621, Ser643, Tyr656 and Asn660 are in the same 
orientations observed in other reductase-competent KRs (Figure 2-12b) (Keatinge-Clay, 
2007; Zheng & Keatinge-Clay, 2011; Zheng et al., 2010; Keatinge-Clay & Stroud, 2006). 
NADP
+
 is bound in the dinucleotide-binding site of the catalytic subdomain as observed 
in the ternary complex of AmpKR2 (Zheng et al., 2010). Adjacent to the active site, 
SpnKR2 has a leucine-aspartate-aspartate motif, which is used by B-type KRs to help 
stereoselectively generate D-hydroxyl groups, as well as a lid helix that is one turn longer 
than the lid helices of KRs from modules that do not contain other processing enzymes 
(Figure 2-12c) (Keatinge-Clay, 2007). In contrast to their equivalents in most other KR 
structures, both of these elements are well ordered and make contacts to active site 
residues as well as to one another, as illustrated by Arg701 of the lid helix binding the 
second aspartate of the leucine-aspartate-aspartate motif through a salt bridge (the 
interactions between these elements may have been promoted in the crystal structure by 
the lid helix being the first element of the C-terminal domain swap; Figure 2-4c). 
SpnER2 structure 
 The ERs of modular PKSs and FASs belong to the acyl-CoA reductase family 
within the MDR superfamily; thus, SpnER2 has two characteristic MDR subdomains 
(Figure 2-13a) (Persson et al., 2008). Residues 190–307 and 448–501 comprise the 
substrate-binding subdomain, whereas residues 308–447 constitute the nucleotide-




ERs of modular PKSs are structurally distinct from their functional analogs in bacterial 
fatty acid biosynthesis (FabI, FabL and FabV), which are SDRs (Kim et al., 2011; Lu & 
Tonge, 2010). SpnER2 is most structurally similar to quinone oxidoreductases (DALI 
server and Protein Data Bank (PDB) codes: 2J8Z, 3JYN and 1QOR; 2.1 Å, 2.3 Å and 2.4 
Å Cα r.m.s. deviation, respectively) (Holm & Rosenstrom, 2010). SpnER2 is also highly 
structurally related to the ER of the mammalian FAS (PDB code 2VZ8; 2.1 Å Cα r.m.s. 
deviation), a trans-acting enoylreductase in the lovastatin biosynthetic pathway (PDB 
code 3B70; 2.6 Å Cα r.m.s. deviation), and 2-enoyl thioester reductases from 
mitochondrial fatty acid synthesis pathways (PDB codes 2VCY, 1N9G and 1GUF; 3.1 Å, 
3.7 Å and 3.7 Å Cα r.m.s. deviation, respectively) (Maier et al., 2008; Chen et al., 2008; 
Torkko et al., 2003; Airenne et al., 2003). The boundaries of the SpnER2 domain are 
defined by two β-strands (β1 and β9) in the substrate-binding subdomain. The substrate-
binding and nucleotide-binding subdomains are oriented relative to one another largely 
by helix αA (secondary-structure elements of the substrate-binding subdomain are 
labeled with numbers, and those of the nucleotide-binding subdomain are labeled with 
letters, as is customary for the Rossmann fold), which spans both subdomains and is bent 
through the insertion of a side chain carboxylate (from Glu250) at its third turn. The 
nucleotide-binding subdomain of SpnER2 adopts a classical Rossmann fold, whereas the 
nine β-strands of the substrate-binding subdomain form two β-sheets (β1 and β2 create a 
small, antiparallel β-sheet, and β3–β9 build a highly twisted, mixed β-sheet) surrounded 




 MDRs usually dimerize via βF and the secondary structural elements around it 
(Persson et al., 2008). The surrounding elements in the ER from the mammalian FAS are 
αF, βG and αG (Kirst, 2010). SpnER2 has αF but not βG or αG. Quinone oxidoreductases 
share a similar one-helix architecture to SpnER2; however, interactions between Asp405 
and Arg426 as well as Leu408 and His435 position helix αF of SpnER2 in an orientation 
that is seemingly incompatible with dimerization (Figures 2-13b, 2-7, 2-8, and 2-14a) 
(Thorn et al., 1995). The highly related trans-acting lovastatin enoylreductase (PDB code 
3B70) is the only other MDR enzyme that crystallized as a monomer. 
 The NADPH-binding site is located in a deep cleft between the subdomains of 
SpnER2 (Figures 2-13c and 2-14b,c). The pyrophosphate moiety of the nicotinamide 
coenzyme is bound to the highly conserved pyrophosphate-binding motif GGVGMA 
(residues 335–340; Figure 2-7) (Maier et al., 2008). The conserved residues Lys360 and 
Arg375 form salt bridges with the adenine ribose phosphate. Elements from the substrate-
binding subdomain, such as Phe231 from helix α1 and His494 from the loop following 
helix α3, also interact with the bound nicotinamide coenzyme. Thus, the 4-pro-R hydride 
of NADPH is positioned to add to the β-carbon of a trans-α,β-unsaturated polyketide 
substrate, in contrast to KRs, which catalyze the addition of the 4-pro-S hydride (Zheng et 
al., 2010). 
SpnER2 function 
 The structures of both the ER from the porcine FAS and SpnER2 reveal an 




nicotinamide hydride (Maier et al., 2008). They may directly participate in substrate 
protonation, stabilize reaction intermediates or aid in binding the substrate (Figure 2-
13c). Structural and functional analyses of many MDRs suggest that a tyrosine following 
helix α1 is the proton source during the reduction reaction; however, only half of the ERs 
from modular PKSs have the corresponding tyrosine (Figure 2-7). When present, it is 
known to have the major role in setting an S configuration at the α-carbons of α-
substituted polyketide intermediates (Kwan et al., 2008). 
 The activities and stereocontrol of isolated KRs have been extensively analyzed in 
vitro34–37, whereas all functional assays of ER domains have been limited to in vivo 
assays within the context of complete modules (Kwan et al., 2008; Kwan & Leadlay, 
2010). Thus, Spn(KR+ER)2 was assayed for in vitro activity toward the trans-α,β-
unsaturated crotonyl-pantetheine, which mimics its natural substrate, trans-(5S)-
hydroxyhept-2-enoyl-SpnACP2 thioester (Figures 2-1b and 2-15). Indeed, 
Spn(KR+ER)2 generates the expected product, butyryl-pantetheine (verified by MS; 
Figure 2-16). A recent study attempted to determine the catalytic residues of the ERs of 
modular PKSs using an in vivo assay; however, activity was preserved in each of the 
generated point mutants (Kwan & Leadlay, 2010). We sought to identify the catalytic 
residues of ER through an in vitro assay with crotonyl-pantetheine. The structures of the 
mammalian FAS and Spn(KR+ER)2 and previous studies guided the selection of residues 
to be examined (Kwan et al., 2008; Kwan & Leadlay, 2010; Maier et al., 2008). Y241F, 
K422A and S444A point mutants were expressed and purified using the same protocol as 




product, a side product with the molecular weight of β-hydroxybutyryl–pantetheine was 
generated (Figure 2-15). That the K422A mutant produced the least butyryl-pantetheine 
suggests that the lysine is most critical for the reductase activity of SpnER2. 
 We sought to determine the steady-state kinetic parameters of the reduction 
reaction catalyzed by SpnER2 and its point mutants on the substrate crotonyl-pantetheine 
(Table 2-2). Because we observed that stand-alone SpnKR2 could catalyze the hydration 
of crotonyl-pantetheine, the Y241F, K422A and D444A mutations were introduced into 
stand-alone SpnER2. The catalytic efficiency of the reduction reaction (R) of wild-type 
SpnER2 (kcat(R)/Km = 0.11 ± 0.02 M−1 s−1; kcat(R) = 0.0085 ± 0.0007 s−1 and Km = 74 ± 
14 mM) is similar to those of isolated KR domains for diketide-N-acetylcysteamine 
thioesters (for example, EryKR1: kcat/Km = 7 M−1 s−1; kcat = 0.26 ± 0.01 s−1 and Km = 35 
± 4 mM)35 but much lower than that of the ER domain of the intact Rattus norvegicus 
FAS for crotonyl-CoA (kcat/Km = 1.6 × 106 M−1s−1; kcat = 9.8 ± 0.5 s−1 and Km = 6.5 ± 
0.6 μM)38. The D444A mutant was slightly more catalytically efficient than wild-type 




). The Y241F mutant was less efficient 
(kcat(R)/Km = 0.08 ± 0.01 M−1 s−1) than the wild type, whereas the K422A mutant was 
the least catalytically efficient of the mutants (kcat(R)/Km = 0.018 ± 0.004 M−1 s−1). Each 
of the SpnER2 point mutants more actively catalyzed the hydration side reaction than 





 The order of PKS enzymes within a module and the reactions they catalyze 
closely parallel those of the mammalian FAS (Khosla et al., 2007; Smith & Tsai, 2007). 
Nonetheless, the combinations of processing enzymes present within PKS modules 
enable a much wider range of products to be generated. Determining the architectures and 
mechanisms of these enzymes are necessary steps toward elucidating how these 
complicated synthetic machines generate chemically diverse polyketides. This structural 
and functional report of a KR-ER didomain from a complete PKS module represents a 
large step toward this goal. 
 Although no mechanism for the ERs from mammalian FASs or modular PKSs has 
been generally accepted, it is thought that NADPH transfers a hydride to the β-carbon of 
the substrate and that a proton is donated by either a general acid or a solvent molecule to 
the α-carbon (Figures 2-13c and 2-15) (Smith & Tsai, 2007; Maier et al., 2008). That 
Lys422 was found to be the most crucial for catalysis makes sense as it is structurally 
conserved in the ERs of both mammalian FASs and modular PKSs, whereas the tyrosine 
is absent in the ERs from mammalian FASs (and half of the ERs from modular PKSs) 
and the aspartate resides in a different location within the ER of the mammalian FAS 
(Figures 2-7 and 2-8) (Maier et al., 2008). 
 The mechanisms by which some ERs from modular PKSs set stereochemistry are 
made less mysterious through the structure of SpnER2. The tyrosine that has the principal 
role in setting an S configuration at a substituted α-carbon (equivalent to Tyr241 in 




2008). The lysine and tyrosine are within 5 Å of one another, and both residues are in 
appropriate positions to protonate the α-carbon of a bound polyketide substrate during the 
reduction reaction (Figure 2-13c). Mutation of this tyrosine has been observed to result 
in an R configuration being set at the α-carbon of an α-substituted substrate, suggesting 
that, in the absence of the tyrosine, the lysine is able to donate a proton from the opposite 
side of the polyketide substrate (Kwan et al., 2008). As shown in the mutagenesis results 
presented here, the lysine serves a key role even when the tyrosine is present, possibly 
lowering the pKa of the tyrosine hydroxyl group so that it may readily donate a proton to 
the substrate. We have also observed the reduction of 2-methylbut-2-enoyl-pantetheine 
by SpnER2; how stereocontrol is enforced by the ERs of modular PKSs on this substrate 
is under investigation. 
 The structures of the monomeric thioesterase from the mammalian FAS and the 
dimeric thioesterase from multimodular PKSs revealed that structural differences exist 
between these related megasynthases (Tsai et al., 2008; Chakravarty et al., 2004). The 
monomeric state of SpnER2 also speaks to the divergent evolution of multimodular PKSs 
and mammalian FASs. Their common ancestor most likely had a dimeric ER; however, 
when some PKSs evolved so that a single polypeptide contained multiple modules, 
disruption of the ER dimer interface may have been necessary to enable the ACPs, 
restricted by a dimeric element immediately downstream, to access each of their cognate 
enzymes. The DH dimer interface within a multimodular PKS is quite different from that 
of the mammalian FAS; as with an evolutionary transition to a monomeric ER, a more 




their cognate enzymes (Keatinge-Clay, 2008; Akey et al., 2010). No structural 
information is available for how a DH domain in a multimodular PKS structurally 
interacts with KR and ER; the presence of DH could result in KR and ER adopting an 
interface different from that observed in the Spn(KR+ER)2 crystal structure. The 
homodimeric oligomerization state of the nucleotide-binding subdomain of the ER from 
phthiocerol synthase PpsC seems to argue against an evolutionary transition to 
monomeric ERs within multimodular PKSs (PDB code 1PQW; the interface is equivalent 
to that of the ER in the mammalian FAS) (Pedelacq et al., 2011). However, PpsC is more 
related to mammalian FASs on a sequence level than modules from multimodular 
PKSs—the C-terminal linker as well as the sequence surrounding βF are very similar to 
that of the mammalian FAS (Figures 2-13b, 2-6, 2-7, and 2-8) (Maier et al., 2008). 
Perhaps the architecture of some monomodular PKSs such as PpsC resembles that of the 
mammalian FASs more than that of the modules of multimodular PKSs. 
 Models of complete PKS modules have been constructed on the basis of the 
structure of the mammalian FAS (Khosla et al., 2007; Maier et al., 2008). However, the 
KR-ER interface observed in Spn(KR+ER)2, the short C-terminal linker between ER and 
KR, the altered tertiary structure of the MDR dimerization region and the flattened 
architecture of the DH dimer of multimodular PKSs indicate that the three-dimensional 
organization of the processing enzymes of multimodular PKSs is quite different from that 
of the mammalian FAS (Figures 2-2, 2-6, 2-7, 2-8, 2-9, and 2-10) (Keatinge-Clay, 2008; 
Maier et al., 2008). Indeed, the two-fold axis of a multimodular PKS does not contain 




restricted by ~20-residue linkers to KR and a downstream dimeric element, require this 
space to access enzymes from the same module (the mammalian FAS and some 
monomodular PKSs do not encounter this geometric problem because their ACPs are not 
C-terminally linked to a dimeric domain). Thus, we propose that within multimodular 
PKSs the ‘reductive loop’ comprises a dimeric DH, two monomeric KRs and two 
monomeric ERs, thereby granting the ACPs more freedom to access cognate enzymes 
and preserving the two-fold symmetry of the synthase (Figure 2-17). Although the 
crystal structure of a complete PKS module remains elusive, the structural and functional 
dissection of its component enzymes provides insights into the architectures and 
mechanisms of these complex megasynthases. 
MATERIALS AND METHODS 
Cloning, expression, and purification 
 Domain boundaries from previous KR structures guided the selection of the first 
and last residues of the Spn(KR+ER)2 didomain (SpnB residues 1216-1989) (Waldron et 
al., 2001). The DNA encoding Spn(KR+ER)2 was amplified using primers 5'- 
ATCGTAATCCATATGGCTCGGTTGTACCGGTTGAG-3' and 5'- 
TGATTCGATGAATTCACAACCGTTTCCGGAGGCTCT-3' (NdeI and EcoRI sites in 
italics; stop codon underlined) from Saccharopolyspora spinosa genomic DNA 
(extracted from S. spinosa using the DNeasy Blood & Tissue Kit from Qiagen), digested 
with NdeI and EcoRI, and ligated into pET28b (Novagen). The DNA encoding the 





TGATTCGATGAATTCACACCGGAGGCATGGTGAGCA-3' and ligated into pET28b 
(Novagen) as described above. Reverse PCR was used to remove the ER domain from 
the Spn(KR+ER)2 didomain construct using 5'-phosphorylated primers 5'-
CCTCCGGTGTGGGACGCCGCAGGCACGGTTCTGGTTAC-3' and 5'-
CCCGGTGCCGTCCGGCACGGGCAGGACGTCATCGCT-3'. E. coli BL21(DE3) 
transformed with the expression plasmid was inoculated into LB media containing 50 
mg/L kanamycin at 37 °C, grown to OD600 = 0.4, and induced with 0.5 mM IPTG. After 
12 h at 15 °C, cells were collected by centrifugation and resuspended in lysis buffer (300 
mM NaCl, 50 mM HEPES, pH 7.5). Following sonication, cell debris was removed by 
centrifugation (30,000 x g for 45 min). The supernatant was poured over a column of 
Nickel-NTA resin (Qiagen), which was then washed with 50 mL lysis buffer containing 
15 mM imidazole and eluted with 5 mL lysis buffer containing 300 mM imidazole. 
Proteins were further purified using a Superdex 200 gel filtration column (GE Healthcare 
Life Sciences) equilibrated with 150 mM NaCl, 10 mM HEPES, pH 7.5. Spn(KR+ER)2 
was concentrated to 24 mg/mL in 25 mM NaCl, 1 mM DTT, 10 mM HEPES, pH 7.5. 
Selenomethionine-labeled Spn(KR+ER)2 was obtained by the pathway inhibition method 
(Keatinge-Clay & Stroud, 2006). Briefly, BL21(DE3) cells were grown in M9 minimal 
media containing 4 g/L glucose, 6 g/L Na2HPO4, 3 g/L KH2PO4, 1 g/L NH4Cl, 0.5 g/L 
NaCl, 1 mM MgSO4, 0.1 mM CaCl2, and 50 mg/L kanamycin at 37 °C. Lysine, 
phenylalanine, threonine (each at 100 mg/L), isoleucine, leucine, valine (each at 50 




minutes at 37 °C, 0.5 mM IPTG was added, and the cells were induced for 16 hours at 15 
ºC. The purification followed the protocol described for the native protein.  
Site-directed mutagenesis 
 The GeneTailor Site-Directed Mutagenesis System (Invitrogen) was used to 
generate all the mutants (verified by sequencing). Purification of the point mutants 
followed the protocol described for the wild-type protein. The following oligonucleotides 







Size-exclusion chromatography  
 Each sample (0.3 mL; 69 μM Spn(KR+ER)2; 132 μM SpnER2; 75 μM SpnKR2) 
was injected onto a Superdex 200 gel-filtration column equilibrated with 150 mM NaCl, 
10 mM sodium phosphate, pH 7.4. The molecular weight was estimated by comparison 
with standards (Gel Filtration Standard, Biorad Laboratories) as previously described 




Analytical ultracentrifugation  
 All sedimentation experiments were performed with a Beckman Optima XL-I at 
the Center for Analytical Ultracentrifugation of Macromolecular Assemblies at the 
University of Texas Health Science Center at San Antonio (UTHSCSA). Sedimentation 
velocity data were analyzed with the UltraScan-II software version 9.93. All calculations 
were performed on the Lonestar and Ranger clusters at the Texas Advanced Computing 
Center at the University of Texas at Austin, and on the Jacinto cluster at the 
Bioinformatics Core Facility at UTHSCSA. All measurements were made at 280 nm in a 
buffer containing 150 mM NaCl, 10 mM sodium phosphate, pH 7.4. The experimental 
data were collected at 20 °C and at 50 krpm using standard Epon 2-channel centerpieces. 
Hydrodynamic corrections for buffer density, viscosity, and partial specific volume were 
made according to methods implemented in UltraScan (Otwinowski et al., 1997). The 
partial specific volumes of Spn(KR+ER)2, SpnER2, and SpnKR2 were determined to be 
0.737 cm3/g, 0.736 cm3/g, and 0.735 cm3/g, respectively. All data were first analyzed by 
2-dimensional spectrum analysis (2DSA) with simultaneous removal of time- and radial-
invariant noise and fitting of the meniscus position, followed by van Holde-Weischet 
analysis and genetic algorithm (GA) refinement, followed by Monte Carlo analysis (MC) 
(Brookes et al., 2009; Demeler & Brooks, 2008). Each protein was measured at 280 nm 
at three loading concentrations (Spn(KR+ER)2, 1.2 μM, 4.1 μM, and 12.0 μM; SpnER2, 




Crystallization and structure determination  
 Crystals of Spn(KR+ER)2 grew over one week by sitting drop vapor diffusion at 
22 °C. Drops were formed by mixing 2 μL protein solution (24 mg/mL Spn(KR+ER)2 in 
25 mM NaCl, 1 mM DTT, 10 mM HEPES, pH 7.5) with 1 μL crystallization buffer (17% 
(w/v) poly(acrylic acid) 5100, 0.4 M MgSO4, 0.1 M HEPES, pH 6.5). Crystals were 
frozen in liquid nitrogen. Three data sets (peak, inflection, and remote) from a crystal of 
selenomethionine-labeled Spn(KR+ER)2 were collected at ALS Beamline 5.0.2 and 
processed by HKL2000 (Otwinowski & Minor, 2007). The structure was solved to 3.40 
Å resolution by multiwavelength anomalous dispersion phasing using the program 
Phenix (Adams et al., 2010). The program Molrep fit the resulting electron density map 
with AmpKR2 (PDB Code: 3MJS) and the ER from the porcine FAS (PDB Code: 
2ZV8), and the solutions were combined to obtain the model of two Spn(KR+ER)2 
molecules in the asymmetric unit (Potterton et al., 2003; Maier et al., 2008; Zheng et al., 
2010). A 3.0 Å-resolution data set collected from a crystal of native Spn(KR+ER)2 at 
ALS Beamline 8.2.1 was used to iteratively build and refine the model through the 
programs Coot and Refmac5 (Potterton et al., 2003; Emsley & Cowtan, 2004).  
SAXS data collection and analysis  
 Spn(KR+ER)2 was exchanged by gel filtration chromatography (Superdex 200) 
into 10% glycerol, 500 mM NaCl, 50mM (NH4)2SO4, and 30 mM HEPES, pH 7.5. SAXS 
data were collected at 5 °C on a Rigaku BioSAXS-1000 (Kratky camera, with a 2.5kW 




BioSAXS facility of the University of Texas Medical Branch at Galveston. A dilution 
series showed no difference between a 10 mg/mL and a 5 mg/mL sample; therefore, a 
sample concentration of 10 mg/mL was used for data collection. Five 30-minute 
exposures were collected. Radiation-induced aggregation effects slowly developed in the 
low-q regime (q<1.3/Rg); however, the scattering curves of all samples converged beyond 
this point, permitting all of the curves to be included in the averaging for the high-q 
regime (q>1.3/Rg). Five more 30-minute data collections were performed, each with fresh 
sample. Using the SAXSLab software (Rigaku), the high-q regions of these ten 
collections were averaged, and the low q-regime of the last five collections were also 
averaged. The high- and low-q curves were merged together and scattering from the 
buffer alone was subtracted (seven 30-minute scans were collected on the buffer alone) 
with the program PRIMUS (Konarev et al., 2003). The resulting SAXS curve was used 
for subsequent analysis. The radius of gyration (Rg) and I(0) were evaluated using the 
Guinier approximation (0.0223 Å
-1
 < q < 0.0437 Å
-1
). The program GNOM was used to 
obtain the distance distribution function, P(r), and to determine the value for the Rg from 
the entire scattering profile (Svergun, 1992). Good agreement of Rg(Guinier) and 
Rg(GNOM) indicated the internal consistency of the data (Putnam et al., 2007). A 
molecular weight of 81 kDa was calculated from the SAXS curve using the invariant 
Kratky integral method (Fischer et al., 2010). The program CRYSOL predicted the 
scattering curves from two models (one model of Spn(KR+ER)2 based on its crystal 
structure and one model of Spn(KR+ER)2 based on the superposition of SpnKR2 and 




experimentally-obtained SAXS curve (Svergun et al., 1995). Ab initio envelopes were 
generated by the program DAMMIF (Franke & Svergun, 2009). A developmental version 
of the pmb_dammif script within the Protein Model Builder (PMB) package was used to 
generate fifty envelopes, which were averaged and filtered with the program DAMAVER 
(Volkov & Svergun, 2003). The resulting consensus envelope was then aligned and fit to 
each model using the program SUPCOMB (Kozin & Svergun, 2000).  
Substrate synthesis  
 Pantethine (278 mg, 0.5 mmol, 1 eq.) was incubated with DTT (77 mg, 0.5 mmol, 
1 eq.) in 1 mL water and stirred for 1 hour at room temperature. The water was removed 
under vacuum, and the clear oil was resuspended in THF (8 mL) and triethylamine (2 
mL). Dimethylaminopyridine (6 mg, 0.05 mmol, 0.1 eq.) was added, and the solution was 
stirred on ice. Chilled crotonyl chloride (50 μL, 55 mg, 0.525 mmol, 1.05 eq.) was added, 
and the reaction was stirred for one hour. The reaction was allowed to warm to room 
temperature and was stirred for another hour. Solvent was removed under vacuum, and 
the remaining orange residue was resuspended in 50% ethyl acetate/acetone. Using the 
same solvent system as a mobile phase, crotonyl-pantetheine was purified by silica gel 
chromatography. Fractions containing crotonyl-pantetheine (Rf = 0.30, silica TLC plate, 
EtOAc) were dried under vacuum; the clear residue was resuspended in water and the 
solution was frozen until needed.  
Crotonyl-pantetheine. Electrospray ionization mass spectrometry (ESI-MS), expected 




[M+Na]+, 369.4). A Varian 400-MHz DirectDrive instrument was used to obtain NMR 
spectra. 
1
H NMR (D2O, 400 MHz) δ 7.05-6.95 (dq, 1H, J=15.53, 6.91); 6.29-6.24 (dq, 
1H, J=15.53, 1.68); 3.95 (s, 1H); 3.51-3.32 (m); 3.07 (t, 2H, J=6.30); 2.44 (t, 2H, J=6.49); 
1.87 (dd, 3H, J=6.88, 1.69); 0.89 (s, 3H); 0.85 (s, 3H). These peaks match those 
previously reported (Gomes et al., 1991).  
HPLC and LC/MS characterization of Spn(KR+ER)2 functional assays  
 To assay the activity of isolated Spn(KR+ER)2 and its point mutants, the 
following reaction was initiated: 40 μM Spn(KR+ER)2, 2 mM crotonyl-pantetheine, 1 
mM NADP
+
, 150 mM glucose, 3 μM glucose dehydrogenase, 12% (v/v) glycerol, 150 
mM HEPES, pH 7.0. After 48 hours, the reaction was injected on a C18 reversed-phase 
HPLC column, and monitored at 235 nm (100% water to 100% MeOH, 30 min.). For 
LC/MS analysis, an Agilent Technologies system (1200 Series HPLC, 6130 quadrupole 
mass spectrometer) was employed; a gradient of 5-95% B (solvent A, water with 0.1% 
formic acid; solvent B, acetonitrile with 0.1% formic acid) was run using a Gemini C18 
column (5 μm, 2 x 50 mm) over 12 min. at a flow rate of 0.7 mL/min. Both the crotonyl-
pantetheine substrate and the butyryl-pantetheine product have been previously 
synthesized and characterized (Gomes et al., 1991; Tran et al., 2008).  
Kinetic assays  
 A kinetic model derived from standard Michaelis–Menten kinetics was employed 





Each reaction was performed in duplicate (50 μL reaction volume: 2.5-160 mM crotonyl-
pantetheine, 1 mM NADPH, 20 μM enzyme, 10% glycerol, 100 mM NaCl, 100 mM 
HEPES, pH 7.5 at 22 ºC). The consumption of NADPH was monitored at 340 nm, and 
readings were corrected for the nonenzymatic consumption of NADPH. Initial velocities 
were plotted against substrate concentration and fit to the kinetic model to obtain Km and 
kcat(R) using the program Prism. To compare the hydration/reduction activities of SpnER 
and its point mutants the ratio of hydrated to reduced product generated by each SpnER2 
mutant was compared to that of SpnER2. Reactions were stopped through the addition of 
an equal volume of methanol and analyzed by LC/MS (after removing precipitated 
protein by centrifugation). Extracted ion chromatograms for the hydration product (365.2 
Da) and the reduction product (349.2 Da) were used to obtain the peak areas for the 
hydrated and reduced products, respectively.  
ACKNOWLEDGEMENTS 
 We thank A.F. Monzingo for helping with in-house diffraction experiments and 




Beamlines 8.2.1 and 5.0.2. Financial support was provided by Welch Foundation Grant 
F-1712 (A.T.K.-C.) as well as the Sealy and Smith Foundation grant to the Sealy Center 
for Structural Biology and Molecular Biophysics (M.A.W.). The development of the 
UltraScan software is supported by the US National Institutes of Health through grant 
RR022200 (B.D.). Supercomputer time allocations were provided through the US 
National Science Foundation grant TG-MCB070038 (B.D.). We acknowledge the support 
of the San Antonio Cancer Institute grant P30 CA054174 for the Center for Analytical 
Ultracentrifugation of Macromolecular Assemblies at the University of Texas Health 

























Figure 2-1. A complete module from the spinosyn PKS. (a) Domain composition of the 
second module of the spinosyn PKS (SpnMod2) and location of the Spn(KR+ER)2 
didomain (approximate sequence scale). KS, ketosynthase; AT, acyltransferase; KRs, 
ketoreductase structural subdomain; ER, enoylreductase; KRc, ketoreductase catalytic 
subdomain; ACP, acyl carrier protein. (b) The processing enzymes of SpnMod2 reduce 
the carbon indicated by an asterisk in the polyketide intermediate to a methylene group 
that appears in the spinosyn products. (c) The complex polyketides spinosyn A and 










Figure 2-2. KR and ER architecture. (a) The crystal structure of Spn(KR+ER)2 shows 
the interface between the structural and catalytic subdomains of its KR (KRs and KRc, 
respectively) and ER, which is mostly formed by hydrophilic residues. The N- and C-
terminal linkers help mediate the interface, Trp506 inserting into a hydrophobic pocket of 
KRc. (b) The structure of the porcine FAS shows a very different interface between its 
KR and ER and how ER dimerizes across the two-fold axis of the FAS. The C-terminal 
linker is longer than that of Spn(KR+ER)2 (29 versus 8 residues). KS, ketosynthase; 
MAT, malonyl/acetyl-CoA transacylase; MT, methyltransferase. (c) SAXS data were 
obtained for Spn(KR+ER)2 and compared to the theoretical curves predicted by the 
program CRYSOL for a model generated from the Spn(KR+ER)2 crystal structure (red 
curve) and for a model generated by superposing SpnKR2 and SpnER2 on the KR and 
ER from the porcine FAS (blue curve). I and II refer to the orientations shown in panel d. 
(d) An ab initio molecular envelope was calculated from the SAXS curve (by the 
program DAMMIF), which was much better fit by the model generated from the 
Spn(KR+ER)2 crystal structure than the model generated by superposing SpnKR2 and 












Figure 2-3. Comparison of the two Spn(KR+ER)2 molecules in the asymmetric unit. (a) 
The superposition of the Spn(KR+ER)2 didomains shows their near-identical 
conformations (0.6 Å Cα r.m.s.d.). (b) The B-factors of ER in Molecule A are elevated 
compared to those of ER in Molecule B (96 Å
2
 vs. 62 Å
2
) (B-factors are indicated on a 








Figure 2-4. Domain-swapped, C-terminal segment. (a) Within the asymmetric unit, a 
KR/KR interface is formed between the two Spn(KR+ER)2 molecules. (b) The 2Fo-Fc 
electron density map (contoured at 1.7 σ) shows the ionic interactions between arginines, 
NADP
+
 molecules, and a sulfate at the pseudo-twofold axis of the asymmetric unit. (c) 
The 60 residues from the adjacent Spn(KR+ER)2 molecule are colored in grey. The 
positions of the swapped residues are as expected from related KR structures. (d) The 
2Fo-Fc electron density map (contoured at 1.7 σ) shows the well-ordered hinge loop 
(terminology from domain-swapping literature) that spans the Spn(KR+ER)2 molecules. 
The lid helix on the left and the tryptophans on the right are located within separate 














Figure 2-5. The KR/ER interface. (a) A stereodiagram shows interactions between 
several hydrophilic residues at interface between ER and the catalytic subdomain of KR. 
(b) A stereodiagram of the 2Fo-Fc electron density map (contoured at 1.0 σ) around these 













Figure 2-6. ER orientation and the C-terminal linker. (a) A stereodiagram shows that 
when SpnKR2 and SpnER2 are superposed on the KR and ER domains of the porcine 
FAS that SpnER2 is in an orientation ~180° from that observed in the Spn(KR+ER)2 
crystal structure. (b) A stereodiagram suggests that Spn(KR+ER)2 cannot be in the FAS 
orientation since the C-terminal linker is not long enough to span the distance between 
ER and the catalytic subdomain of KR (the asterisks would need to connect). The 
insertion of W506 (middle of C-terminal linker) into a hydrophobic pocket of KR 
effectively reduces the length of the linker from 8 to 3 residues. (c) A stereodiagram 
illustrates the well-resolved electron density (2Fo-Fc, contoured at 1.7 σ) from the C-
terminal linker of Spn(KR+ER)2. (d) A sequence alignment shows the conservation of 
the ~29-residue linker of FASs and the conservation of the 8-residue linker of polyketide 
synthases. GenBank accession numbers: Mouse (Mus musculus), NP_032014; Rat 
(Rattus norvegicus), AAA41145; Human (Homo sapiens), NP_004095; Goat (Capra 
hircus), ABI95140; Cow (Bos taurus), NP_001012687; Horse (Equus caballus), 
XP_001491342; Dog (Canus lupus familiaris), XP_540497; Pig (Sus scrofa), 
NP_001093400; Chicken (Gallus gallus), NP_990486; Frog (Xenopus tropicalis), 
XP_002937357; ConMod9 (module 9 of the concanamycin PKS from Streptomyces 
neyagawensis), AAG23265; RapMod13 (module 13 of the rapamycin PKS from 
Streptomyces hygroscopicus), CAA60462; HbmMod1 (module 1 of the herbimycin PKS 
from Streptomyces hygroscopicus), AAY28225; AmpMod16 (module 16 of the 
amphotericin PKS from Streptomyces nodosus), AAK73502; EryMod4 (module 4 of the 
erythromycin PKS from Saccharopolyspora erythraea), AAV51821; MegMod4 (module 
4 of the megalomicin PKS from Micromonospora megalomicea), AAG13918, LanMod4 
(module 4 of the lankamycin PKS from Streptomyces avermitilis), TylMod5 (module 5 of 
the tylosin PKS from Streptomyces fradiae), AAB66506; OlmMod10 (module 10 of the 
oligomycin PKS from Streptomyces avermitilis), BAC70603; SpnMod2 (module 2 of the 



































Figure 2-7. Sequence alignment of KR+ER didomains from multimodular PKSs. The 
secondary structure shown above the alignment is from Spn(KR+ER)2. The N- and C-
terminal linkers connecting KR and ER are underlined in orange and yellow, 
respectively. The residues at the KR/ER interface are labeled “+”. Active site residues of 
KR are labeled “*”. The GGVGMA sequence motif of ER for NADPH binding is labeled 
“@”. The TGGTG sequence motif of KR for NADPH binding is labeled “^”. The 
conserved K360 and R375 that form salt bridges with the NADPH ribose phosphate are 
labeled “#”. D405 and R426, which help orient αF, are labeled “$”. The ER active site 
residues are labeled “%”. The aligned KR+ER didomain sequences are named by their 
corresponding PKS and module of origin. GenBank accession numbers: SpnKE2 
(module 2 of spinosyn PKS), AAG23265; TylKE5 (module 5 of tylosin PKS), 
AAB66506; AmpKE16 (module 16 of amphotericin PKS), AAK73502; EryKE4 (module 
4 of amphotericin PKS), CAM00064; MegKE4 (module 4 of megalomicin PKS), 
AAG13918; LanKE4 (module 4 of lankamycin PKS), BAC76492; OlmKE10 (module 10 
of oligomycin PKS), BAC70603; OlmKE7 (module 7 of oligomycin PKS), BAC70608; 
ConKE9 (module 9 of concanamycin PKS), AAZ94389; RapKE1 (module 1 of 
rapamycin PKS), CAA60460; RapKE13 (module 13 of rapamycin PKS), CAA60462; 





























Figure 2-8. Sequence alignments of regions within ERs of mammalian FASs and PpsC. 
The top alignment shows the N-terminal linkers connecting KR and ER (underlined in 
orange). The bottom alignment shows the region mediating ER dimerization and the 
close sequence similarity of PpsC to the mammalian FASs (compare with the sequences 
surrounding βF in the multimodular PKSs in Figure 2-7). ER active site residues are 
labeled by asterisks. GenBank accession numbers: Porcine (Sus scrofa), NP_001093400; 
Bovine (Bos taurus), Q71SP7; Mouse (Mus musculus), P19096; Rat (Rattus norvegicus), 
P12785; Human (Homo sapiens), P49327; Chick (Gallus gallus), P12276; PpsCKE 












Figure 2-9. SAXS analysis of Spn(KR+ER)2. (a) The SAXS experimental scattering 
data is compared to a curve predicted by the program CRYSOL from a model of 
Spn(KR+ER)2 based on its crystal structure. The green line labelled “Fit” indicates the 
discrepancy between the SAXS data and the CRYSOL-predicted curve. The low 
discrepancy score indicates a good fit. An ab initio molecular envelope was also 
predicted by the program DAMMIF, and the Spn(KR+ER)2 model was fit to this 
envelope by the program SUPCOMB. (b) The curve predicted by CRYSOL from a 
model generated by superposing SpnKR2 and SpnER2 on the KR and ER domains of the 
porcine FAS is quite different from the experimental scattering data, as indicated by the 
high discrepancy score. This model does not fit the ab initio molecular envelope well. 
The experimental radius of gyration (Rg) determined from the Guinier plot and the 
program GNOM were also much closer to Rg predicted by CRYSOL for the model based 











Figure 2-10. Molecular weight estimation by size-exclusion chromatography. SpnER2 
migrates at ~40 kDa (expected monomer mass: 36 kDa), SpnKR2 migrates at ~60 kDa 
(expected monomer mass: 51 kDa), and Spn(KR+ER)2 migrates at ~90 kDa (expected 
monomer mass: 83 kDa) compared to standards (running buffer: 150 mM NaCl, 10 mM 
sodium phosphate, pH 7.4). Domain-swapping does not occur in solution since 
dimerization was not observed with an injection of 345 μM Spn(KR+ER)2 (purple trace); 
supplementing the running buffer with 0.1 mM NADP
+
 and pre-incubating 345 μM 
Spn(KR+ER)2 with 5 mM NADP
+


























Figure 2-11. Sedimentation velocity analysis of Spn(KR+ER)2, SpnER2, and SpnKR2. 
(a-c) On the right side are the combined van Holde-Weischet integral S-value 
distributions of three loading concentrations measured at 280 nm (a, right, 
Spn(KR+ER2): black: 1.2 μM, white: 4.1 μM, and gray: 12.0 μM; b, right, SpnER2: 
black: 3.0 μM, white: 10.5 μM, and gray: 31 μM; c, right, SpnKR2: black: 2.5 μM, white: 
7.5 μM, and gray: 23 μM). On the left side the combined genetic algorithm-Monte Carlo 
analysis of each protein is shown. All proteins have frictional ratios less than 1.5 and 
display one major species. The van Holde-Weischet analysis clearly shows no change in 
sedimentation coefficient and partial concentration upon change in loading concentration, 
indicating that in this concentration range there is no reversible association occurring and 
more than 80% of the sample corresponds to the monomeric form of each protein. (d) 
Molecular weights determined by the genetic algorithm analysis unambiguously show 
monomer only. Lower and higher molecular weight species are only minor contaminants 
































Figure 2-12. SpnKR2 close-up. (a) Superposition of SpnKR2 (blue), AmpKR2 (green), 
EryKR1 (yellow), and TylKR1 (grey). (b) A simulated annealing Fo-Fc omit map 
(contoured at 3.0 σ) shows NADP
+
 bound at the SpnKR2 active site next to the catalytic 
tyrosine, lysine, serine, and asparagine. (c) The interactions between the lid helix (from 
the adjacent molecule in the asymmetric unit) and the Leu-Asp-Asp motif. Of particular 
note is the salt bridge formed between the nearly invariant arginine (Arg701) and the 













Figure 2-13. The structure of SpnER2. (a) SpnER2 is an MDR enzyme comprising a 
substrate-binding domain (residues 190–307 and 448–501) and a nucleotide-binding 
subdomain (residues 308–447). (b) A superposition of SpnER2 (green) and the ER from 
the porcine FAS (cyan) shows the different organization of the region surrounding βF, 
which usually forms the dimerization interface in MDR enzymes. (c) Conserved SpnER2 
active site residues form specific interactions with a bound NADP
+
 molecule. Next to 
where the 4-pro-R hydride of NADPH would be positioned during the reduction reaction 
(indicated by an asterisk) are the lysine and aspartate implicated in catalysis as well as a 







Figure 2-14. SpnER close-up. (a) A stereodiagram shows the 2Fo-Fc electron density 
map (contoured at 1.0 σ) surrounding helices in the region usually employed by MDR 
enzymes for dimerization. (b) A simulated annealing Fo-Fc omit map (contoured at 2.5 σ) 
of NADP
+
 bound at the SpnER2 active site. (c) The substrate binding tunnel (residues 




















Figure 2-15. Functional analysis of SpnER2. SpnER2 reduces the α,β-unsaturated 
substrate analog crotonyl-pantetheine. To determine the relative contributions of SpnER2 
active site residues to catalysis, three Spn(KR+ER)2 mutants were generated. Unmutated 
Spn(KR+ER)2 and each of the point mutants were incubated with crotonyl-pantetheine 
for 2 d before analysis by reversed-phase HPLC. The negative control (red) does not 
contain Spn(KR+ER)2. Unmutated Spn(KR+ER)2 (dark blue) completely converts 
crotonyl-pantetheine to butyryl-pantetheine. D444A (yellow) and Y241F (green) mutants 
are still active, whereas the K422A mutant (cyan) was much less so, revealing the 
importance of the lysine in catalysis. Each reaction contains trace impurities (filled 
circles). Reactions with ER mutants generate larger quantities of a byproduct (asterisk) 
with a mass equivalent to that of β-hydroxybutyryl-pantetheine. Details are in Figures 2-
















Figure 2-16. Characterization of ER reactions by mass spectrometry. (a-c) The crotonyl-
pantetheine substrate, the butyryl-pantetheine product, and a side product that has the 















Figure 2-17. Synthase schematic. (a) The structure of the mammalian FAS revealed that 
the ketosynthase (KS), DH and ER comprise the dimer interface. (b) The data presented 
here indicate that the ERs of multimodular PKSs are monomeric and loop out from the 
two-fold axis. ACPs from a complete module of a multimodular PKS access all of the 
enzymes within that module as well as a downstream dimeric KS or dimeric thioesterase 
(TE). Already restrained by the short peptide that joins them to the downstream KS or 
TE, ACPs would be prevented from accessing their cognate enzymes by a dimeric ER. In 
the illustrated mycolactone multimodular PKS, the ACPs of the complete second module 
can access each of their cognate enzymes because ER is looped out. Artwork was 
reproduced with permission from N. Ban (Maier et al., 2008). MAT, malonyl/acetyl-CoA 




















Table 2-2. Steady-state kinetic parameters for reduction of crotonyl-pantetheine by 































































Chapter 3. Structure and stereospecificity of the dehydratase domain 
from the terminal module of the rifamycin polyketide synthase 
 
ABSTRACT 
RifDH10, the dehydratase domain from the terminal module of the rifamycin 
polyketide synthase, catalyzes the stereospecific syn dehydration of the model substrate 
(2S,3S)-2-methyl-3-hydroxypentanoyl-RifACP10, resulting in the exclusive formation of 
(E)-2-methyl-2-pentenoyl-Rif-ACP10. RifDH10 does not dehydrate any of the other 
three diastereomeric, RifACP10-bound, diketide thioester substrates. On the other hand, 
when EryACP6, from the sixth module of the erythromycin polyketide synthase, is 
substituted for RifACP10, RifDH10 stereospecifically dehydrates only (2R,3R)-2-methyl-
3-hydroxypentanoyl-EryACP6 to give exclusively (E)-2-methyl-2-pentenoyl-EryACP6, 
with no detectable dehydration of any of the other three diastereomeric, EryACP6-bound, 
diketides. An identical alteration in substrate diastereospecificity was observed for the 
corresponding N-acetylcysteamine or pantetheine thioester analogues, regardless of acyl 
chain length or substitution pattern. Incubation of (2RS)-2-methyl-3-ketopentanoyl-
RifACP10 with the didomain reductase-dehydratase RifKR10-RifDH10 yielded (E)-2-
methyl-2-pentenoyl-RifACP10, the expected product of syn dehydration of (2S,3S)-2-
methyl-3-hydroxypentanoyl-RifACP10, while incubation with the corresponding 
EryACP6-bound substrate, (2RS)-2-methyl-3-ketopentanoyl-EryACP6, gave only the 
reduction product (2S,3S)-2-methyl-3-hydroxypentanoyl-EryACP6 with no detectable 
Chapter 3 was adapted from the following published work: Gay D, You YO, Keatinge-Clay AT, and Cane 
DE. (2013) Structure and stereospecificity of the dehydratase domain from the terminal module of the 
rifamycin polyketide synthase. Biochemistry 52, 8916−8928. Each author contributed to the experimental 




dehydration. These results establish the intrinsic syn dehydration stereochemistry and 
substrate diastereoselectivity of RifDH10 and highlight the critical role of the natural 
RifACP10 domain in chaperoning the proper recognition and processing of the natural 
ACP-bound undecaketide substrate. The 1.82 Å-resolution structure of RifDH10 reveals 
the atomic-resolution details of the active site and allows modeling of the syn 
dehydration of the (2S,3S)-2-methyl-3-hydroxyacyl-RifACP10 substrate. These results 
suggest that generation of the characteristic cis double bond of the rifamycins occurs after 
formation of the full-length RifACP10-bound acyclic trans-unsaturated undecaketide 
intermediate, most likely during the subsequent macrolactamization catalyzed by the 
amide synthase RifF. 
INTRODUCTION 
Polyketides make up an enormously diverse group of microbial natural products, 
many of which are important antibacterial, antifungal, immunosuppressive, and 
anticancer agents. The multimodular polyketide synthases (PKSs) that assemble complex 
polyketides are structurally and mechanistically related to the metazoan fatty acid 
synthases (FASs) (Smith & Tsai, 2007; Sherman & Smith, 2006; Cane, 2010). While 
FASs condense two-carbon acetate units and reduce newly formed β-ketoacyl groups in 
an iterative fashion, multimodular PKSs exploit an assembly line logic in which 5−25 
modules (sets of enzymes similar to those in an FAS) each perform a decarboxylative 
chain-elongation reaction that adds successive malonyl, methylmalonyl, or ethylmalonyl 




oxidation level and stereochemistry of the substituents attached to the α- and β-positions 
of the newly extended chain.  
Type I PKS modules contain at least three independently folded catalytic 
domains: (1) an acyltransferase (AT) that selects a unique malonyl-, methylmalonyl-, or 
ethylmalonyl-CoA chain extender from the cellular acyl-CoA pool, (2) an acyl carrier 
protein (ACP) that acquires the extender unit from the AT through a flexible, 18 Å 
phosphopantetheine arm, and (3) a β-ketoacyl-ACP synthase [ketosynthase (KS)] that 
catalyzes the decarboxylative chain-elongation reaction between a growing polyketide 
transferred to the KS by the upstream module and the ACP-tethered α-carboxyacyl 
extender unit (the closely related trans-AT PKS modules lack an integrated AT domain) 
(Piel, 2010). Most modules also contain one or more processing domains, such as a 
ketoreductase (KR) that stereoselectively catalyzes the NADPH-dependent reduction of 
the β-keto group and can stereospecifically set the configuration of a neighboring α-
substituent, a dehydratase (DH) that eliminates the resulting β-hydroxyl group as well as 
an α-proton to form an α,β-enoyl double bond, and an enoylreductase (ER) that catalyzes 
the stereoselective, NADPH-dependent reduction of the double bond. During polyketide 
assembly, growing chains remain covalently bound through a thioester linkage either to 
the phosphopantetheinyl thiol of an ACP or, transiently, to the active site cysteine residue 
of the KS domain, with the relatively mobile ACP domains shuttling the attached 
substrates among processing domains and to downstream modules. In most PKSs, the 




thioesterase (TE) domain located at the C-terminal end of the ultimate module in the 
synthase, resulting in either macrolactonization or hydrolysis.  
The vast majority of the more than 2000 known complex polyketides contain one 
or more double bonds, most of which have trans (E) geometry. A minor but nonetheless 
significant fraction of complex polyketides also harbor one or more cis (Z) double bonds 
(Figure 3-1). How these cis double bonds are installed in polyketides such as the protein 
phosphatase inhibitors fostriecin (Lewy et al., 2002; Kong et al., 2013) and 
phoslactomycin (Palaniappan et al., 2008), the anti-angiogenic agent borrelidin (Olano et 
al., 2004), the microtubule stabilizer epothilone (Tang et al., 2000), the microtubule 
polymerization inhibitor curacin A, (Akey et al., 2010) and the rifamycin family of 
antibacterials (Schupp et al., 1998; August et al., 1998; Tang et al., 1998) remains largely 
unknown. Reynolds and co-workers have recently established that Plm1, the first module 
of the phoslactomycin PKS, most likely produces cis-3-cyclohexylpropenoate and that 
the PlmKR1 domain generates a (3S)-hydroxyacyl thioester intermediate that serves as 
the substrate for the PlmDH1 domain (Alhamadsheh et al., 2007; Bonnett et al., 2013).  
The ansamycin antibiotic rifamycin B (Figure 3-2) is produced by the 
actinomycete Amycolatopsis mediterranei. The semisynthetic derivatives rifapentine, 
rifampicin, and rifabutin inhibit the RNA polymerase of mycobacteria and are clinically 
prescribed to tuberculosis patients, with rifampicin listed by the World Health 
Organization as one of the five essential antituberculosis drugs (World Health 
Organization, 2010). Rifamycins are distinguished from the more common macrolide and 




aminonaphthoquinone, a macrolactam ring, and a trisubstituted cis double bond 
(Hertweck, 2009). The rifamycin biosynthetic gene cluster harbors a 10-module PKS that 
extends a 3-amino-5-hydroxybenzoate (AHBA) starter unit with two acetates and eight 
propionates (Schupp et al., 1998; August et al., 1998; Tang et al., 1998). The rifamycin 
PKS lacks the typical TE domain fused to terminal module 10. Instead, release of the 
fully processed, RifACP10-bound undecaketide is catalyzed by the separately encoded 
amide synthase, RifF. Although two research teams have independently reported that 
mutation or deletion of rifF leads to release of acyclic 2-methyl-2-enoyl undecaketides, 
these investigators reached contradictory conclusions regarding the geometry of the 15,16 
double bond (rifamycin numbering) of this abortive product (Stratmann et al., 1999; Yu 
et al., 1999; Floss et al., 1999). The geometry of the double bond in the fully processed 
RifACP10-undecaketide intermediate produced by the rifamycin PKS, which serves as 
the actual substrate for cyclization by amide synthase RifF, therefore remains unsettled, 
nor is it known whether RifDH10 itself or the cyclase RifF sets the characteristic cis 
double bond geometry of the rifamycins (Figure 3-2).  
Neither sequence nor structural alignments have revealed any features that 
correlate DH protein sequence with the trans or cis geometry of the double bond in the 
resultant product (Keatinge-Clay, 2008). For example, the active site of EryDH4, which 
catalyzes the formation of a trisubstituted trans (E) double bond (Donadio et al., 1993; 
Valenzano et al., 2010) is structurally equivalent to that established for the DH domains 
of curacin PKS subunits CurF and CurH, one of which is thought to generate a cis double 




often paired with KR domains that produce (3R)-hydroxyacyl products. Such KR 
domains are readily recognized by their characteristic amino acid sequence fingerprints 
(Reid et al., 2003; Caffrey, 2003; Keatinge-Clay, 2007; Castonguay et al., 2008). On the 
other hand, there is only limited circumstantial evidence correlating KR domains that 
generate (3S)-hydroxyacyl intermediates with the generation of cis double bonds by their 
paired DH domains (Keatinge-Clay, 2008). For example, KR domains may provide (3S)-
hydroxyacyl substrates for the DH domains of modules 2 and 3 of the fostriecin PKS that 
generate cis double bond diketide and triketide intermediates (Kong et al., 2013), as well 
as for the DH domains of modules 1 and 2 of the phoslactomycin PKS (Alhamadsheh et 
al., 2007; Bonnett et al., 2013; Palaniappen et al., 2003), module 4 of the epothilone PKS 
(Tang et al., 2004), the CurG module of the curacin PKS (Akey et al., 2010), and module 
10 of the rifamycin PKS (Schupp et al., 1998; August et al., 1998; Tang et al., 1998). 
Whether modules that contain both an A-type KR and a DH actually generate cis double 
bonds, however, is still largely untested, except in the case of phoslactomycin module 1 
mentioned above (Alhamadsheh et al., 2007; Bonnett et al., 2013). As a further 
complication, the formation of some cis double bonds can involve post-PKS 
transformations such as dehydration (Palaniappan et al., 2008) or double-bond 
isomerization (Vergnolle et al., 2011).  
We have recently established that RifKR10, the KR domain from module 10 of 
the rifamycin PKS, and RifKR7 from module 7 of the same PKS each mediate the 
stereospecific epimerization and/or reduction of (2R)-2-methyl-3-ketoacyl-ACP 




2013). The RifKR10-generated product must serve as the substrate for the paired 
dehydratase domain of module 10, RifDH10. Although the 3S configuration of this 3-
hydroxyacyl substrate might superficially suggest the formation of a cis-2-methyl-2-
enoyl-ACP product, this geometry cannot be generated by syn dehydration of a (2S,3S)-
2-methyl-3-hydroxyacyl intermediate. In fact, all DH domains that have been 
stereochemically characterized to date, including EryDH4 from the erythromycin 
synthase (Valenzano et al., 2010), NanDH2 from the nanchangmycin synthase (Guo et 
al., 2010), and TylDH2 from the tylactone synthase (Castonguay et al., 2008), display 
strict specificity for the diastereomeric (2R,3R)-2-methyl-3-hydroxyacyl-ACP substrates 
and catalyze completely stereospecific syn dehydration to give the corresponding trans-
(E)-2-methyl-2-enoyl-ACP products. In light of not only its unusual substrate 
stereochemistry but also the uncertainty in the actual cis or trans geometry of its natural 
undecaketide product, the RifDH10-catalyzed dehydration reaction presents an intriguing 
and important mechanistic, stereochemical, and biosynthetic puzzle.  
We now report the expression and purification of the recombinant RifDH10 
domain, the determination of its protein structure to 1.82 Å resolution, and the 
demonstration that RifDH10 catalyzes the diastereospecific syn dehydration of (2S,3S)-2-
methyl-3-hydroxypentanoyl-RifACP10 to give exclusively the corresponding trans-(E)-
2-methyl-2-pentenoyl thioester product. Unexpectedly, the natural diastereospecificity of 
RifDH10 is reversed when the dehydratase is incubated with thioester substrates that are 
tethered to the noncognate ACP domain EryACP6 or to the corresponding pantetheinyl or 




only the diastereomeric (2R,3R)-2-methyl-3-hydroxypentanoyl thioesters to give the 
corresponding (E)-2-methyl-2-pentenoyl thioester products.  
RESULTS 
Expression and purification of RifDH10 and RifACP10 
To investigate the mechanism and structure of RifDH10, we used a synthetic gene 
with codons optimized for expression in E. coli to express the RifDH10 domain as a 
discrete recombinant protein corresponding to the region from A2569 to G2872 of RifE 
(EMBL AAC01714.1; UniProt entry O54593; residues herein numbered 1−304), based 
on alignment with the previously described stand-alone EryDH4 domain (Keatinge-Clay, 
2008; Valenzano et al., 2010) and flanked by the deduced C-terminal and N-terminal 
boundaries, respectively, of the RifAT10 and RifKR10 domains (August et al., 1998; 
Tang et al., 1998) (Figures 3-3 and 3-4). After ligation of the synthetic gene into pET28a 
and transformation into E. coli BL21(DE3), the expressed recombinant RifDH10 carrying 
an N-terminal His6 tag was purified by Ni(II) affinity chromatography and analyzed for 
purity and Mr by SDS−PAGE (Figure 3-5). Attempted expression of recombinant 
RifACP10 corresponding to the region from L3324 to L3409 of RifE, using a synthetic 
RifACP10 gene with codons optimized for expression in E. coli (Figure 3-6), gave only 
insoluble inclusion bodies. Instead, apo-RifACP10-NusA (hereafter simply termed apo-
RifACP10) could be obtained as a soluble fusion protein carrying an N-terminal His6 tag 
and a C-terminal NusA (De Marco, 2004). The resultant protein was readily purified by 




Stereochemistry of RifDH10-catalyzed dehydration of 2-methyl-3-hydroxyacyl-
RifACP10 
We have recently reported that (2S,3S)-2-methyl-3-hydroxypentanoyl-RifACP10 
(1a) can be prepared by stereospecific reduction of (2RS)-2-methyl-3-ketopentanoyl-
RifACP10 with either RifKR7 or RifKR10 in the presence of NADPH (Figure 3-7a and 
3-9) (You et al., 2013). The requisite RifACP10-bound 3-keto acylthioester was 
generated in situ by chemoenzymatic incubation of (2RS)-2-methyl-3-ketopentanoyl-
CoA with apo-RifACP10 and the phosphopantetheinyl transferase Sfp (You et al., 2013). 
Incubation of (2S,3S)-1a with RifDH10 gave as the exclusive dehydration product (E)-2-
methyl-2-pentenoyl-Rif-ACP10 (2), as established by enzymatic hydrolysis with PicTE, 
the thioesterase domain from the picromycin synthase, followed by GC−MS analysis and 
direct comparison of the derived (E)-2-methyl-2-pentenoate (3) with an authentic sample 
of 3, as well as with the isomeric (Z)-2-methyl-2-pentenoic acid (Figures 3-7a and 3-8) 
(Valenzano et al., 2010). Omission of RifDH10 resulted in exclusive formation of 
(2S,3S)-1a, as confirmed by PicTE-catalyzed hydrolysis and chiral GC−MS analysis of 
the derived methyl ester (2S,3S)-4a, which was identical in both retention time and mass 
spectrum by direct comparison with authentic 4a, as previously observed (Figure 3-9) 
(You et al., 2013). By contrast, incubations of RifDH10 under identical conditions with 
any of the chemoenzymatically prepared diastereomeric substrates, (2R,3R)-1b 
(TylKR1), (2R,3S)-1c (EryKR6), or (2S,3R)-1d (EryKR1) (Castonguay et al., 2008; 
Valenzano et al., 2009; Castonguay et al., 2007) resulted at most in generation of only 




(You et al., 2013) generation of minor amounts of contaminating (2S,3S)-1a by TylKR1 
and EryKR1 upon incubation with (2RS)-2-methyl-3-ketopentanoyl-RifACP10 (Figures 
3-10, 3-11, and 3-12).  
We have previously established that RifKR10 has a stereospecificity identical to 
that of RifKR7, reducing (2RS)-2-methyl-3-ketopentanoyl-RifACP10 to the 
corresponding (2S,3S)-2-methyl-3-hydroxypentanoyl-RifACP10 (1a) (You et al., 2013). 
To confirm that the observed stereochemistry of the coupled RifDH10-catalyzed 
dehydration reaction is not influenced by the origin of the 2S,3S-specific ketoreductase 
domain, we prepared a RifDH10-RifKR10 fusion protein. Incubation of 
Rif[DH10][KR10] with (2RS)-2-methyl-3-ketopentanoyl-Rif-ACP10 and NADPH gave 
(E)-2-methyl-2-pentenoyl-RifACP10 (2), as established by GC−MS analysis of the 
derived (E)-2-methyl-2-pentenoic acid (3) (Figures 3-7c and 3-13). Analysis of the 
methyl ester derived from the reduced diketide intermediate 1a confirmed the expected 
exclusive formation of (2S,3S)-4a.   
syn stereochemistry of RifDH10-catalyzed hydration of (E)-2-methyl-2-pentenoyl-
RifACP10 
In a complementary experiment, we also investigated the reverse RifDH10-
catalyzed hydration of (E)-2-methyl-2-pentenoyl-RifACP10 (2). Incubation of 
chemoenzymatically prepared (E)-2-methyl-2-pentenoyl-RifACP10 (2) resulted in 




RifACP10 (1a), as confirmed by PicTE hydrolysis, methylation, and chiral GC−MS 
detection of methyl (2S,3S)-4a (Figures 3-7b and 3-14). 
Stereochemistry of RifDH10-catalyzed dehydration of 2-methyl-3-hydroxyacyl 
thioester analogues 
Although these results are all congruent with the previously established 2S,3S 
stereospecificity of RifKR10 (You et al., 2013), which generates the natural substrate for 
RifDH10, the observed syn dehydration of a (2S,3S)-2-methyl-3-hydroxyacyl-ACP 
substrate by RifDH10 to give the corresponding (E)-2-methyl-2-enoylacyl-ACP product 
is biochemically unprecedented. Thus, all other mechanistically characterized DH 
domains catalyze syn dehydration of only the diastereomeric (2R,3R)-2-methyl-3-
hydroxyacyl-ACP substrates to give (E)-2-methyl-2-enoyl-ACP products (Valenzano et 
al., 2010; Guo et al., 2010), while a (3S)-hydroxyacyl intermediate has been implicated in 
the formation of a cis-enoyl thioester in the biosynthesis of phoslactomycin (although the 
overall stereochemistry of the latter dehydration has not been determined) (Bonnett et al., 
2013). To explore any influence of RifACP10 on the overall stereochemistry of the 
RifDH10-catalyzed reaction, we therefore also examined the stereospecificity of 
RifDH10-catalyzed dehydration of diketide thioester substrates that are covalently 
tethered to alternative thioester analogues of RifACP10. To our surprise, we found that 
replacement of RifACP10 with the heterologous EryACP6 domain, obtained from 
module 6 of the erythromycin PKS, resulted in an unexpected complete alteration of the 




stereospecificity of the dehydration reaction or the trans geometry of the resulting 
unsaturated product (Figure 3-15). Thus, although RifDH10 was unable to dehydrate 
chemoenzymatically prepared (2S,3S)-2-methyl-3-hydroxyacyl-EryACP6 (5a), as 
established by the TLC−phosphorimaging assay (Figure 3-16), RifDH10 did catalyze the 
syn dehydration of the diastereomeric anti-(2R,3R)-2-methyl-3-hydroxyacyl-EryACP6 
(5b), which could be generated in situ by coupled incubation of the Ery[KS6][AT6] 
didomain from module 6 of the erythromycin PKS, EryACP6, and TylKR1 (from module 
1 of the tylactone PKS) with propionyl-SNAC, methylmalonyl-CoA, and NADPH, as 
previously described (Valenzano et al., 2010; Castonguay et al., 2008; Valenzano et al., 
2009; Castonguay et al., 2007). The reaction gave exclusively (E)-2-methyl-2-pentenoyl-
EryACP6 (6), whose structure and stereochemistry were established by hydrolysis with 
0.5 M NaOH for 20 min at 65 °C and GC− MS analysis of the derived methyl ester 3 
(Figures 3-15a and 3-17). Similarly, an analogous incubation in which (2S,3R)-2-methyl-
3-hydroxypentanoyl-SNAC was substituted for propionyl-SNAC gave exclusively (E)-
(4R,5R)-2,4-dimethyl-5-hydroxy-2-heptenoyl-ACP6, as established by GC−MS analysis 
of the derived methyl ester (Figure 3-18). On the other hand, RifDH10 did not dehydrate 
either of the diastereomeric EryACP6-bound syn thioesters, (2R,3S)-5c or (2S,3R)-5d 
(Figure 3-15a and 3-16). RifDH10 also catalyzed the reverse syn hydration of (E)-2-
methyl-2-pentenoyl-EryACP6 (6), chemoenzymatically prepared in situ, as previously 
described (Valenzano et al., 2010) to give methyl (2R,3R)-2-methyl-3-hydroxypentanoyl-
EryACP6 (5b), whose structure and stereochemistry were established by PicTE catalyzed 




of the derived methyl ester (2R,3R)-4b with authentic standards of each of the four 
diastereomeric diketide methyl esters (Figure 3-15b and 3-19).  
A parallel series of incubations of RifDH10 with the corresponding pantetheine 
and NAC thioesters also resulted in syn dehydration and hydration of only the anomalous 
(2R,3R)-2-methyl-3-hydroxyacyl thioester diastereomers and their corresponding (E)-2-
methyl-2-enoylacyl thioesters (Figure 3-15c, 3-20, 3-21, 3-22, 3-23, 3-24, 3-25, and 3-
26). Thus, incubation of RifDH10 with (2R,3R)-2-methyl-3-hydroxypentanoyl-S-
pantetheine (7b), prepared by diastereospecific reduction of (2RS)-2-methyl-3-
ketopentanoyl-S-pantetheine with TylKR1 (Keatinge-Clay, 2007; Piasecki et al., 2011; 
Siskos et al., 2005) and a coupled enzymatic NADPH regenerating system (Piasecki et 
al., 2011), gave exclusively (E)-2-methyl-2-pentenoyl-S-pantetheinate (8), as established 
by HPLC analysis and direct comparison with authentic synthetic standards (Figures 3-
15c, 3-22, and 3-23). In agreement with this result, incubation of RifDH10 with (E)-2-
methyl-2-butenoyl-S-pantetheine (11) yielded exclusively the syn hydration product 
(2R,3R)-2-methyl-3-hydroxybutanoyl-Spantetheine (12b) (Figures 3-15d, 3-25, and 3-
27). The isomeric (Z)-2-methyl-2-butenoyl-S-pantetheine (13) did not undergo RifDH10-
catalyzed hydration. RifDH10 did not dehydrate diastereomeric diketide S-pantetheinate 
(2S,3S)-7a, (2R,3S)-7c, or (2R,3S)-2-methyl-3-hydroxypentanoyl-S-pantetheine (7d). 
Analogous results were also obtained using the corresponding NAC thioester analogues. 
Thus, RifDH10 catalyzed the syn dehydration of only (2R,3R)-2-methyl-3-
hydroxypentanoyl-S-NAC (9b) to give the corresponding (E)-2-methyl-2-pentenoyl-S-




and substitution pattern, observing that RifDH10 catalyzed the reversible dehydration of 
(3R)-hydroxybutanoyl-S-pantetheine (Figures 3-24 and 3-27) and the hydration of (E,E)-
2,4-hexadienoyl-Spantetheine (Figure 3-26).  
Incubation of the Rif[DH10][KR10] fusion protein with chemoenzymatically 
prepared (2RS)-2-methyl-3-ketopentanoyl-EryACP6 gave only the corresponding product 
of reduction by RifKR10, (2S,3S)-2-methyl-3-hydroxypentanoyl-EryACP6 (5a), with no 
detectable dehydration product, in contrast to the processing of the RifACP10-bound 
substrate, which resulted in both reduction and dehydration to give the corresponding 
(E)-2-methyl-3-pentenoyl-RifACP10 product, as described above. In a like manner, 
although Rif[DH1]-[KR10] produced alcohol (2S,3S)-5a by diastereospecific reduction of 
(2R)-2-methyl-3-ketopentanoyl-EryACP6, generated in situ by decarboxylative 
condensation of propionyl-S-NAC and methylmalonyl-CoA catalyzed by Ery[KS6][AT6] 
plus EryACP6, none of the corresponding dehydration product could be detected 
(Figures 3-7c and 3-28). 
Structure of RifDH10 
To improve our understanding of the protein structural basis for the dehydration 
reaction catalyzed by RifDH10, its structure was determined to 1.82 Å resolution (Figure 
3-29 and Table 3-1). RifDH10 is structurally highly homologous to the other previously 
determined DH domains, including EryDH4 and the four DH domains from CurF, CurH, 
CurJ, and CurK of the curacin PKS [PDB entries 3EL6, 3KG6, 3KG7, 3KG8, and 3KG9, 




respectively] (Akey et al., 2010; Keatinge-Clay, 2008). RifDH10 possesses a 
characteristic double-hotdog fold and dimerizes through an interface largely created by 
its ∼25 N-terminal residues (Figure 3-29a). The catalytic dyad, comprised of a histidine 
(H50) and an aspartic acid (D220), almost perfectly superimposes with the dyads of each 
of the other DH structures (Figure 3-29b). A hydrogen bonding network beginning with 
the phenolic hydroxyl of Y164 may increase the pKa of the active site aspartate, thereby 
allowing it to act as a general acid for the dehydration reaction. A similar hydrogen 
bonding network is conserved in five of the six known DH structures, which employ 
either a glutamine or histidine (H224 in RifDH10) to bridge the network between Y164 
and the catalytic aspartate. The exception is the CurH DH, in which an arginine occupies 
the corresponding site. 
DISCUSSION 
RifDH10 is only the second PKS DH domain for which both the protein structure 
and the stereospecificity of the dehydration reaction have been experimentally 
determined (Valenzano et al., 2010). Consistent with the high degree of similarity in 
overall protein architecture between RifDH10 and EryDH4, as well as the essentially 
identical relative positioning of their conserved active site histidine and aspartate 
residues, we have established that both dehydratases catalyze syn elimination of water to 
give trans-unsaturated, trisubstituted carboxylic acid thioesters. On the other hand, these 
two closely related dehydratases actually catalyze the dehydration of effectively 




reaction is believed to involve deprotonation of C2 of the substrate by the imidazole side 
chain of H50 that acts as the general base, with either stepwise or concerted elimination 
of water promoted by protonation of the C3 hydroxyl by the carboxylic acid side chain of 
D220 (Figure 3-29b). These conserved active site residues have been shown to be 
essential not only in EryDH4 (Bevitt et al., 1993) and in the dehydratase domain of 
animal FAS (Pasta et al., 2007) but also in the corresponding type II FabZ dehydratase 
proteins of bacterial fatty acid biosynthesis (Kimber et al., 2004). The topological 
relationship of the active site histidine and aspartate residues is consistent only with net 
syn elimination of water from the substrate. Crotonase (enoyl-CoA hydratase), a 
mechanistically closely related enzyme from the fatty acid β-oxidation pathway, although 
differing from PKS and FAS DH domains in both active site residues and overall protein 
structure, has also been shown to catalyze reversible concerted syn addition of water to 
trans-enoyl-CoA substrates (Agnihotri & Liu, 2003; Bahnson et al., 1991).  
In spite of all these mechanistic and structural similarities to other characterized 
DH domains, RifDH10 is unique in catalyzing the diastereospecific syn dehydration of a 
(2S,3S)-2-methyl-3-hydroxyacyl-RifACP10 substrate. This is in contrast to the 
demonstrated specificity of EryDH4, TylDH2, and NanDH2, all of which utilize only 
(2R,3R)-2-methyl-3-hydroxyacyl-ACP substrates, as well as the specificity of the DH 
domain of yeast FAS for (3R)-hydroxyacyl-ACP substrates (Sedgwick et al., 1978). 
Intriguingly, the intrinsic preference of RifDH10 for the (2S,3S)-2-methyl-3-hydroxyacyl 
thioesters is only evident when the substrate is tethered to its native acyl carrier protein, 




noncognate EryACP6 as well as the NAC and pantetheine thioester analogues is specific 
for the corresponding (2R,3R)-2-methyl-3-hydroxyacyl diastereomers, while in no case 
do either the (2R,3S)- or (2S,3R)-2-methyl-3-hydroxyacyl derivatives undergo 
dehydration. This reversal of substrate specificity is unprecedented. Although several 
EryKS domains have been shown to exhibit strong preferences for their cognate ACP 
domains in both intramodular condensation reactions and intermodular chain transfers 
(Kim et al., 2004; Kapur et al., 2012; Guo et al., 2012), and the stereoselectivity of KR-
catalyzed reductions can require or be enhanced by tethering of 3-ketoacyl thioester 
substrates to an ACP domain (Valenzano et al., 2009; Siskos et al., 2005), this is the first 
example of the complete reversal of the diastereospecificity of a biochemical reaction 
based on the nature of the thioester conjugate.  
Several interlocking lines of argument support the biosynthetic relevance of the 
observed strict preference for the RifACP10-linked, (2S,3S)-2-methyl-3-hydroxyacyl 
thioester substrate. (1) RifACP10 is derived from the same parent module of the 
rifamycin synthase as is RifDH10 and therefore must represent the native carrier for 
dehydration of the natural ACP-bound acyclic undecaketide substrate within Rif module 
10. (2) RifKR10, the paired KR domain that is also harbored in Rif module 10, generates 
exclusively the (2S,3S)-2-methyl-3-hydroxyacyl thioester, independent of the nature or 
origin of the attached ACP domain. Under natural conditions, therefore, RifDH10 should 
encounter only the (2S,3S)-2-methyl-3-hydroxyacyl undecaketide that will be tethered to 
RifACP10. (3) While most of the substrate analogues that have been tested in vitro with 




the observed stereospecificity of RifDH10. (4) It highly unlikely that the in vitro results 
are artifacts and that the natural reaction on the undecaketide substrate would generate a 
cis double bond on the basis of both the highly conserved active site geometry of 
RifDH10, including the precise positioning of the catalytic histidine and aspartate 
residues in a topology that has been shown to catalyze syn dehydration by several other 
DH domains, and the exclusive formation and rehydration of trans-α,β-unsaturated 
trisubstituted enoyl thioesters. (5) If these in vitro results were simply the spurious 
consequence of the use of a deconstructed in vitro enzyme system, one would expect to 
see a simple degradation in overall diastereospecificity, rather than the observed complete 
reversal of the diastereospecificity that is cleanly correlated with the use of RifDH10 
within its natural context.  
The syn stereochemistry of the DH-catalyzed dehydration reaction is thus an 
intrinsic catalytic property that is rooted in the topological placement of the active site 
histidine and aspartate residues. This reaction stereochemistry should not be influenced 
by simple variations in the structure and stereochemistry of the substrate. While it is not 
unusual to observe degradation in substrate stereospecificity with the use of alternative 
substrates, to the best of our knowledge it is unprecedented to encounter a complete 
reversal in the apparent diastereospecificity that is a consequence of a change in the 
nature of the thioester conjugate. Although both the (2S,3S)- and (2R,3R)-2-methyl-3-
hydroxyacyl thioesters can be modeled into the RifDH10 active site, with productive 
alignments of both the syn-related C2 proton and the C3 hydroxyl group with the 




differently positioned in each case (Figure 3-30). While there is as yet no protein 
structure of a DH−ACP complex, several lines of evidence have supported the postulated 
existence of strong interactions between DH domains and their cognate ACP domains. 
Both pull-down and surface plasmon resonance experiments have shown a high affinity 
of the Helicobacter pylori ACP (HpACP) for the HpFabZ protein, with a Kd of 10 nM 
(Liu et al., 2007). Similarly, in silico protein ligand docking and molecular dynamics 
simulations have been used to model complexes involving specific interactions of 
EryDH4 and holo-EryACP4 (Anand & Mohanty, 2012). We surmise that substitution by 
the noncognate EryACP6, which has a sequence that is only 43% identical to that of 
RifACP10, or by the simpler NAC and pantetheine analogues results in the loss of critical 
RifDH10-RifACP10 interactions that are essential for the proper positioning of the 
tethered substrate within the active site, thereby permitting syn dehydration of the 
anomalously bound, diastereomeric (2R,3R)-2-methyl-3-hydroxyacyl thioester analogues.  
Our results strongly indicate that during the course of rifamycin biosynthesis the 
combined action of the RifKR10 and RifDH10 domains from the terminal module of the 
rifamycin PKS naturally generates an acyclic (E)-2-methyl-2-enoyl undecaketide. We 
therefore suggest that isomerization of the (E)-2,3-double bond of the initially formed 
RifACP10-bound undecaketide intermediate to the corresponding cis geometry that is 
characteristic of both the cyclized intermediate proansamycin X and the ultimately 
derived rifamycin B probably most likely occurs during the subsequent 




MATERIALS AND METHODS 
Isopropyl thio-β-D-galactopyranoside (IPTG) was purchased from Invitrogen. All 
other chemical reagents were purchased from Sigma-Aldrich and utilized without further 
purification. Ni-NTA affinity resin was purchased from Qiagen. Amicon Ultra 
Centrifugal Filter Units [Amicon Ultra-15, 30000 molecular weight cutoff (MWCO)] 
were purchased from Millipore. DNA primers were synthesized by Integrated DNA 
Technologies. Recombinant Ery[KS6][AT6], EryACP6, RifKR7, RifKR10, TylKR1, 
EryKR1, EryKR6, PicTE, and Sfp were each expressed and purified as previously 
described (You et al., 2013; Chen et al., 2006; Chen et al., 2007; Kim et al., 2004). 
Reference standards for chiral GC−MS analysis of methyl (2S,3S)-2-methyl-3-
hydroxypentanoate (4a), methyl (2R,3R)-2-methyl-3-hydroxypentanoate (4b), methyl 
(2R,3S)-2-methyl-3-hydroxypentanoate (4c), and methyl (2S,3R)-2-methyl-3-
hydroxypentanoate (4d) were each prepared synthetically or chemoenzymatically as 
previously described (You et al., 2013; Valenzano et al., 2009). (E)-2-Methyl-2-
pentenoic acid (3) was purchased from Sigma-Aldrich and used to prepare (Z)-2-methyl-
2-pentenoic acid as previously described (Valenzano et al., 2010). Propionyl-N-
acetylcysteamine thioester and (2S,3R)-2-methyl-3-hydroxypentanoyl-SNAC were 
prepared as described previously (Valenzano et al., 2009). The synthesis of acyl-S-NAC 
and acyl-S-pantetheine thioester substrates and products is described in the Supporting 
Information. (2RS)-2-Methyl-3-ketopentanoyl-CoA was prepared by L. Collett Pilcher as 
previously described (You et al., 2013; Wu et al., 2001; Haapalainen et al., 2007; 




chromatography (HPLC), and characterized by 
1
H nuclear magnetic resonance and 
electrospray ionization mass spectrometry (ESI-MS). Synthetic genes encoding 
recombinant domains RifDH10 and RifACP10, optimized for expression in Escherichia 
coli, were designed and prepared by DNA2.0 and supplied in vector pJ201.  
General methods were as previously described (Valenzano et al., 2009; Sambrook 
et al., 1989). Growth media and conditions used for E. coli and standard methods for 
handling E. coli in vivo and in vitro were those described previously, unless otherwise 
noted (Sambrook et al., 1989). All DNA manipulations were performed following 
standard procedures (Sambrook et al., 1989). DNA sequencing was conducted at the 
University of California Davis Sequencing Facility (Davis, CA). All proteins were 
handled at 4 °C unless otherwise stated. Protein concentrations were determined 
according to the method of Bradford (Bradford, 1976), using Hewlett-Packard 8452A 
Diode Array or Thermo Evolution Array UV−vis spectrophotometers with bovine serum 
albumin as the standard. Sodium dodecyl sulfate−polyacrylamide gel electrophoresis 
(SDS−PAGE) and DNA gels were imaged and analyzed with a Bio-Rad ChemiDoc MP 
System. A Bio-Rad FX-Pro Plus Molecular Imager was utilized for radio thin layer 
chromatography (TLC) analysis. GC−MS analysis was performed on a GC−MS Hewlett-
Packard Series 2 GC-MSD instrument (70 eV EI) in positive ion mode using a capillary 
CP-Chirasil-Dex CB column (25 m × 0.32 mm) from Agilent Technologies. For 
resolution and analysis of (E)-2-methyl-2-pentenoic acid (3) and (Z)-2-methyl-2-
pentenoic acid, three different programs were used: method 1, initial oven temperature of 




temperature of 50 °C for 1 min, increased to 200 °C at a rate of 15 °C/min; method 3, 
initial oven temperature of 65 °C for 1 min, increased to 100 °C at a rate of 0.5 °C/min 
and then to a final temperature of 200 °C at a rate of 20 °C/min. For resolution and 
analysis of the four diastereomers of methyl 2-methyl-3-hydroxypentanoate (4), the 
following program was used: method 4, initial oven temperature of 50 °C for 1 min, 
increased to 90 °C at a rate of 1 °C/min and then to 200 °C at a rate of 20 °C/min. A 
Thermo LXQ instrument equipped with a Surveyor HPLC system and Waters Symmetry 
C18 column (2.1 mm × 50 mm, 3.5 μm) was utilized for HPLC−ESI-MS analysis in 
positive ion mode.  
General cloning strategy 
The design of rifamycin module 10 domain boundaries for cloning of RifDH10, 
RifDH10-RifKR10, and RifACP10-NusA is described in the Supporting Information 
(Figures 3-3, 3-4, and 3-6). Synthetic genes encoding RifDH10, RifDH10-RifKR10, and 
RifACP10-NusA (De Marco, 2004), optimized for expression in E. coli and flanked by 
suitable restriction sites, were ligated into pET28a, and the resultant plasmids were used 
to transform the expression host E. coli BL21(DE3).  
RifDH10 expression and purification  
The synthetic gene for RifDH10, flanked by 5′-NdeI and 3′-XhoI sites, was 
ligated into pET28a. E. coli BL21(DE3) transformed with the RifDH10 expression 
plasmid was inoculated into Luria-Bertani medium containing 50 μg/L kanamycin at 37 




were collected by centrifugation and resuspended in lysis buffer [0.5 M NaCl, 10% (v/v) 
glycerol, and 0.1 M 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid (HEPES) 
(pH 7.5)]. Following sonication, cell debris was removed by centrifugation (30000g for 
30 min). The supernatant was poured over a column of nickel-NTA resin (Thermo 
Scientific), which was then washed with 50 mL of lysis buffer containing 15 mM 
imidazole and eluted with 5 mL of lysis buffer containing 150 mM imidazole. RifDH10 
was further purified using a Superdex 200 gel filtration column (GE Healthcare Life 
Sciences) equilibrated with 150 mM NaCl and 10 mM HEPES (pH 7.5). The eluted 
protein (∼100 mg of purified RifDH10 from 2 L of culture) was concentrated to 15 
mg/mL in the equilibration buffer and stored at −80 °C until the protein was needed. 
SDS−PAGE analysis of purified His6RifDH10 protein showed an Mr of 34900 (calcd 
molecular mass of 34109 Da) (Figure 3-5).  
Apo-RifACP10-NusA fusion protein 
The synthetic gene for RifACP10, flanked by 5′-NdeI and 3′-XhoI sites, was 
initially ligated into the NdeI and XhoI sites of pET28a. Because the resultant 
recombinant RifACP10 was obtained only as insoluble inclusion bodies when expressed 
in E. coli BL21(DE3), we constructed the corresponding RifACP10-NusA protein. The 
synthetic DNA encoding RifACP10 was amplified via polymerase chain reaction from 
the RifACP10 construct using the primer pair of pET28a-FP (5′-
ATGGGCAGCAGCCATCATCAT-3′) and RifACP10-EcoRI-RP [5′-




italics)]. The resultant amplified DNA was digested with NdeI and EcoRI and ligated into 
the previously described plasmid (You et al., 2013), RifKR10-NusA-pET28, that had 
been digested with NdeI and EcoRI to excise the DNA segment encoding RifKR10 and 
to replace it with DNA encoding RifACP10, thus giving apo-RifACP10-NusA-pET28 
that was used to transform E. coli BL21(DE3). Recombinant His6 tag-apo-RifACP10-
NusA, harboring an HRV 3C protease cleavage site between RifACP10 and the C-
terminal NusA, was expressed in soluble form by growth in Terrific Broth or in Super 
Broth until the OD600 reached 0.4−0.8. Protein expression was induced by addition of 
0.2 mM IPTG, and the cell culture was continuously grown for an additional 16− 18 h at 
18 °C overnight. The cells were harvested by centrifugation at 4200g for 20 min, and the 
cell pellet was collected and stored at −80 °C. The frozen cells were thawed at room 
temperature (RT) and dissolved and lysed on ice for 30 min in starting buffer [500 mM 
NaCl and 50 mM phosphate (pH 7.8)] containing 1 mg/mL lysozyme, followed by 
sonication. The cell supernatant and the pellet were separated by centrifugation at 23000g 
for 30 min, and the supernatant was loaded on a precharged Ni-NTA column. The 
column was washed with starting buffer and then washing buffer [300 mM NaCl, 50 mM 
phosphate (pH 7.6), and 10 mM imidazole], and proteins were eluted from the Ni column 
with elution buffer [150 mM NaCl, 50 mM phosphate (pH 7.5), 150 mM imidazole, and 
10% glycerol]. The eluted fractions were collected and concentrated with an Amicon 
MWCO 30000 filter, and buffer was exchanged with a PD-10 column with 150 mM 
NaCl, 50 mM phosphate (pH 7.5), and 10% glycerol, yielding ∼200 mg of His6 tag-apo-




RifACP10-NusA protein showed an Mr of 70900 (calcd molecular mass of 68955 Da) 
(Figure 3-5).  
RifDH10-KR10 fusion protein 
DNA encoding the synthetic gene for RifKR10 was amplified from the previously 
described expression construct (You et al., 2013) using the primer pair of RifKR10-NdeI-
BamHI-FP [5′-
ATTTTCGAATTACATATGATGAATTTTAAAGGATCCCTGTACCGCGTCGACTG
-3′ (NdeI site in bold and BamHI site in italics)] and pET-28a XhoI RP (5′-
TCGGGCTTTGTTAGCAGC-3′). The amplified DNA fragment was digested with NdeI 
and XhoI followed by ligation into the pET-28a vector to give RifKR10-NdeI-BamHI-
pET28a. DNA encoding RifDH10 was amplified from the expression construct described 
above using the primer pair of RifDH10-PAGA-BamHI-RP [5′-
TAATTCGAAAATGGATCCTGCACCCGCTGGACCCGCTGCAGTGGTC-3′ (BamHI 
site in italics)] and pET28a-FP (5′-ATGGGCAGCAGCCATCATCAT-3′) followed by 
DNA restriction by NdeI and BamHI. The resultant DNA fragment was ligated into NdeI 
and BamHI-digested plasmid RifKR10-NdeI-BamHI-pET28a. The His6 tag-RifDH10-
KR10 protein was expressed in E. coli BL21(DE3) and purified by the same procedures 
used to express the His6 tag-apo-RifACP10-NusA protein and then further purified by 
size exclusion chromatography, yielding 16 mg of partially purified His6 tag-




purified His6 tag-Rif[DH10][KR10] protein gave an Mr of 80100 (calcd molecular mass 
of 80150 Da) (Figure 3-5).  
Incubation of RifDH10 with (2S,3S)-2-methyl-3-hydroxypentanoyl-RifACP10-NusA  
A mixture of 500 μM (2RS)-2-methyl-3-ketopentanoyl-CoA, 40 μM Sfp 
(surfactin phosphopantetheinyl transferase) (Weinreb et al., 1998), and 400 μM apo-
RifACP10-NusA was added to reaction buffer [150 mM NaCl and 50 mM NaH2PO4 (pH 
7.2)] containing 20 mM MgCl2 and 4 mM DTT. After incubation at 37 °C for 1 h, 300 
μM RifKR7, 300 μM RifDH10, and 2 mM NADPH were added, and the mixture was 
incubated for an additional 1 h at RT. The final reaction volume was 500 μL. The 
RifACP10-NusA protein was hydrolytically released by incubation with 100 μM PicTE 
for 10 min at RT. The reaction mixtures were acidified with 1 M HCl to pH <3 and 
extracted with ethyl acetate. After solvent evaporation, the product was dissolved in 100 
μL of methanol and the unsaturated diketide was analyzed by chiral GC−MS and direct 
comparison with authentic standards of (E)-2-methyl-2-pentenoic acid and (Z)-2-methyl-
2-pentenoic acid, using both methods 1 and 2 (Figure 3-8) (Valenzano et al., 2010). In 
control experiments conducted in the absence of RifDH10, 20 μL of TMS-diazomethane 
was added to the hydrolyzed organic extract and the derived diketide methyl ester was 
analyzed by chiral GC−MS and direct comparison with authentic methyl (2S,3S)-2-
methyl-3-hydroxypentanoate, using method 4 (Figure 3-9). As previously reported, 
direct comparison with authentic standards 4a and 4b was essential because the observed 




elution never changed (You et al., 2013; Valenzano et al., 2009). Incubations with 
TylKR1, EryKR6, and EryKR1 in place of RifKR7 were also conducted to generate the 
corresponding RifACP10-bound intermediates (2R,3R)-1b, (2R,3S)-1c, and (2S,3R)-1d. 
The derived hydrolysis products were analyzed by GC−MS and direct comparison with 
authentic standards of each diastereomer of methyl 2-methyl-3-hydroxypentanoate (4a−d) 
(method 4) and both (E)-2-methyl-2-pentenoic acid (3) and (Z)-2-methyl-2-pentenoic 
acid (method 2), as described for the incubations using RifKR7 (Figures 3-10, 3-11, and 
3-12).  
Incubation of the recombinant RifDH10-RifKR10 didomain with 
chemoenzymatically generated (2RS)-2-methyl-3-ketopentanoyl-RifACP10 
A mixture of 500 μM (2RS)-2-methyl-3-ketopentanoyl-CoA, 40 μM Sfp, and 400 
μM apo-RifACP10-NusA was added to reaction buffer [150 mM NaCl and 50 mM 
NaH2PO4 (pH 7.2)] containing 20 mM MgCl2 and 4 mM DTT. After incubation at 37 °C 
for 1 h, 300 μM RifDH10-RifKR10 and 2 mM NADPH were added, and the mixture was 
incubated for an additional 1 h at RT. The final reaction volume of each assay was 500 
μL. The diketide acid was hydrolytically released from RifACP10-NusA by incubation 
with 100 μM PicTE for 10 min at RT. The reaction mixtures were acidified with 1 M HCl 
to pH <3 and extracted with ethyl acetate. After solvent evaporation, the product was 
dissolved in 100 μL of methanol and the formation of unsaturated (E)-2-methyl-2-
pentenoic acid was confirmed by GC−MS (method 2) and direct comparison with 




reduced diketide product, 20 μL of TMS-diazomethane was added and the derived 
diketide methyl ester, methyl (2S,3S)-2-methyl-3-hydroxypentanoate (4a), was identified 
by chiral GC−MS (method 4) and direct comparison with authentic standards (Figure 3-
13). 
 Incubation of recombinant RifDH10 with chemoenzymatically generated (E)-2-
methyl-2-pentenoyl-Rif-ACP10 and (E)-2-methylpentenoyl-EryACP6.  
A mixture of 500 μM (E)-2-methyl-2-pentenoyl-CoA, 40 μM Sfp, and either 400 
μM apo-RifACP10-NusA or 200 μM apo-EryACP6 was added to reaction buffer [150 
mM NaCl and 50 mM NaH2PO4 (pH 7.2)] containing 20 mM MgCl2 and 4 mM DTT. 
After incubation at 37 °C for 1 h, 300 μM RifDH10 was added and the mixture was 
incubated for an additional 1 h at RT. The final reaction volume of each assay was 500 
μL. The RifACP10-NusA or EryACP6 was hydrolytically released by incubation with 
100 μM PicTE for 10 min at RT. The reaction mixtures were acidified with 1 M HCl to 
pH <3 and extracted with ethyl acetate. After solvent evaporation, the product was 
dissolved in 100 μL of methanol and 20 μL of TMS-diazomethane was added. The 
derived diketide methyl esters were analyzed as described above by chiral GC−MS and 
direct comparison with authentic standards [Figure 3-14 (RifACP10) and Figure 3-19 
(EryACP6)]. In a control incubation without the added RifDH10 domain, the 
chemoenzymatically generated 2-methyl-2-pentenoyl-RifACP10-NusA was treated with 
HRV 3C protease to remove the C-terminal NusA and the molecular mass of the resulting 




observed value of 13144 Da (calcd for [M + H]+ ion of 2-methyl-2-pentenoyl-RifACP10, 
13143.9 Da) (Figure 3-31). LC−ESI(+)-MS was also used to confirm the formation of 2-
methyl-2-pentenoyl-ACP6 (6), with a molecular mass (observed) of 11728 Da (calcd 
11727.7 Da), compared to the peak for holo-eryACP6, with a molecular mass (observed) 
of 11632 Da (calcd 11631.6 Da), with the difference of 96 Da matching that expected for 
addition of the 2-methyl-2-pentenoyl moiety. Additional control incubations established 
that the isomeric (Z)-2-methylpentenoyl-EryACP6 was not a substrate for RifDH10.  
TLC−phosphorimaging assay of the incubation of recombinant RifDH10 with 
reconstituted Ery[KS6]-[AT6], EryACP6, and recombinant KR domains 
A radio-TLC assay of the conversion of propionyl-SNAC to 2-methyl-3-
hydroxypentanoic acids and 2-methyl-2-pentenoic acid by coupled incubation with 
reconstituted Ery[KS6][AT6] and EryACP6 in combination with EryKR6, TylKR1, 
EryKR1, or RifKR7 and RifDH10 was conducted as previously described (Valenzano et 
al., 2010; You et al., 2013; Valenzano et al., 2009). For each incubation, 5 mM 
propionyl-SNAC and 40 μM Ery[KS6][AT6] were added to reaction buffer [50 mM 
NaH2PO4 (pH 7.2)] containing 2.5 mM TCEP and the mixture was incubated at RT. After 
1 h, 200 μM holo-EryACP6, 300 μM methylmalonyl-CoA containing a trace amount of 
[2-14C]methylmalonyl-CoA, 2 mM NADPH, and individual KR domains (300 μM) with 
or without 300 μM RifDH10 were added to the reaction mixture, which was then 
incubated for an additional 1 h. The final reaction volume of each assay was 125 μL. The 




EryACP6 by addition of 0.5 M NaOH (40% by volume) followed by incubation at 65 °C 
for 20 min. After adjustment to pH <3 with 1 M HCl and extraction with ethyl acetate, 
the concentrated organic extracts were dissolved in 15 μL of ethyl acetate and spotted on 
a silica gel TLC plate, which was developed with a 1:9 dichloromethane/ ethyl acetate 
mixture containing 0.1% AcOH. The dried TLC plate was then visualized by 
phosphorimaging for 48 h (Figure 3-16).  
Incubation of recombinant RifDH10 or the RifDH10-RifKR10 didomain with 
reconstituted Ery[KS6][AT6], EryACP6, and TylKR1 
The incubation procedures for the in situ generation of (2R,3R)-2-methyl-3-
hydroxyacyl-EryACP6 derivatives were based on those previously described (You et al., 
2013; Valenzano et al., 2009). In a typical assay, 5 mM propionyl-SNAC or 5 mM 
(2S,3R)-2-methyl-3-hydroxypentanoyl-SNAC was preincubated with 40 μM 
Ery[KS6][AT6] in 50 mM NaH2PO4 (pH 7.2) containing 2.5 mM tris-2-
carboxyethylphosphine (TCEP) at RT. After 1 h, 200 μM holo-EryACP6, 300 μM 
methylmalonyl-CoA, 2 mM NADPH, 300 μM recombinant TylKR1, and 300 μM 
recombinant RifDH10 were added to the reaction mixture, which was then incubated for 
an additional 1 h (Figure 3-17). In a second experiment, 300 μM Rif[DH10][KR10] 
didomain was added instead of the TylKR1 and RifDH10 pair (Figure 3-28). The final 
reaction volume of each assay was 500 μL. The reaction was quenched, and EryACP6 
was hydrolytically released from the product by addition of 0.5 M NaOH (40% by 




released by incubation with 100 μM PicTE for 10 min at RT. The reaction mixtures were 
acidified with 1 M HCl to pH <3 and then extracted with ethyl acetate. After solvent 
evaporation, the product was dissolved in 100 μL of ethyl acetate or methanol and 
analyzed by chiral GC−MS (method 3) (Figures 3-17 and 3-28). TMS-diazomethane (20 
μL) was added to convert recovered 2-methyl-3-hydroxypentanoates to the derived 2-
methyl-3-hydroxypentanoate methyl esters that were analyzed by chiral GC−MS and 
direct comparison with synthetic standards (method 4) (Valenzano et al., 2009). For the 
GC−MS analysis of methyl (2E,4R,5R)-2,4-dimethyl-5-hydroxy-2-heptenoate, the 
temperature program of method 3 was used (Figure 3-18).  
Incubation of RifDH10 with acyl-S-NAC or pantetheine thioesters 
RifDH10 (30 μM) was incubated overnight with each of the chemoenzymatically 
prepared 2-methyl-3-hydroxyacyl or 2,3-unsaturated enoyl-S-NAC or pantetheine 
thioester analogues (at 10 mM) in a 25 μL solution containing 150 mM NaCl, 10% (v/v) 
glycerol, and 150 mM HEPES (pH 7.5). After 16 h, the reaction mixture was injected 
onto a C18 reversed-phase HPLC column and monitored over a range of λ values of 
200−600 nm (100% water with 0.1% TFA to 100% MeOH with 0.1% TFA, over 30 
min). All products were characterized by mass spectrometry and comparison with 





RifDH10-catalyzed dehydration of (2R,3R)-2-methyl-3-hydroxybutanoyl-S-
pantetheine and subsequent acyl transthioesterification to NAC.  
trans-2-Methyl-2-butenoyl-S-pantetheine (11) (20 mg) was incubated overnight in 
150 mM NaCl, 150 mM HEPES (pH 7.5), 10% (v/v) glycerol, and 1 mg/mL RifDH10 in 
a total volume of 1 mL at 22 °C. After 16 h, the reaction mixture was injected onto a C18 
reversed-phase HPLC column and monitored over a range of λ values of 200− 600 nm 
(100% water with 0.1% TFA to 100% MeOH with 0.1% TFA, over 15 min). A peak that 
was not observed in a control reaction without RifDH10 with a λmax of 232 nm was 
collected and concentrated. The concentrated fractions yielded 5 mg of the hydrated 
product, (2R,3R)-2-methyl-3-hydroxybutanoyl-S-pantetheine (12b). To confirm its 
stereochemistry, 3 mg of (2R,3R)-2-methyl-3-hydroxybutanoyl-S-pantetheine (12b) was 
resuspended in 5 mL of 50 mM NaHCO3 (aqueous) and 50 mM NAC and stirred 
overnight. The reaction mixture was injected onto a C18 reversed-phase HPLC column 
and monitored at a range of λ values of 200−600 nm (100% water with 0.1% TFA to 
100% MeOH with 0.1% TFA, over 15 min). A peak that was not observed in a control 
reaction without NAC with a λmax of 232 nm was collected and concentrated. The 
compound ran in a manner identical to that of authentic (2R,3R)-2-methyl-3-
hydroxybutanoyl-S-NAC (9b) on a ChiralCel OC-H column (250 mm × 4.6 mm) on a 
Beckman Coulter HPLC system equipped with a 20 μL loop with an isocratic flow rate of 
0.6 mL/min using a 1:24 mixture of ethanol and hexanes as the mobile phase (Figure 3-




Synthetic standards, prepared as previously described, were provided by S. Piasecki 
(Piasecki et al., 2011).  
Crystallization and structure determination 
Crystals of RifDH10 grew over a period of 2 days to 1 week by sitting drop vapor 
diffusion at 22 °C. Drops were formed by mixing 3 μL of a protein solution [15 mg/mL 
RifDH10, 150 mM NaCl, and 10 mM HEPES (pH 7.5)] with 1 μL of crystallization 
buffer [1.1 M sodium citrate and 0.1 M HEPES (pH 6.8)]. Crystals were soaked briefly in 
crystallization buffer with 15% (v/v) glycerol before being frozen in liquid nitrogen. The 
diffraction data, collected at ALS beamline 5.0.2, were processed with iMosflm and 
scaled with SCALA from the CCP4 suite (Collaborative Computational Project Number 
4, 1994). The structure was determined to 1.82 Å resolution by molecular replacement 
with PhaserMR (McCoy et al., 2007) using EryDH4 [Protein Data Bank (PDB) entry 
3EL6] as the search model (Keatinge-Clay, 2008). The model generated from the 
molecular replacement solution was refined with Coot (Emsley et al., 2010) and Refmac5 
(Murshudov et al., 1997). Aside from the N- and C-termini, only loop residues 232−242 
were not shown in the electron density maps.  
NMR and LC-MS characterization of S-pantetheine esters 
 1
H NMR analysis of S-pantetheine esters was performed on a Varian Mercury 400 
MHz instrument. LC-MS was performed on an Agilent Technologies 1200 Series HPLC 
with a Gemini C18 column (5 μm, 2 × 50 mm; Phenomenex) coupled to an Agilent 




ionization source. A 5–95% B gradient over 12 min at a flow rate of 0.7 mL/min was run 
in which the mobile phases were (A) H2O with 0.1% formic acid and (B) acetonitrile with 
0.1% formic acid. 
 N-Acetylcysteamine (NAC), Meldrum’s acid derivatives, the methylketene dimer, 
(2RS)-2-methyl-3-ketobutanoyl-S-NAC, (2RS)-2-methyl-3-ketopentanoyl-S-NAC, and 
(3R)-3-hydroxypentanoyl-S-NAC were synthesized as previously reported (Piasecki et 
al., 2011), as was trans-2-butenoyl-S-pantetheine (Zheng et al., 2012).  
(2RS)-2-methyl-3-ketopentanoyl-S-pantetheine 
 Sodium borohydride (80 mg, 16 eq.) was added to 94 mg D-pantethine (1 eq.) 
dissolved in 5 mL 80:20 MeOH:0.25 M NaHCO3 (aq.) over 20 min at 22 °C. After 1 h, 
the reaction was quenched by adding glacial acetic acid dropwise until bubbling ceased 
and then was buffered with 250 mM HEPES (pH 7.5). 11.2 mg (1.4 eq.) of methylketene 
dimer was added to the solution at 22 °C. After 1 h, the reaction was evaporated and salts 
were removed using a plug of silica gel (2% MeOH:dichloromethane).  
(2RS)-2-Methyl-3-ketopentanoyl-S-pantetheine: 
1
H NMR (400 MHz, D2O): 0.71 (s, 3H), 
0.74 (s, 3H), 0.81-0.88 (t, 3H, J = 8 Hz), 1.20-1.25 (d, 3H, J = 8 Hz), 2.28-2.33 (m, 2H) 
2.51-2.58 (q, 2H, J = 8 Hz), 2.90-2.97 (t, 2H, J = 7.2 Hz), 3.20-3.26 (m, 2H), 3.30-3.40 
(m, 2H), 3.40-3.45 (m, 2H), 3.81 (s, 1H), 4.00-4.05 (q, 1H, J = 8 Hz). ESI-MS expected 






pantetheine, and (2S,3S)-2-methyl-3-hydroxypentanoyl-S-pantetheine 
 Each of the stereoisomers of 2-methyl-3-hydroxypentanoyl-S-pantetheine was 
prepared from the incubation of (2RS)-2-methyl-3-ketopentanoyl-S-pantetheine with 
various recombinant KR domains that have been shown to stereospecifically reduce the 
corresponding NAC-bound compounds (TylKR1, AmpKR2, EryKR1, and AmpKR1, 
respectively).
1
 Reduction reactions were carried out in 10% (v/v) glycerol, 150 mM 
HEPES (pH 7.5), 100 mM NaCl, 200 mM D-glucose, 500 μM NADP
+
, 10 μM KR, 1 μM 
GDH (cloned from Bacillus subtilis), and 2-10 mM (2RS)-2-methyl-3-ketopentanoyl-S-
pantetheine in a total volume of 200 μL for 24 h at 22 °C. The reaction was monitored by 
TLC, and the reduction product was purified by silica gel chromatography with 1:1 ethyl 
acetate:acetone. 
trans-2-methyl-2-butenoyl-S-pantetheine (11) 
 D-pantethine (1 mL of 0.5 M aq. soln) was reduced to D-pantetheine by addition 
of 75 mg DTT (1 eq.) and stirring for 1 h at 22 °C. Water was removed by vacuum to 
leave a clear, viscous liquid that was resuspended in 10 mL DCM. trans-2-Methyl-2-
butenoic acid (100 mg, 2.1 eq.) (TCI Chemicals), 150 mg EDC (2.0 eq.) (Alfa Aesar), 
and 15 mg DMAP (0.25 eq.) (Acros Organics) were dissolved in 2 mL DCM and added 
to the pantetheine solution. The reaction was stirred at 0 °C for 1 h and 22 °C for an 




was purified by silica gel chromatography with 1:1 ethyl acetate:acetone. trans-2-Methyl-
2-butenoyl-S-pantetheine (11): 
1
H NMR (400 MHz, D2
1.66-1.70 (m, 6H), 2.29 (t, 3H, J = 6.5 Hz), 2.91 (t, 3H, J = 6.5 Hz), 3.20-3.36 (m, 8H), 
3.81 (s, 1H), 6.80 (qq, 1H, J1 = 1.0 Hz, J2 = 6.6 Hz). 
3R-hydroxybutanoyl-S-pantetheine  
 RifDH10 (30 μM) was incubated with 10 mM trans-2-butenoyl-S-pantetheine in a 
1 mL solution containing 150 mM NaCl, 10% (v/v) glycerol, 150 mM HEPES pH 7.5. 
After 24 h, the reaction was injected on a C18 reversed-phase HPLC column (100% water 
with 0.1% TFA to 100% MeOH with 0.1% TFA, 30 min), and the peak corresponding to 
the hydrated species was collected and concentrated under vacuum.  
3R-Hydroxybutanoyl-S-pantetheine: 
1
H NMR (400 MHz, D2
3H), 1.05 (d, 3H, J = 6.4 Hz), 2.29 (t, 3H, J = 6.5 Hz), 2.63 (d, 2H, J = 6.4 Hz), 2.89 (td, 
2H, J1 = 2.2 Hz, J2 = 6.3 Hz), 3.21 (m, 3H), 3.32 (m, 3H) 3.46 (d, 1H, J = 4.4 Hz), 3.48 
(d, 1H, J = 4.4 Hz), 3.81 (s, 1H), 4.09 (h, 1H, J = 6.5 Hz). 
(2R,3R)-2-methyl-3-hydroxybutanoyl-S-pantetheine (12b) 
 Prepared in the same manner as 3R-hydroxybutanoyl-S-pantetheine, substituting 
trans-2-methyl-2-butenoyl-S-pantetheine for trans-2-butenoyl-S-pantetheine.  
(2R,3R)-2-Methyl-3-hydroxybutanoyl-S-pantetheine (12b): 
1
H NMR (400 MHz, D2O)  
0.71 (s, 3H), 0.74 (s, 3H), 0.96 (d, 3H, J = 7.1 Hz), 1.04 (d, 3H, 6.3 Hz), 2.29 (t, 3H, J = 





 Prepared similarly to trans-2-butenoyl-S-pantetheine, substituting 100 mg of cis-
2-methyl-2-butenoic acid (TCI Chemicals) for trans-2-methyl-2-butenoic acid. cis-2-
Methyl-2-butenoyl-S-pantetheine (13): 
1
H NMR (400 MHz, CDCl3)  0.95 (s, 3H), 1.06 
(s, 3H), 1.28 (t, 3H, J = 7.1 Hz), 1.96 (dq, 3H, J1 = 1.7 Hz, J2 = 7.3 Hz), 2.02 (t, 3H, J = 
2.0 Hz), 2.44 (t, 2H, J = 6.3 Hz), 3.11 (q, 2H, J = 6.7 Hz), 3.49-3.65 (m, 4H), 4.01 (d, 1H, 
J = 4.8 Hz), 4.14 (q, 3H, J = 7.4 Hz), 5.93 (qq, 1H, J1 = 2.4 Hz, J2 = 7.8 Hz). 
trans,trans-2,4-hexadienoyl-S-pantetheine 
trans,trans-2,4-Hexadienoic acid (1.0 g, Alfa Aesar) was stirred in 5 mL oxalyl 
chloride at 22 °C under a flow of nitrogen gas. After the oxalyl chloride had evaporated, 
reduced D-pantetheine (see synthesis of trans-2-methyl-2-butenoyl-S-pantetheine for D-
pantethine reduction protocol) dissolved in 8.5 mL DCM and 1.5 mL TEA was added to 
the activated acid, and set to stir at 0 °C for 1 h, followed by quenching with 2 mL 
methanol. The reaction was washed with brine and all solvent was removed under 
vacuum, leaving a viscous liquid that was purified by silica gel chromatography with 1:1 
ethyl acetate:acetone.  
trans,trans-2,4-Hexadienoyl-S-pantetheine: 
1
H NMR (400 MHz, D2O): 0.71 (s, 3H), 0.74 
(s, 3H), 1.12 (t, 1H, J = 7.3 Hz), 1.71 (d, 2H, 6.6), 2.29 (t, 3H, J = 6.5 Hz), 2.96 (t, 3H, J 
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Figure 3-2. RifDH10 dehydrates a RifACP10-bound (2S,3S)-2-methyl-3-hydroxyacyl 
undecaketide generated by the paired ketoreductase domain RifKR10 in the terminal 
module 10 of the rifamycin PKS. The amide synthase RifF catalyzes the 
macrolactamization of the acyclic undecaketide product to the rifamycin B precursor, 
















Figure 3-3. Rifamycin PKS partial module 9 and module 10. Rifamycin polyketide 









































N-terminus: CATATG (NdeI site) 
C-terminus: TAACTCGAG (Stop codon/XhoI) 
 
Figure 3-4. RifDH10 amino acid sequence. The synthetic gene encoding RifDH10 
domain was subcloned in the pET-28a vector and the recombinant protein was expressed 
with a N-terminal His6-tag in E.coli BL21(DE3). Protein expression and purification 



















































N-terminus: CATATG (NdeI site) 
 
Figure 3-6. RifACP10 amino acid sequence. The synthetic gene encoding RifACP10 was 
initially ligated into the NdeI/XhoI sites of pET-28a. Since the resultant recombinant 
RifACP10 was obtained only as insoluble inclusion bodies when expressed in E.coli 




































Figure 3-7. RifDH10-catalyzed dehydration/hydration of RifACP10-bound substrates. 
(a) Dehydration of (2S,3S)-2-methyl-3-hydroxypentanoyl-RifACP10 (1a) (b) Hydration 
of (E)-2-methyl-2-pentenoyl-RifACP10 (2). (c) Incubation of Rif[DH10+KR10] with 








Figure 3-8. Chiral GC-MS analysis (Method 1) of the incubation of (2RS)-2-methyl-3-
ketopentanoyl-RifACP10-NusA with RifKR7 and RifDH10. A and D: (E)-2-Methyl-2-
pentenoic acid (3) from RifKR7-catalyzed reduction of (2RS)-2-methyl-3-ketopentanoyl-
RifACP10-NusA followed by dehydration by RifDH10. B: (Z)-2-methylpentenoic acid 
authentic standard. C: Co-injection of A with B. E: Co-injection of (E)-2-methyl-2-
pentenoic acid standard with D. A-1, B-1, C-1, D-1 and E-1: Extracted ion current (XIC) 
at m/z 114 (base peak). A-2, B-2, C-2, D-2 and E-2: mass spectra of selected peak, upper 





Figure 3-9. Chiral GC-MS analysis of the incubation of (2RS)-2-methyl-3-
ketopentanoyl-RifACP10-NusA with RifKR7 in the absence of RifDH10 (Method 4). A: 
(2S,3S)-2-Methyl-3-hydroxypentanoate (4a) from RifKR7-catalyzed reduction of (2RS)-
2-methyl-3-ketopentanoyl-RifACP10-NusA and B: Co-injection of (2S, 3S)-4a with A. 
A-1 and B-1: Extracted ion current (XIC) at m/z 88 (base peak). A-2 and B-2: Mass 
spectra of selected peak corresponding to (2S,3S)-4a upper half, observed spectra, lower 
















Figure 3-10. Chiral GC-MS analysis of the incubation of (2RS)-2-methyl-3-
ketopentanoyl-RifACP10-NusA with TylKR1 and RifDH10 (Methods 2 and 4). A: 2-
Methyl-3-hydroxypentanoates from TylKR1-catalyzed reduction of (2RS)-2-methyl-3-
ketopentanoyl-RifACP10-NusA and B: Minor peak corresponding to (E)-2-methyl-2-
pentenoic acid (3) generated by RifDH10-coupled dehydration of A. A-1: Extracted ion 
current (XIC) at m/z 88 (base peak). The major diastereomer observed was (2R,3R)-4b. 
The minor diastereomers are marked with asterisks as (2R,3S)-4c (*), (2S,3R)-4d (**) and 
(2S,3S)-4a (***). A-2: mass spectra of selected peak corresponding to (2R,3R)-4b, upper 
half, observed spectrum, lower half, inverted mass spectrum of reference standard. B-1: 
Extracted ion current (XIC) at m/z 114 (base peak). B-2: Mass spectrum of selected peak, 
upper half, observed spectrum, lower half, inverted mass spectra of reference standard. 
(Note both the lower intensity and lower purity of the ret. time 7.31 min peak containing 
3 plus contaminants, compared to the yield and purity of 3 derived from an incubation 













Figure 3-11. Chiral GC-MS analysis of the incubation of (2RS)-2-methyl-3-
ketopentanoyl-RifACP10-NusA with EryKR6 and RifDH10 (Method 4). Left panel: 
Extracted ion current (XIC) at m/z 88 (base peak). Right panel, mass spectra of a selected 
peak corresponding to (2R,3S)-4c, upper half, observed spectrum, lower half, inverted 
































Figure 3-12. Chiral GC-MS analysis of the incubation of (2RS)-2-methyl-3-
ketopentanoyl-RifACP10-NusA with EryKR1 and RifDH10. A: 2-Methyl-3-
hydroxypentanoates from EryKR1-catalyzed reduction of (2RS)-2-methyl-3-
ketopentanoyl-RifACP10-NusA (Method 4) and B: Co-injection of (2S,3R)-4d 
diastereomer with A. Envelope at 32.79 min contains minor amounts of (2S,3S)-4a. C: 
Minor amount of 3 generated by RifDH10-coupled reaction of A, due to presence of 
(2S,3S)-1a in reduced RifACP10-bound diketide. (Method 1) A-1 and B-1: Extracted ion 
current (XIC) at m/z 88 (base peak). A-2 and B-2: mass spectra of selected peak 
corresponding to (2S,3R)-4d, upper half, observed spectrum, lower half, inverted mass 
spectrum of reference standard. C-1: Extracted ion current (XIC) at m/z 114 (base peak). 
C-2: mass spectrum of selected peak, upper half, observed spectrum, lower half, inverted 






Figure 3-13. Chiral GC-MS analysis of the incubation of (2RS)-2-methyl-3-
ketopentanoyl-RifACP10-NusA with RifDH10-KR10 (Methods 2 and 4). Left panels: 
A1. Extracted ion current (XIC) at m/z 88 (base peak for 4a) (Method 4); B-1 and C-1. 
Extracted ion current (XIC) at m/z 114 (base peak for 3) (Method 2). Right panels, mass 
spectra of selected peaks, upper half, observed spectrum, lower half, inverted mass 
spectrum of reference standard. A. (2S,3S)-4a produced by RifDH10-KR10. B. (E)-2-












Figure 3-14. Chiral GC-MS analysis (Method 4) of the incubation of (E)-2-methyl-2-
pentenoyl-RifACP10-NusA with RifDH10. Left panels: Extracted ion current (XIC) at 
m/z 88 (base peak). Right panels, mass spectra of selected peaks corresponding to 
diastereomers of methyl 2-methyl-3-hydroxypentanoate, upper half, observed spectrum, 
lower half, inverted mass spectrum of reference standard. A and C. (2S,3S)-4a generated 






Figure 3-15. RifDH10-catalyzed dehydration/hydration of acyl thioester analogues. (a) 
Dehydration of (2R,3R)-2-methyl-3-hydroxypentanoyl-EryACP6 (5b). (b) Hydration of 
(E)-2-methyl-2-pentenoyl-EryACP6 (6). (c) Dehydration of (2R,3R)-2-methyl-3-
hydroxypentanoyl-S-Pant (7b) and –S-NAC (9b) analogues. (d) Incubation of RifDH10 






Figure 3-16. TLC-phosphorimaging of diketide acid products from combinatorial 
enzyme reactions involving propionyl-SNAC, Ery[KS6][AT6], EryACP6, RifDH10, 
[
14
C]-methylmalonyl-CoA, NADPH, and varying KR domains. Only Expt 4 with 
TylKR1 and RifDH10 produced 2-methyl-2-pentenoic acid. Note that the achiral TLC 
assay cannot distinguish syn-(2S,3R)- from the enantiomeric syn-(2R,3S)-2-methyl-3-










Figure 3-17. GC-MS analysis of the incubation of in situ-generated (2R)-2-methyl-3-
ketopentanoyl-EryACP6 with TylKR1, NADPH, and RifDH10 (Method 3). Left panels: 
Extracted ion current (XIC) at m/z 114 (base peak). Right panels, mass spectra of selected 
peaks corresponding to unsaturated diketide acid 3, upper half, observed peaks, lower 
half, mass spectrum of reference standard 3. A. Reaction product. B. A plus authentic 








Figure 3-18. Chiral GC-MS analysis of the incubation of in situ-generated (2R,4S,5R)-
2,4-dimethyl-3-keto-5-hydroxyheptanoyl-EryACP6 with TylKR1 and RifDH10. Reaction 
produces (2E,4R,5R)-2,4-dimethyl-5-hydroxy-2-heptenoyl methyl ester resulting from 
dehydration of the intermediate (2R,3R,4S,5R)-2,4-dimethyl-3,5-dihydroxyheptanoyl-
EryACP6, hydrolysis, and methylation. Left panel: Extracted ion current (XIC) at m/z 
128 (base peak for (2E,4R,5R)-2,4-dimethyl-5-hydroxy-2-heptenoyl methyl ester). Right 
panel: mass spectrum of selected peak corresponding to the unsaturated triketide acid 





























Figure 3-19. Chiral GC-MS analysis of the incubation of (E)-2-methylpentenoyl-
EryACP6 with RifDH10 (Method 4). Left panels: Extracted ion current (XIC) at m/z 88 
(base peak). Right panels, mass spectra of selected peaks corresponding to diastereomers, 
upper half, observed spectrum, lower half, inverted mass spectrum of reference standard. 































Figure 3-21. Dehydration of (3R)-3-hydroxybutanoyl-S-NAC. Reversed-phase HPLC 
analysis of a control (red, no enzyme) and the RifDH10-catalyzed dehydration (blue) of 
(3R)-3-hydroxybutanoyl-S-NAC (9.2 min), with product eluting at 13.5 min. Product 




















Figure 3-22. Dehydration of (2R,3R)-2-methyl-3-hydroxypentanoyl-S-NAC. Reversed-
phase HPLC analysis of a control (red, no enzyme) and the RifDH10 catalyzed 
dehydration (blue) of (2R,3R)-2-methyl-3-hydroxypentanoyl-S-NAC (10.2 min), with 
product eluting at 14.8 min. The significant peak at 8.9 min is residual (2RS)-2-methyl-3-
oxopentanoyl-S-NAC which was not reduced by the preceding TylKR1 catalyzed 
reduction. Product peak was collected and confirmed with LC/MS: expected mass 215.3; 
















Figure 3-23. Dehydration of (2R,3R)-2-methyl-3-hydroxypentanoyl-S-pantetheine. 
Reversed-phase HPLC analysis of a control (red, no enzyme) and the RifDH10-catalyzed 
dehydration (blue) of (2R,3R)-2-methyl-3-hydroxypentanoyl-S-pantetheine (13.8 min), 
with product eluting at 16.4 min. Product peak was collected and confirmed with LC/MS: 



















Figure 3-24. Hydration of (E)-2-butenoyl-S-pantetheine. Reversed-phase HPLC analysis 
of a control (red, no enzyme) and the RifDH10-catalyzed hydration (blue) of (E)-2-
butenoyl-S-pantetheine (17.6 min), with product eluting at 13.8 min. Product peak was 




















Figure 3-25. Hydration of (E)-2-methyl-2-butenoyl-S-pantetheine. Reversed-phase 
HPLC analysis of a control (red, no enzyme) and the RifDH10-catalyzed hydration (blue) 
of (E)-2-methyl-2-butenoyl-S-pantetheine (14.8 min), with product eluting at 12.6 min. 




















Figure 3-26. Hydration of (E,E)-2,4-hexadienoyl-S-pantetheine. Reversed-phase HPLC 
analysis of a control (red, no enzyme) and the RifDH10 catalyzed hydration (blue) of 
(E,E)-2,4-hexadienoyl-S-pantetheine (16.1 min), with product eluting at 14.3 min. The 
hydrated product has been highlighted with an asterisk due to adjacent contaminating 
peaks, which are also present in the control reaction. Product peak was collected and 


















Figure 3-27. Stereochemistry of hydrated product from RifDH10-catalyzed hydration of 
(E)-2-methyl-2-butenoyl-S-pantetheine. (E)-2-Methyl-2-butenoyl-S-pantetheine was 
incubated with RifDH10, and the resultant hydrated product was purified by reverse-
phase HPLC. The acyl group was subsequently transferred to S-NAC, and subjected to 
chiral HPLC analysis. (a) Chiral HPLC trace of the product of the RifDH10 catalyzed 
hydration of (E)-2-methyl-2-butenoyl-S-pantetheine (red). The run was repeated after 
being spiked with authentic (2S,3S)-2-methyl-3-hydroxy-butanoyl-S-NAC (black trace). 
(b) A series of authentic standards analyzed on the same chiral column used to determine 














Figure 3-28. Chiral GC-MS analysis of the incubation of in situ-generated (2R)-2-
methyl-3-ketopentanoyl-EryACP6 with RifDH10-KR10 (Method 4). Formation of 
methyl (2S,3S)-2-methyl-3-hydroxypentanoate. Left panels: Extracted ion current (XIC) 
at m/z 88 (base peak). Right panels, mass spectra of selected peaks corresponding to 4a, 
upper half, observed spectrum, lower half, inverted mass spectrum of reference standards. 
A (2S,3S)-4a generated by RifDH10-KR10. B. A plus (2S,3S)-4a generated by enzymatic 




















Figure 3-29. The 1.82 Å-resolution structure of RifDH10. (a) The 2Fo-Fc electron density 
map (contoured at 1.8 ) shows a water molecule, bound to the catalytic histidine (H50) 
and aspartate (D220), as well as a nearly invariant Y174, that is representative of the 
water molecule eliminated through a syn-dehydration reaction. H224 and Y164 may help 
increase the pKa of D220 through a hydrogen-bond network. (b) Stereodiagram of the 
superposition of the active sites of RifDH10, EryDH4, CurF DH, CurH DH, CurJ DH, 




















Figure 3-30. RifDH10-catalyzed dehydration. (a) syn-Dehydration of a (2S,3S)-2-
methyl-3-hydroxyacyl thioester substrate generates a trans (E) double bond. (b) 
Stereodiagram showing (2S,3S)-2-methyl-3-hydroxyacyl thioester substrate modeled into 
the active site of RifDH10. See Figure 3-32 for modeling of diastereomeric thioesters into 





















Figure 3-31. LC-ESI(+)-MS analysis of (E)-2-methyl-2-pentenoyl-RifACP10 generated 
by incubation of (E)-2-methylpentenoyl-CoA with Sfp and apo-RifACP10-NusA, 
followed by proteolytic cleavage of the NusA fragment with HRV 3C protease. (a) LC-
MS; (b) LC-ESI(+)-MS; (c) calculated full mass of (E)-2-methylpentenoyl-RifACP10 
(theoretical [M+H]
+
 13143.9 Da). apo-RifACP10 was also observed (theoretical mass 
[M+H]
+
 12706.7 Da).  
RT:0.00 - 29.99
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Figure 3-32. Dehydration of (2R,3S)- and (2R,3R)-2-methyl-3-hydroxyacyl thioesters. (a) 
The syn dehydration of a (2R,3S) intermediate would result in a cis-enoyl thioester. The 
stereodiagram shows how the C2 proton and the C3 hydroxyl group of a (2R,3S)-2-
methyl-3-hydroxypentanoyl intermediate would be aligned within the active site of 
RifDH10 for the syn elimination reaction. (b) The syn dehydration of a (2R,3R) 
intermediate would result in a trans-enoyl thioester. The stereodiagram shows how the 
C2 proton and the C3 hydroxyl group of a (2R,3R)-2-methyl-3-hydroxypentanoyl 


















Table 3-1. Crystallographic data and refinement statistics. Values in parentheses refer to 





Chapter 4. Rapid modification of the pET-28 expression vector for 




The ability to rapidly customize an expression vector of choice is a valuable tool 
for any researcher involved in high-throughput molecular cloning for protein 
overexpression. Unfortunately, it is common practice to amend or neglect protein targets 
if the gene that encodes the protein of interest is incompatible with the multiple-cloning 
region of a preferred expression vector. To address this issue, a method was developed to 
quickly exchange the multiple-cloning region of the popular expression plasmid pET-28 
with a ligation-independent cloning cassette, generating pGAY-28. This cassette contains 
dual inverted restriction sites that reduce false positive clones by generating a linearized 
plasmid incapable of self-annealing after a single restriction-enzyme digest. We also 
establish that progressively cooling the vector and insert leads to a significant increase in 
ligation-independent transformation efficiency, demonstrated by the incorporation of a 
10.3 kb insert into the vector. The method reported to accomplish plasmid reconstruction 
is uniquely versatile yet simple, relying on the strategic placement of primers combined 
with homologous recombination of PCR products in yeast. 
INTRODUCTION 
 Originally derived from pBR322, the pET series of cloning plasmids has been an 
extremely popular choice for laboratory scale inducible protein production (Studier & 
Chapter 4 was adapted from the following published work: Gay G, Wagner D, Keatinge-Clay AT, and Gay 
DC. (2014) Rapid modification of the pET-28 expression vector for ligation-independent cloning using 
homologous recombination in Saccharomyces cerevisiae. Plasmid 76, 66-71. Each author contributed to 




Moffatt, 1986; Rosenberg et al., 1987; Studier et al., 1990). The system is currently 
marketed by Novagen
®
 as the most powerful set of vectors yet developed for the 
subcloning and overexpression of recombinant proteins in Escherichia coli, with nearly 
1000 scientific publications reporting the use of the pET-28 variant for protein expression 
in 2013
†
. Genes that encode a protein of interest are generally inserted into a restriction-
enzyme based multiple cloning region downstream of a T7 promoter for IPTG-inducible 
transcription by the T7 RNA polymerase. While this gene insertion method remains a 
widely used technique, alternative procedures have recently gained attention for side-
stepping several disadvantages inherent to restriction-enzyme based methods, including 
restriction-sites internal to the gene of interest and the requirement for ligase-catalyzed 
vector circularization.  
  One method for inserting genes into expression vectors that has become an 
increasingly popular substitute for restriction-enzyme based methods is ligation-
independent cloning (LIC) (Aslanidis & Jong, 1990; Haun et al., 1992). The LIC method 
does not require ligase to covalently circularize the vector and insert, but instead relies on 
the affinity of sufficiently long base-pair overhangs that anneal in vitro to afford a stable 
circular product. Base-pair overhangs of a predetermined length are generated by 
treatment with T4 DNA polymerase, capitalizing on the potent 3′→5′ exonuclease 
activity of this enzyme in the absence of free nucleotides. Primers for amplification of the 
gene of interest are designed to include overhangs complementary to those of the vector, 
avoiding complications associated with a multiple cloning region that may contain 




among structural biologists (Stols et al., 2002; Luna-Vargas et al., 2011), who often 
screen multiple constructs of a single protein target to determine if modifying the location 
of N- and C-termini impacts the crystallizability of the macromolecule. The simplicity of 
LIC primer design combined with the inherent amenability to parallel processing makes 
this cloning strategy an attractive alternative to traditional restriction-enzyme based 
methods for high-throughput plasmid generation.  
 The ability to rapidly modify an expression vector is a powerful tool that can be 
implemented to increase the efficiency of standard molecular cloning prevalent 
throughout academic and industrial laboratories. Robust methods for plasmid assembly 
that employ in vivo homologous recombination techniques have been previously reported 
(Ma, et al., 1987, Oldenburg, et al., 1997; Chino, et al., 2010). We have applied these 
methods to construct pGAY-28, in which the multiple cloning region of the common 
pET-28 cloning vector was replaced with a custom LIC cassette. While Novagen
® 
does 
market a limited number of pET vectors that contain LIC options for gene integration, the 
methods outlined here represent a rapid and uniquely versatile protocol that can be used 
to quickly modify any genetic element within an expression vector using homologous 
recombination in S. cerevisiae. By strategically designing primers that are positioned to 
anneal upstream of a unique restriction-site within the parental vector, the final step of 
plasmid re-circularization is greatly facilitated to enable the complete reconstruction of 
plasmids within a relatively short time frame (3 days). The robust nature of the new 
cloning vector is demonstrated through a comparison of cloning efficiencies when 




RESULTS AND DISCUSSION 
 The pGAY-28 vector was generated to provide a LIC alternative to restriction-
enzyme based cloning predominant within the pET system, while retaining all the other 
features found within the pET-28 subtype that has made it such a popular choice for 
protein overexpression in E. coli. The methods outlined here provide a simple and 
general procedure that can be adapted to reconstruct a multiple cloning region, generate a 
LIC cassette, or incorporate any genetic element of choice into an expression vector 
within several days.  
 The pGAY-28 expression vector was generated by amplifying the parent pET-
28b(+) vector in three parts (A, B, and C), using primer pairs a1:a2, b1:b2, and c1:c2 
(Figure 4-1). A key feature that permitted the rapid reconstitution of the final plasmid 
product involved exploiting the single XmaI site within the original pET-28 sequence. 
The primers a1 and c2 were designed to anneal upstream of the XmaI site of pET-28, so 
that the recombined product contained two XmaI sites adjacent to the sequences for yeast 
shuttle vector integration. The recombined vector (YEpADH2p / pGAY-28) becomes the 
DNA template for the following PCR amplification, such that primers a1 and c2 are used 
in conjunction to amplify only the pGAY-28 portion of the plasmid. The incorporation of 
identical restriction sites at the 5′ and 3′ ends of this amplicon facilitates the 
circularization of the final product that can be restricted and ligated to itself. XmaI was 
chosen for pGAY-28 construction to completely preserve the sequence of pET-28b(+) 
outside of the multiple cloning region, but any restriction site that does not exist in the 




of selecting false positive yeast colonies is sufficiently low, and therefore the second 
round of PCR amplification can simply be a “colony PCR”, avoiding purification and 
sequencing of the recombined dual vector. In this step, several yeast colonies that likely 
contain the recombined construct (e.g., YEpADH2p / pGAY-28) can be combined and 
lysed to provide template DNA for the subsequent amplification. Barring unusual 
recombination events, amplified DNA of the correct molecular weight in the second 
round of PCR is highly indicative that the recombination was successful. 
 The LIC cassette of pGAY-28 that replaces the multiple cloning region of pET-28 
has several unique features (Figure 4-2). Two BseRI restriction sites within the cassette 
provide a single-step linearization of the vector using one restriction enzyme, generating 
short sticky ends that are incapable of self-annealing and susceptible to T4 DNA 
polymerase digestion. T4 DNA polymerase exhibits potent 3′→5′ exonuclease activity 
towards linear DNA, but this activity is significantly attenuated towards specific bases if 
high concentrations of the nucleoside triphosphate of that base exist in the reaction 
condition (Aslanidis & Jong, 1990). In the presence of millimolar concentrations of a 
specific nucleoside triphosphate, the T4 DNA polymerase will stall when it reaches that 
specific base in the sequence, generating considerably longer sticky ends than can be 
achieved with restriction enzyme digests. If BseRI linearized pGAY-28 is treated with T4 
DNA polymerase in the presence of dATP, the polymerase removes nucleotides 3′→5′ 
from both ends of the vector until it reaches an adenine, exposing lengthy segments of 
single-stranded DNA. Similarly, if the amplified gene to be inserted into the LIC cassette 




are generated that can anneal to the vector. Simply mixing the T4 DNA polymerase 
treated vector and insert before transformation is sufficient to achieve acceptable 
transformation efficiency of positive clones. To increase transformation efficiency 
further, the vector and insert should be subjected to progressive cooling, easily 
programmed into modern thermal cyclers. It is suspected that slowly cooling the mixture 
from 98 ºC to 38 ºC increases the population of complementary sticky ends that find and 
anneal to one another properly.  
 Using restriction-based methods, it has been generally observed that the size of a 
gene insert corresponds inversely to the number of positive clones. Our laboratory has 
observed a precipitous decrease in cloning efficiency with pET-28b(+) after the size of 
the insert exceeds 6-7 kb. To compare the cloning efficiencies of pET-28b(+) and pGAY-
28, a 10.3 kb fragment (corresponding to 12 polyketide synthase domains housed within 
the pksJ gene from B. subtilis) was selected to challenge both systems. The gene 
fragment was amplified using a primer set encoding NotI and XhoI restriction sites for 
insertion into pET-28b(+), in addition to amplification using a primer set encoding the 
LIC annealing sequences for insertion into pGAY-28. Highly competent E. coli Top10 
cells (cfu > 1 × 10
7
/μg) were used to transform the constructs by electroporation, and 
transformants were plated on selective media. The pET-28b(+) construct yielded 10 
colonies, however 5 randomly selected colonies were screened and only contained the 
pET-28b(+) vector without insert. The pGAY-28 construct yielded 40 colonies, and 11 of 
these were selected and screened. Of these, 2 were positive clones and 9 were the pGAY-




colonies for the pET-28b(+) construct are attributed to incomplete digestion with either 
NotI or XhoI, and the false positive colonies for the pGAY-28 construct are attributed to 
incomplete digestion with BseRI. Although 18% is a relatively low success rate, it must 
also be considered that the pET-28b(+) vector produced no positive clones, and that the 
transformation of a ~16 kb nicked vector was at least possible with pGAY-28. When 
smaller inserts are used to generate pGAY-28 constructs (1-2 kb), it is exceptionally rare 
to encounter false positive colonies due to the abundance of positive clones.  
 As no other features of pET-28 were modified through the incorporation of the 
LIC cassette, the T7 promoter, lac operator, ribosomal binding site, N-terminal 
hexahistidine tag, and thrombin cleavage site still precede the gene of interest. Translated 
protein products expressed from pGAY-28 will read: 
MGSSHHHHHHSSGLVPRGSS(#)HHHHHHH(stop), where (#) corresponds to the 
translation of the gene cloned into pGAY-28 for overexpression. The serine that 
immediately precedes (#) is the only N-terminal residue inconsistent with expression of 
proteins cloned into the NdeI site of pET-28b(+). While the N-terminal hexahistidine tag 
is mandatory and can be removed with thrombin digestion, the C-terminal heptahistidine 
tag is optional, and can be avoided by the incorporation of a stop codon in the reverse 
primer for the gene of interest. 
 The protocol described here can be easily adapted to modify any expression 
vector of choice via homologous recombination in S. cerevisiae. In the manner by which 
primers b2 and c1 harbor the LIC cassette used to generate pGAY-28, any sequence (and 




to any region of the parent plasmid. Although the pET-28b(+) multiple cloning region 
that was replaced with the LIC site is relatively small, the strategy is clearly amenable to 
large-scale modifications, such as the exchange of drug-resistance cassettes. If longer 
regions (greater than 50 nucleotides) are to be incorporated, an additional set of primers 
will be required to first amplify the genetic material of interest. As long as the primers 
used for this amplification contain ends that can recombine with homologous regions of 
adjacent amplicons (or linearized plasmid), there is no limit to the modifications that can 
be achieved within a relatively short time frame. It is conceivable that the 10.3 kb insert 
described in this study could have been amplified with regions designed to recombine 
with pET-28b(+) (i.e., the annealing sequences for primers b2 and c1, Figure 4-1), 
transformed into yeast with the shuttle vector for recombination, followed by colony PCR 
of the entire 15.7 kb fragment corresponding to pET-28b(+) containing the appropriately 
placed insert. This fragment could subsequently be restricted with XmaI and ligated to 
itself to yield a construct exceptionally challenging to generate with traditional 
restriction-based cloning methods. Our laboratory has observed a significant increase in 
transformation efficiency using pGAY-28 in place of pET-28, and recently solved several 
crystal structures of proteins expressed from this vector (Gay et al., 2014). We encourage 
labs engaged in high-frequency cloning coupled to protein overexpression to explore 
possible modifications to their vector of choice in order to increase throughput and 
efficiency, and recommend assembly via the protocol described herein as the most rapid 




MATERIALS AND METHODS 
Strains and plasmids 
 E. coli TOP10 (Invitrogen) and BL21(DE3) were used as the host strains for 
subcloning and protein production from the pGAY-28 vector, respectively. The pET-
28b(+) expression vector used as the template for plasmid modification was obtained 
from Novagen. S. cerevisiae strain BJ5464-NpgA (MATα ura3-52 his3-Δ200 leu2-Δ1 
trp1 pep4::HIS3 prb1 Δ1.6R can1 GAL) was used for the recombinatorial assembly of 
PCR products (Ma et al., 2009). The YEpADH2p plasmid used for colony selection in S. 
cerevisiae is a 2μ YEplac195-based shuttle vector with a URA3 selection marker (Gietz 
and Akio, 1989; Ma et al., 2009). Genomic DNA was extracted from Bacillus subtilis 
ssp. 168 as a template for the amplification of the 10.3 kb fragment from the pksJ gene.  
PCR amplification of pET-28b and yeast shuttle vector integration 
 Unless otherwise mentioned, all DNA samples were purified by agarose gel 
excision using the QIAquick Gel Extraction Kit (Qiagen) and eluted into deionized water 
before use. Amplification of pET-28 for integration into the YEpADH2p vector was 
performed using standard PCR methods with KAPA HiFi polymerase (KAPA 
Biosystems). The vector was divided into three pieces for amplification (A, B, and C; 
Figure 4-1) using the following primers: a1: 5′-
CAAAAAGCATACAATCAACTATCAACTATTAACTATATCGTAATACCATATGTGTTTT
CCCGGGGATCGCAG-3′, a2: 5′-CGCATCCATACCGCCAGTTGTTTAC-3′, b1: 5′- 





GAGCCGCGCGGCACCAG-3′, c1: 5′- 
TTTGCAGTCAGCTCCTCTGCACGTCGCTAGACGAGGAGTCATGCACAACACC
ACCACCACCACCACTGAGATC-3′, and c2: 5′- 
CGCACAAATTTGTCATTTAAATTAGTGATGGTGATGGTGATGCACGTGATGCATGG
TTACTCACCACTGCGATC-3′ (BseRI sites in bold, LIC cassette underlined, and 
YEpADH2p homologous recombination sites (Y-3′ and Y-5′) are italicized). YEpADH2p 
was restricted with NdeI and PmlI to form a linearized vector prepared for homologous 
recombination. The three pET-28b amplicons and linearized YEpADH2p vector were 
mixed to molar equivalency, and transformed into S. cerevisiae strain BJ5464-NpgA 
using the S. C. EasyComp Transformation Kit (Life Technologies). Cells were plated on 
uracil deficient media for selection. Many colonies (>200) appeared within 2-3 days, and 
six out of six colonies screened positive as successful transformants.  
PCR amplification of pGAY-28 from recombined shuttle vector 
 Several transformed S. cerevisiae colonies (5-10) were transferred into 100 µl of 
water, and incubated at 100 ºC for 5 minutes to induce cell lysis. The cell suspension was 
then centrifuged at 21,000 rcf for 3 minutes, and 5 µl of the supernatant was used as the 
template DNA for the subsequent PCR amplification (50 µl total reaction volume), in 
which the primers used were a1 and c2. The 5′ and 3′ ends of this amplicon contained the 
XmaI restriction site native to the original pET-28b(+) vector, and therefore restriction 




28 expression vector that was transformed into competent E. coli TOP10 cells. Due to the 
use of a single restriction site, the number of colonies from this transformation was 
greater than 500. False positive clones are extremely unlikely using this method since the 
plasmid was generated by PCR amplification, reducing the background often observed 
with the transformation of doubly-digested vectors. Therefore, only two colonies were 
screened by DNA sequencing, and both revealed the successful construction of pGAY-
28.  
Standard protocol for subcloning into pGAY-28 for overexpression in E. coli  
 The gene of interest is amplified using the sense primer 5′-
GCGGCCTGGTGCCGCGCGGCTCTAGC(X)-3′ and anti-sense primer 5′-
GTGGTGGTGGTGGTGGTGATG(Z)-3′, where (X) represents the sequence designed to 
anneal to the 5′ end of the target gene, and (Z) represents the reversed complementary 
sequence designed to anneal to the 3′ end of the target gene. The LIC cassette of pGAY-
28 contains dual histidine tags for purification of proteins by immobilized metal affinity 
chromatography, with a mandatory N-terminal hexahistidine tag and an optional C-
terminal heptahistidine tag. The optional C-terminal tag can be avoided by incorporating 
a stop codon 5′ of the (Z) sequence during primer design (e.g., 5′-
GTGGTGGTGGTGGTGGTGATGTTA(Z)-3′, stop codon underlined). Amplification of 
the desired gene is followed by agarose gel purification, and eluted into 50 µl of water. 2 
µg of the pGAY-28 vector are restricted with BseRI (NEB), agarose gel purified, and 




Independently, both the linearized pGAY-28 and the target amplicon are incubated with 
nucleoside triphosphates in the following manner: 2 µl of 100 mM dATP is added to 50 
µl of the purified vector, and 2 µl of 100 mM dTTP is added to 50 µl of the purified 
insert. To both (but separately), the following are then added: 11 µl water, 1 µl 0.5 M 
DTT, 8 µl NEB Buffer 2, 8 µl of 1 mg/ml BSA, and 2 µl T4 DNA polymerase (NEB). 
Both reactions are incubated at 22 ºC for 30 minutes, followed by polymerase 
inactivation by incubation at 75 ºC for 20 minutes. The vector and insert are then mixed 





                





 is the ratio of vector to insert in µl (e.g., 
 
 
 = 2 would indicate that 6 µl of T4 
DNA polymerase treated vector should be added to 3 µl of T4 DNA polymerase treated 
insert),            and            are the A260 values measured before T4 DNA 
polymerase treatment, and          is equal to the kilobase pairs of the gene to be 
inserted into the vector. To promote the annealing of base-pair overhangs between the 
vector and insert, the reaction is subjected to progressive cooling using the following 
thermal cycler protocol: 98 ºC for 30 seconds, followed by 60 cycles (3 seconds each) 
where the reaction temperature is reduced by 1 ºC each cycle. While not critical for 
successful gene integration, this step has been observed to increase transformation 
efficiency of positive clones ~5 fold. After the thermal cycler reaches 38 ºC, 1 µl of 50 




minutes. Ultimately, 1 – 5 µl of the reaction mixture can be transformed into competent 
E. coli, and plated on solid media containing kanamycin for selection of positive clones.  
Comparison of cloning efficiencies between pET-28b and pGAY-28.  
 The pksJ gene from B. subtilis is a single ORF that encodes multiple 
nonribosomal peptide synthetase and polyketide synthase domains. To amplify the 10.3 
kb gene fragment from pksJ that encodes 12 independently-folded polyketide synthase 
domains, primers were designed to anneal beginning with L1623 and end with the natural 
stop codon following V5043 (National Center for Biotechnology Information Reference 
Sequence: NP_389598.3). To amplify the region for insertion into pET-28b(+), the 
following primers were used: 5′-
CATCACTTAGCGGCCGCAATGCTTGATCATATGCCGTTAACTCCGAAC-3′ and 
5′-CATCACTTACTCGAGGACCTCCACCTCATAAGTATCCCATATG-3′ (NotI and 
XhoI restriction sites underlined). To amplify the region for insertion into pGAY-28, the 
following primers were used: 5′- 
GCGGCCTGGTGCCGCGCGGCTCTAGCCTTGATCATATGCCGTTAACTCCGAAC
-3′ and 5′- 
GTGGTGGTGGTGGTGGTGATGTTAGACCTCCACCTCATAAGTATCCCATATG-
3′ (LIC cloning regions underlined). The amplicon generated using the primers designed 
for incorporation into pET-28b(+) was digested with NotI and XhoI, and ligated into a 
pET-28b(+) vector that had been previously digested with the same restriction enzymes. 




treated according to the protocol described above. Both constructs were then transformed 
into highly competent E. coli cells (cfu > 1 × 10
7
/μg) by electroporation.  
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Figure 4-1. Construction of pGAY-28. The modification of pET-28 to replace the 
multiple cloning region (MCR) with a LIC cassette was accomplished in five steps. In 
step (1), the parent pET-28 vector is amplified in three segments: A, B, and C. Segment 
A contains a region homologous to the 3′-end of the linearized yeast shuttle vector 
YEpADH2p (Y-3′). Segment B contains the LIC cassette at its 3′-end. Segment C 
contains the LIC cassette at its 5′-end, and a region homologous to the 5′-end of 
YEpADH2p (Y-5′). In step (2), transformation of linearized YEpADH2p and the three 
amplified segments into competent S. cerevisiae leads to step (3), where the overlapping 
segments undergo homologous recombination in vivo. In step (4), two of the original 
primers from step (1) are used again to amplify the modified expression vector using 
“colony PCR”. Since these primers were originally designed to anneal upstream of a 
single XmaI restriction site, step (5) involves digestion of the amplicon with XmaI 







Figure 4-2. Cloning into pGAY-28 for heterologous overexpression in E. coli. To insert a 
target gene into pGAY-28, the vector is first digested with the restriction-enzyme BseRI. 
Two inverted BseRI sites ensure that the short sticky ends of the linearized vector are 
incapable of annealing. The gene that encodes the protein of interest (#) is PCR amplified 
using primers that include tails specific to the LIC integration sequence of pGAY-28. 
Both the linearized vector and gene insert are then digested with T4 DNA polymerase (in 
the presence of dATP and dTTP, respectively), generating lengthy single-stranded 
overhangs. The vector and insert are then combined, heated, and progressively cooled to 
increase the fidelity of successful gene integration (triangles on single-stranded 












Chapter 5. A double-hotdog with a new trick: structure and mechanism 
of the trans-acyltransferase polyketide synthase enoyl-isomerase 
 
ABSTRACT 
Many polyketide natural products exhibit invaluable medicinal properties, yet 
much remains to be understood regarding the machinery responsible for their 
biosynthesis. The recently-discovered trans-acyltransferase polyketide synthases employ 
processing enzymes that catalyze modifications unique from those of the classical cis-
acyltransferase polyketide synthases. The enoyl-isomerase domains of these 
megasynthases shift double bonds and are well-represented by an enzyme that helps forge 
the triene system within the antibiotic produced by the prototypical bacillaene synthase. 
This first crystal structure of an enoyl-isomerase, at 1.73 Å-resolution, not only revealed 
relationships between this class of enzymes and dehydratases but also guided an 
investigation into the mechanism of double bond migration. The catalytic histidine, 
positioned differently from that of dehydratases, was demonstrated to independently 
shuttle a proton between the γ- and α-positions of the intermediate. This unprecedented 
mechanism highlights the mechanistic diversity of divergent enzymes within trans-
acyltransferase polyketide synthases. 
INTRODUCTION 
 Polyketides are a structurally diverse class of natural products manufactured by a 
broad spectrum of bacteria, fungi, and plants. The clinical importance of such polyketides 
Chapter 5 was adapted from the following published work: Gay DC, Spear P, and Keatinge-Clay AT. 
(2014) A double-hotdog with a new trick: structure and mechanism of the trans-acyltransferase polyketide 
synthase enoyl-isomerase. ACS Chem. Biol. 9, 2374-2381. Each author contributed to the experimental 




as the antibiotic erythromycin and the cholesterol-lowering agent lovastatin has led to the 
structural, functional, and mechanistic investigation of the enzymatic machinery 
responsible for their synthesis (Keatinge-Clay, 2012). Type I polyketide synthases 
(PKSs) employ biosynthetic logic similar to the metazoan fatty acid synthase, which 
iteratively condenses and reduces acetate units into fatty acyl chains (Smith et al., 2007; 
Maier et al., 2008). In contrast to fatty acid synthesis, PKSs operate in an assembly line 
fashion, where modules (sets of domains responsible for a single round of condensation 
and processing) are structured in a linear arrangement, each obtaining a ketide extender 
unit selected by an acyltransferase domain (AT), condensing that extender unit to a 
growing polyketide chain with the ketosynthase domain (KS), and processing the 
resulting β-ketoacyl chain depending on which processing domains are associated with 
the module. These domains include a ketoreductase (KR) that catalyzes stereoselective 
reduction of the β-carbonyl, a dehydratase (DH) that yields an α,β-double bond through 
the elimination of water, and an enoylreductase (ER) that reduces the double bond to 
yield a completely saturated acyl intermediate. 
 Type I PKSs have been subdivided into two classes depending on whether ATs 
are encoded within modules (cis-AT PKSs) or discretely encoded as separate 
polypeptides that dock to the synthase (trans-AT PKSs) (Piel, 2010). While each of the 
domains from cis-AT PKSs have been structurally characterized (Keatinge-Clay, 2012), 
only recently has structural information become available for domains found within 
trans-AT PKS assembly lines (Bretschneider et al., 2013; Gay et al., 2014; Piasecki et 




Bacillus subtilis and Bacillus amyloliquefaciens genomes (PksX and Bae, respectively) 
and is responsible for the biosynthesis of the polyketide bacillaene, a polyene diamide 
that inhibits prokaryotic protein synthesis (Patel et al., 1995). This PKS is illustrative of 
the unusual combinatorial logic in trans-AT PKS systems, which are commonly fused 
with non-ribosomal peptide synthetases (NRPS) and employ processing domains such as 
methyltransferases, enoyl-CoA hydratases, pyran synthases, and β-branching domains 
(B), rarely or not observed in cis-AT PKSs (Piel, 2010). The evolutionary acquisition of 
these additional processing domains has permitted trans-AT PKSs to explore a vast realm 
of possible molecular configurations, yielding natural products with functionalities not 
accessible to PKSs restricted to the traditional processing reactions employed in fatty acid 
biosynthesis.  
 One of the additional processing domains available to trans-AT PKSs is the enoyl 
isomerase domain (EI), which has been previously annotated as an inactive DH or DH* 
due to sequence alignments that predicted a DH double-hotdog fold (Kusebauch et al., 
2010; Moldenhauer et al., 2010; Lohr et al., 2013). This domain is located in what has 
been termed “shift-modules” that yield intermediates with β,γ-double bonds, in contrast 
to the classic α,β-unsaturated products of DH catalysis (Figure 5-1). Olefins within 
polyketides impact the sterically-available conformations of the final product more so 
than any other functional group, and therefore several studies have recently been 
conducted to determine if this domain is responsible for the isomerization of double 
bonds to positions “out-of-register” with classical PKS biosynthetic logic. Some DH 




PKS (Figure 5-1b) (Moldenhauer et al., 2010). Both dehydration and α,β → β,γ-double 
bond isomerization for C5-C6 and C7-C8 in bacillaene were demonstrated to occur 
within the first two DHs of PksN, without the participation of a dedicated EI domain. 
Whether the isomerization of the β,γ-double bond at C3-C4 of bacillaene was also 
catalyzed by the inherent isomerase activity of the third DH remained undetermined, and 
sequence alignments revealed that the following module could potentially be a shift-
module. 
 The EI domain within the rhizoxin PKS (at the N-terminus of RhiE) has been 
shown to be responsible for α,β → β,γ-double bond isomerization, and a strain with an EI 
knockout prevented polyketide transfer downstream of the disruption (Kusebauch et al., 
2010). Whether this is due to KS selectivity for the properly isomerized product or 
interference with docking between RhiD and RhiE is unclear. A mechanism was 
proposed for EI-catalyzed isomerization that involved a histidine conserved between DH 
and EI domains, as well as an unknown residue that could act as a general base. More 
recently, the EI domain from the corallopyronin A synthase was isolated and studied 
(Lohr et al., 2013). In vitro reconstitution of isomerase activity coupled with site-directed 
mutagenesis revealed that the proposed active site histidine is indeed required for 
catalysis; however, the unknown residue that acts in cooperation with this histidine could 
not be determined through mutagenic knockouts of proposed active site residues.  
 Here we report the 1.73-Å resolution crystal structure and reconstituted in vitro 
activity of the EI domain from the fourteenth module of the bacillaene PksX synthase 




conserved among PKS DH domains permits the catalytic histidine to act as both a general 
base and general acid in the isomerization of a double bond. Experiments conducted in 
deuterated solvent reveal that the mechanism proceeds through the relocation of a 
substrate γ-proton to the α-position without solvent interference, similar to the 
mechanism of double bond isomerization catalyzed by ketosteroid isomerase (Pollack, 
2004). The structure also shows that EI domains may not contribute significantly to the 
dimerization of trans-AT PKS polypeptides, in contrast to what has been observed for 
cis-AT PKSs (Keatinge-Clay, 2008; Akey et al., 2010; Gay et al., 2013). The structural 
and biochemical evidence presented here reveals an unprecedented mechanism for double 
bond isomerization and suggests that PksEI14 is responsible for the final step in the 
formation of the C3-C8-triene system characteristic of bacillaene. 
RESULTS AND DISCUSSION 
 The boundaries chosen for PksEI14 were based on the boundaries of domains 
upstream and downstream of PksR (PksKS14 and PksACP14, respectively). Crystals 
provided diffraction data enabling a model of PksEI14 to be refined to a resolution of 
1.73 Å, with phasing obtained by single-wavelength anomalous dispersion from crystals 
soaked in methyl mercury acetate (Table 5-1). The structure revealed a double-hotdog 
fold with an overall architecture very similar to cis-AT PKS DH domains (Cα r.m.s.d.: 2.4 
Å over 250 Cα when aligned with the DH from the fourth module of the erythromycin 




all known cis-AT DH structures, PksEI14 crystallized as a monomer, without the ~20-
residue N-terminal region observed in those DHs that mediates their dimeric interfaces.  
 A structural alignment of PksEI14 with EryDH4 reveals that the α-carbon of the 
catalytic histidine (His18 of PksEI14) conserved in both PKS DH and EI domains 
superposes with the α-carbon of the catalytic histidine of EryDH4; however, the 
imidazole rings are offset by ~1.7 Å (as measured between N atoms) (Figure 5-2). In 
PKS DHs, the catalytic histidine lies in a highly conserved HX8P motif, in which its 
imidazole stacks against the proline ring (Keatinge-Clay 2008). This motif is HX8V in 
PksEI14, with the Cγ1 methyl group of the valine sterically repositioning the imidazole 
ring. In other PKS EI domains, leucine is observed to substitute for the proline (Figure 5-
3). The aspartic acid that completes the catalytic dyad of PKS DHs is often substituted for 
an asparagine in EI domains, and the structure reveals that this asparagine (Asn182) is 
also repositioned relative to the aspartic acid. A highly-conserved glutamine or histidine 
in PKS DHs located four residues upstream of the catalytic aspartic acid is presumably 
responsible for increasing the pKa of this residue, priming it as a proton donor during the 
dehydration reaction (Gay et al., 2013). The conservation of the glutamine/histidine 
residue is not maintained among EIs and is substituted by either a valine or leucine 
(Leu186 in PksEI14, Figure 5-3).  
 The previously suggested mechanism of α,β → β,γ-double bond isomerization by 
the EI domain involves an unknown residue that acts as a general base and abstracts a 
proton from the γ-carbon, similar to the isomerization mechanism for FabA (Kusebauch 




active site pocket dominated by hydrophobic residues that cannot participate in acid-base 
catalysis. The only ionizable residue within the PksEI14 active site in position to play this 
role is Tyr185, although it is not conserved among available EI sequences. To determine 
whether Tyr185 is involved in catalyzing double bond isomerization, an assay was 
developed to reconstitute in vitro activity from the isolated PksEI14 domain. As 
obtaining an analogue of the natural polyketide substrate to observe the reaction in the 
forward direction was challenging (a lengthy, highly-functionalized polyene diamide), an 
analogue of the reaction product, (E)-hex-3-enyl-S-pantetheine, was prepared instead. 
PksEI14-mediated isomerization yielding (E)-hex-2-enyl-S-pantetheine would thus 
resemble the anticipated reverse direction for double bond migration, namely β,γ → α,β-
double bond isomerization. The reverse of the biological reaction is anticipated to be 
thermodynamically more favorable for this analogue since the double bond of the product 
is conjugated with the thioester carbonyl. Incubation of (E)-hex-3-enyl-S-pantetheine 
with PksEI14 followed by reversed-phase HPLC analysis revealed substrate conversion 
to a distinct species with a retention time equivalent to (E)-hex-2-enyl-S-pantetheine and 
UV absorbance maxima of 225 and 263 nm, characteristic of α,β-unsaturated thioesters 
(Figures 5-4 and 5-5) (Xiang et al., 1999). LC/MS analysis revealed that the generated 
compound exhibited a molecular weight also consistent with the anticipated product. 
Surprisingly, the active site mutant in which the suspected tyrosine was replaced with a 
phenylalanine, PksEI14(Tyr185Phe), catalyzed the isomerization ~3.1-fold more rapidly, 
revealing that the tyrosine is not necessary for catalysis (Figure 5-4). The N-acetyl-




was also incubated with PksEI14 under similar conditions, but isomerization to (E)-hex-
2-enyl-S-NAC was negligible (Figure 5-5b). 
 Since the structure does not reveal any other active site residues that could 
catalyze acid-base chemistry, the general base in the biological reaction could simply be a 
solvent-supplied water molecule, similar to the isomerization mechanism proposed for 
the isomerase domain of multifunctional enzyme, type-1 (Kasaragod, et al., 2013). The 
reverse in vitro reaction described herein would require water to play the role of a general 
acid wherein the active site histidine abstracts a proton from the α-carbon of the β,γ-
unsaturated substrate and a solvent water molecule donates a proton to the γ-carbon. The 
PksEI14-catalyzed reaction described above was conducted in D2O to determine if a 
solvent-supplied deuteron would label the γ-carbon in the product, generating (E)-4-
deutero-hex-3-enyl-S-pantetheine. However, in contrast to an identical reaction in H2O, 
the reaction would not go to completion (as monitored by reversed-phase HPLC). After 
~20-24 hours, the reaction stalled and both substrate and product slowly degraded due to 
the background hydrolysis of the thioester. Despite using millimolar concentrations of 
enzyme, insufficient isomerized product could be obtained for analysis by 
1
H NMR. Due 
to the remarkably decreased rate of isomerization catalyzed by wild-type PksEI14 in 
D2O, the PksEI14 mutant generated in this study (Tyr185Phe) was used for the reaction 
in deuterated solvent for its enhanced catalytic rate (Figure 5-4). It is suspected that the 
observed rate enhancement is the result of using a substrate analogue which does not 
perfectly mimic the true polyketide intermediate beyond the γ-carbon. The δ- and ε-




intermediate), and the tyrosine to phenylalanine mutation likely accommodates the 
bulkier substrate by increasing the volume of the active site cavity. This mutation is 
unexpected to alter the mechanism for isomerization from the wild-type, as it is already 
present in the Rhizoxin EI domain (Figure 5-3). The reaction catalyzed by PksEI14 
(Tyr185Phe) in deuterated solvent afforded sufficient isomerized product for analysis by 
1
H NMR (~3 mg), revealing a characteristic β-carbon proton splitting pattern that 
corresponded to a completely protonated methylene γ-carbon (Figure 5-6). As the α,β-
unsaturated reaction product was not purified from the β,γ-unsaturated substrate before 
1
H NMR analysis, (E)-hex-3-enyl-S-pantetheine was still clearly visible in the spectrum 
(1:0.52 molar ratio by proton signal integration). Greater than 95% of the α-protons of 
(E)-hex-3-enyl-S-pantetheine had exchanged for deuterons during the course of the 
reaction, confirming that the degree of contamination by residual solvent protons was 
insignificant (Figure 5-7c). The rate of solvent-catalyzed α-proton exchange is 
approximately on the same time scale as the concurrent background hydrolysis of the 
labile thioester in both substrate and product, complicating the analysis of reactions 
incubated longer than 24 hours (Figure 5-7d). To determine if the remarkable decrease 
(>10-fold) in catalytic rate of the reaction in D2O was the result of an abnormally large 
kinetic isotope effect, (E)-2,2-dideutero-hex-3-enyl-S-pantetheine was incubated with 
PksEI14 in H2O. Although isomerization to (E)-hex-2-enyl-S-pantetheine was observed, 
it could not be excluded that the product was generated primarily from a substrate species 
that had first undergone background exchange of α-deuterons for solvent protons, 




reduced catalytic rate observed for the reaction conducted in D2O resulted from the 
exchange of deuterons for protons within PksEI14, potentially shifting the catalytic 
histidine out of optimal range from either the α- or γ-carbon of the substrate. It has been 
demonstrated that deuteration of haloalkane dehalogenase restructures the active site 
resulting in enzymatic inactivation (Liu, et al., 2007).  
To our knowledge, the only polyketide from cis-AT PKSs that contains a β,γ-
double bond is ansamitocin (Figure 5-1a). Intriguingly, the ansamitocin PKS does not 
contain an EI domain, yet studies have shown that the formation of the β,γ-double bond 
occurs while the polyketide is tethered to the synthase, and the positioning of this double 
bond is critical for downstream transfer of the growing intermediate (Taft et al., 2009). A 
sequence alignment of DH domains reveals that the highly conserved catalytic aspartic 
acid in the responsible DH (AsmDH3) is replaced by a glutamic acid, which may help 
enable an unusual β,-dehydration of the substrate. Although the migration of double 
bonds by polyunsaturated fatty acid synthases has also been proposed to be catalyzed by 
dedicated shift modules (Sossa et al., 2012), no cis-AT PKS pathway has been discovered 
that employs a dedicated EI domain to catalyze α,β → β,γ-double bond isomerization.  
 As suggested by the results presented here, the forward biological reaction (α,β → 
β,γ double bond isomerization) would be thermodynamically unfavorable if the substrate 
did not harbor a moiety at the δ-position available for conjugation with a β,γ-double bond 
(e.g., double bond, amide, carbonyl). For PksEI14, this functional group is supplied by 
the δ,ε-double bond installed by PksDH12. This δ,ε-double bond is in conjugation with 




the preceding NRPS module. While the amide likely sets a thermodynamically favorable 
foundation for the three subsequent double bond shifts, sequence alignments do not 
provide a clear explanation for how PksDH11 and PksDH12 are able to catalyze both 
dehydration and isomerization without a dedicated EI domain. It is possible that 
PksDH13 is also capable of catalyzing isomerization, and that PksEI14 has been retained 
as a secondary checkpoint to ensure that the isomerization occurs before the polyketide is 
hydrolyzed from the synthase. These DHs could mediate isomerization after normal α,β-
dehydration, similar to the mechanism proposed for FabA (Moynié et al., 2013). Also 
possible is that the DHs of these modules directly dehydrate the β,γ-positions through the 
elimination of a γ-proton and β-hydroxyl; this type of dehydration may be facilitated by 
the increased acidity of the γ-proton adjacent to the amide or double bond at the δ,ε-
position. In addition to the bacillaene EI domain, the EIs of both the rhizoxin and 
corallopyronin PKSs isomerize double bonds into conjugation with preexisting functional 
groups at the δ,ε position (a double bond and amide, respectively).  
 Our results suggest that the mechanism for double bond isomerization by the EI 
domain proceeds via the shuttling of a substrate proton by a single active site histidine, 
similar to the mechanism of triose phosphate isomerase (Plaut and Knowles, 1972). An 
alignment of the six crystal structures of cis-AT PKS DHs solved to date reveal that the 
imidazole groups of the catalytic histidines superpose nearly perfectly (Gay et al., 2013), 
yet the imidazole group of PksEI14 is relatively shifted ~1.7 Å (as measured between N 
atoms) (Figure 5-2b). Since the EI domain possesses the same double-hotdog fold as the 




these two domains in a similar manner. The shifting of the catalytic histidine from its 
position in DH domains is approximately the distance of a carbon-carbon bond and could 
position the imidazole group between the sites of proton abstraction and donation. The 
shuttling of a substrate proton catalyzed by a single residue to isomerize a double bond 
has been proposed for several other isomerases, including ketosteroid isomerase (Pollack, 
2004), human mitochondrial enoyl-CoA isomerase (Partanen et al., 2004), 





isomerase (Zhang et al., 2001). 
 The possible intermediate of the mechanism proposed here involves either the 
transient protonation of the thioester carbonyl to an enol or the formation of an enolate 
that is stabilized by an oxyanion hole. To better understand how the single active site 
histidine catalyzes isomerization unaided and what the intermediate may be, substrate and 
product analogues were modeled into the active site of PksEI14. The location of the 
substrate and product were subjected to several restraints. First, a conserved positively-
charged residue and phenylalanine have been suggested to form the ACP-docking site for 
cis-AT PKS DHs (Keatinge-Clay, 2008), and these residues are retained in PksEI14 
(Lys257 and Phe204). The modeled substrate and product were therefore oriented so that 
the phosphopantetheinyl arm would be in close proximity to these residues. Second, since 
the active site histidine must interact with both the α- and γ-carbons of the polyketide, a 
second restraint limited the distance of these carbons to within 3.0 angstroms of the ε-
nitrogen of the catalytic histidine. Finally, the remaining atoms were manually adjusted to 




positioned to replace Wat2, forming hydrogen bonds with both the backbone amide of 
Gly28 and Wat3 (Figure 5-8). Gly28 forms the N-terminus of the first central α-helix, 
which contributes a partial positive charge from the helical dipole. Wat3 is coordinated 
by the carboxamide side chain of Asn182 (which replaces the catalytic aspartic acid of 
PKS DHs) and the backbone amide of Ala29, the second residue of this central helix 
(Figure 5-2c). An oxyanion hole formed by these two interactions could stabilize the 
thioester in an enolate form. No ionizable side chain is available in this region to donate a 
proton to the thioester carbonyl to form an enol intermediate. The participation of water 
molecules as oxyanion hole hydrogen bond donors is quite common amongst enolizing 
enzymes (Pihko et al., 2009). If the model presented in Figure 5-8 is an accurate 
representation of how the substrate binds to the active site of PksEI14, the 
stereoselectivity of the in vivo reaction would generate an S stereochemistry at the 
methyl-bearing α-carbon (C2 of bacillaene).  
 In contrast to each of the structures of cis-AT PKS DHs that have been solved to 
date, PksEI14 crystallized as a monomer. This raises questions regarding the architecture 
of trans-AT PKS shift-modules, represented by module 14 of PksX (generally composed 
of a condensation-incompetent KS, an EI, and an ACP domain). cis-AT PKS DHs 
dimerize primarily through interactions between their 20 N-terminal residues (Keatinge-
Clay 2008; Akey et al., 2010; 2013; Gay et al., 2013). However, an equivalent N-
terminal stretch is absent in both PksEI14 and the homologous domain from the Bae 
synthase. The recently published structure of the KS-B didomain from the rhizoxin trans-




quite differently from cis-AT PKS DHs with a less extensive interface (Bretschneider et 
al., 2013). This smaller interface may also be the only interaction between the EI 
domains of shift modules. 
 This study reports the first structure of the trans-AT PKS EI domain, revealing 
how divergent evolution of the double-hotdog fold has rendered an additional PKS 
domain capable of distinct chemistry (Pidugu et al., 2009; Lohman et al., 2013, He et al., 
2014). The results presented here strongly suggest that a key active site modification 
between PKS DH and EI domains enables the EI histidine to shuttle a proton between the 
α- and γ-carbons of an enoyl intermediate. Characterization of the reconstituted in vitro 
activity catalyzed by PksEI14 in deuterated solvent supports a mechanism whereby a γ-
proton (C4 of bacillaene) is abstracted by the active site histidine and is relocated to the 
α-position (C2) without the participation of solvent protons. To our knowledge, this 
enzymatic mechanism is the first example of a histidine independently shuttling a 
substrate proton to catalyze α,β → β,γ-double bond isomerization.  
MATERIALS AND METHODS 
Cloning, expression, and purification of PksEI14 
 Domain boundaries for the polypeptide fragment containing PksEI14 were 
determined based on sequence alignments of the previous and subsequent domains 
(PksKS14 and PksACP14, respectively). The N-terminus was chosen to be Ser1124 of 




terminus was chosen to be Asn1395, 17 residues before the first conserved residue of 




(ligation independent cloning regions underlined) from Bacillus subtilis subsp. 168 and 
inserted into pGAY28b, a ligation-independent cloning vector constructed from pET28b 
(Gay et al., 2014). E. coli BL21(DE3) transformed with the expression plasmid was 
inoculated into LB media containing 50 mg/L kanamycin at 37 °C, grown to OD600 = 0.4, 
and induced with 0.5 mM IPTG. After 12 h at 15 °C, cells were collected by 
centrifugation and resuspended in lysis buffer (0.5 M NaCl, 10% (v/v) glycerol, 0.1 M 
HEPES, pH 7.5). Following sonication, cell debris was removed by centrifugation 
(30,000 x g, 30 min). The supernatant was poured over a column of Nickel-NTA resin 
(Thermoscientific), which was then washed with 50 mL lysis buffer containing 15 mM 
imidazole and eluted with 5 mL lysis buffer containing 150 mM imidazole. PksEI14 was 
further purified using a Superdex 200 gel filtration column (GE Healthcare Life Sciences) 
equilibrated with 150 mM NaCl, 10 mM HEPES, pH 7.5. The eluted protein was 
concentrated to 30 mg/mL in the equilibration buffer and stored at -80 ˚C until needed.  
 The PksEI14(Tyr185Phe) expression plasmid was generated by PCR 







CAGCCCGC -3’ (EcoRI site underlined). The PCR product was digested with EcoRI and 
ligated. Purification of the mutant protein was performed as described for unmutated 
PksEI14. 
Cloning, expression, and purification of 4-coumaroyl-CoA-ligase (CCL) 
 The DNA encoding CCL was amplified using primers 5’-
TCACTTAGACATATGTTCCGCAGCGAGTACGCA-3’ and 5’- 
TGGACGTTAACTCGAGTCATCGCGGCTCCCTGAGCTGT-3’ (NdeI and XhoI 
restriction sites underlined) from S. coelicolor A3(2) and inserted into pET28b. E. coli 
BL21(DE3) transformed with the expression plasmid was inoculated into LB media 
containing 50 mg/L kanamycin at 37 °C, grown to OD600 = 0.4, and induced with 0.5 mM 
IPTG. After 12 h at 15 °C, cells were collected by centrifugation and resuspended in lysis 
buffer (0.5 M NaCl, 10% (v/v) glycerol, 0.1 M HEPES, pH 7.5). Following sonication, 
cell debris was removed by centrifugation (30,000 x g, 30 min). The supernatant was 
poured over a column of Nickel-NTA resin (Thermoscientific), which was then washed 
with 50 mL lysis buffer containing 15 mM imidazole and eluted with 5 mL lysis buffer 
containing 150 mM imidazole. CCL was further purified using a Superdex 200 gel 
filtration column (GE Healthcare Life Sciences) equilibrated with 150 mM NaCl, 10 mM 
HEPES, pH 7.5. The eluted protein was concentrated to 30 mg/mL in the equilibration 




Crystallization, structure determination, and refinement 
 Crystals of PksEI14 grew in 1-4 d by sitting drop vapor diffusion at 22 °C. Drops 
were formed by mixing 3 μL of protein solution (30 mg/mL PksEI14, 150 mM NaCl, 10 
mM HEPES, pH 7.5) with 1 μL of crystallization buffer (1.9 M ammonium sulfate, 0.1 M 
Tris-HCl, pH 8.3). Crystals were frozen in liquid nitrogen after a 5-min soak in the 
crystallization buffer modified with 10% (v/v) glycerol. Diffraction data, collected at 
APS GMCA Beamline 23-ID-D, were processed by HKL2000 (Otwinowski & Minor, 
1997). The structure was initially solved to 1.88-Å resolution by single-wavelength 
anomalous dispersion (Table 5-1). To generate a heavy atom derivative data set for 
phasing, crystals of PksEI14 were grown as described above and frozen in liquid nitrogen 
after a 30-min soak in the crystallization buffer modified with 10% (v/v) glycerol and 3 
mM methyl mercuric acetate. Diffraction data for derivative crystals were collected at 
ALS Beamline 5.0.2, and processed by HKL2000. Heavy atom sites were located and an 
initial model generated using AutoSol and AutoBuild within the Phenix suite (Terwilliger 
et al., 2008; Terwilliger et al., 2009). The initial model was then refined using a data set 
collected on a native crystal to 1.73 Å resolution, by iteratively building into the 
remaining electron density map with Coot (Emsley et al., 2010) and refining with 





Synthesis of thioester substrates 
 
(E)-hex-3-enyl-S-pantetheine: A solution of D-pantetheine (90 mg, 0.35 mmol, 1 eq.) 
dissolved in 5 ml DCM was set to stir at 4 ºC. To this solution was added (E)-hex-3-enoic 
acid (40 mg, 0.35 mmol, 1eq.), EDC (67.1 mg, 0.35 mmol, 1 eq.), and DMAP (4 mg, 
0.035 mmol, 0.1 eq.) and was set to stir at 4 ºC for 1 h and then at 22 ºC for an additional 
hour. Solvent was removed in vacuo, and the remaining material was chromatographed 
on silica gel eluting with 1:1 EtOAc:acetone to afford (E)-hex-3-enyl-S-pantetheine (100 
mg, 81%) as a clear oil.  
 
Rf = 0.3 (1:1 EtOAc:acetone) 
1
H NMR: 400 MHz (CDCl3) δ = 7.34 (t, J = 5.3 Hz, 1H), 6.16 (t, J = 5.3 Hz, 1H), 5.71-
5.63 (m, 1H), 5.51-5.43 (m, 1H), 3.99 (d, J = 5.2 Hz, 1H), 3.82 (d, J = 5.2 Hz, 1H), 3.59-
3.32 (m, 6H), 3.24 (dq, J1 = 7.0 Hz, J2 = 1.1 Hz, 2H), 3.08-2.95 (m, 2H), 2.41 (t, J = 5.8 
Hz, 2H), 2.11-2.03 (m, 2H), 1.02 (s, 3H), 0.99 (t, J = 7.4 Hz, 3H), 0.92 (s, 3H).  
LC/MS: Calc. for C17H31N2O5S [M+H]
+









(E)-hex-2-enyl-S-pantetheine: Prepared identically to (E)-hex-3-enyl-S-pantetheine, 





Rf = 0.3 (1:1 EtOAc:acetone) 
1
H NMR: 600 MHz (CDCl3) δ = 6.90 (dt, J1 = 15.5 Hz, J2 = 7.4 Hz, 1H), 6.10 (dt, J1 = 
15.5 Hz, J2 = 1.6 Hz, 1H), 3.56-3.34 (m, 7H), 3.13-3.01 (m, 2H), 2.39 (t, J = 5.9 Hz, 2H), 
2.17 (qd, J1 = 7.6 Hz, J2 = 1.5 Hz, 2H), 1.48 (m, 2H), 1.00 (s, 3H), 0.92 (t, J = 7.4 Hz, 
3H), 0.90 (s, 3H). 
 
 
(E)-hex-3-enyl-S-NAC: This compound was prepared identically to (E)-hex-3-enyl-S-
pantetheine, replacing 90 mg of D-pantetheine with 42 mg of N-acetyl-cysteamine 
(NAC) (0.35 mmol, 1 eq.). The crude material was chromatographed on silica gel eluting 
with EtOAc to afford (E)-hex-3-enyl-S-NAC (55 mg, 67%) as a white powder. The 
compound was dissolved in 1.3 ml of 3:1 DMSO:H2O to provide a 200 mM stock 
solution.  
 






H NMR: 400 MHz (CDCl3) δ = 5.67 (m, 1H), 5.49 (m, 1H), 3.43 (q, J = 6.3 Hz, 2H), 
3.24 (d, J = 7.0 Hz, 2H), 3.01 (t, J = 6.5 Hz, 2H), 2.07 (t, J = 5.6 Hz, 2H), 1.96 (s, 3H), 
1.00 (t, J1 = 7.4 Hz, 3H).  
 
 
(E)-2,2-dideutero-hex-3-enoic acid: To a 5 ml solution of 5 M KOH dissolved in D2O, 
(E)-hex-3-enoic acid was added (200 mg). The solution was set to stir at 50 ºC for 1 h, 
after which the solvent was removed in vacuo. An additional 5 ml of D2O was added to 
solution, which was again set to stir at 50 ºC for 1 h, and the solvent was removed in 
vacuo. The process of adding fresh D2O followed by removal in vacuo was repeated a 
total of four times. The solution was then acidified with 10 M HCl to a pH of 
approximately 2, and extracted three times with EtOAc. Solvent was removed in vacuo, 
to afford (E)-2,2-dideutero-hex-3-enoic acid (195 mg, 98%).  
 
Rf = 0.8 (75:24:1 hexanes:EtOAc:acetic acid) 
1
H NMR: 400 MHz (CDCl3) δ = 5.64 (dt, J1 = 15.3 Hz, J2 = 6.3 Hz, 1H), 5.49 (d, J = 






(E)-2,2-dideutero-hex-3-enoyl-S-pantetheine: To a round bottom flask, the following 
were added: 5 ml of 1 M HEPES (dissolved in H2O), 284 mg of MgCl2•6H2O, 1 ml of 
glycerol, and 1 ml of 0.35 M D-pantetheine (dissolved in H2O, 0.35 mmol, 1 eq.), pH 7.5. 
Solvent was removed in vacuo, and the contents were resuspended in 5 ml D2O. This was 
set to stir at 50 ºC for 1 h, after which the solvent was removed again in vacuo. The 
process of removing the solvent in vacuo and resuspending in D2O was repeated two 
additional times. The contents were then resuspended in 15 ml D2O, and the following 
were added: 300 mg NaCl, 355 mg adenosine triphosphate disodium salt, (E)-2,2-
dideutero-hex-3-enoic acid (50 mg, 0.44 mmol, 1.3 eq.), and 200 μl of purified CCL (30 
mg/ml, 150 mM NaCl, 15 mM HEPES, pH 7.5, H2O). This reaction was allowed to 
incubate 16 h at 22 ºC, and the following day was extracted twice with 20 ml of EtOAc, 
which was removed in vacuo to afford (E)-2,2-dideutero-hex-3-enyl-S-pantetheine (85 
mg, 65%). 
 
Rf = 0.3 (1:1 EtOAc:acetone) 
1
H NMR: 400 MHz (CDCl3) δ = 7.34 (t, J = 5.3 Hz, 1H), 6.16 (t, J = 5.3 Hz, 1H), 5.64 




3.82 (d, J = 5.2 Hz, 1H), 3.59-3.32 (m, 6H), 3.08-2.95 (m, 2H), 2.41 (t, J = 5.8 Hz, 2H), 
2.11-2.03 (m, 2H), 1.02 (s, 3H), 0.99 (t, J = 7.4 Hz, 3H), 0.92 (s, 3H). 
LC/MS: Calc. for C17H29D2N2O5S [M+H]
+





, and 399.2 [M+Na]
+
. 
Enzymatic activity assays 
In vitro reconstitution of PksEI14 activity in H2O.  
 A master mix was first generated, composed of the following: 8 μl from a stock of 
100 mM (E)-hex-3-enyl-S-pantetheine, 20 μl of glycerol, 20 μl of 1 M HEPES (pH 7.5), 
20 μl of 4 M NaCl, and 132 μl of water. This was split into three 40 μl reactions, to which 
were added either (1) 40 μl of protein equilibration buffer (150 mM NaCl, 10 mM 
HEPES, pH 7.5), (2) 40 μl of purified PksEI14, or (3) 40 μl of purified 
PksEI14(Tyr185Phe). The final concentration of each component would be: 2 mM (E)-
hex-3-enyl-S-pantetheine, 5% glycerol (v/v), 55 mM HEPES (pH 7.5), 275 mM NaCl, 
and 15 mg/ml (460 μM) of PksEI14 for reaction (2) and 15 mg/ml (460 μM) of 
PksEI14(Tyr185Phe) for reaction (3). The reactions were incubated for 24 h at 37 ºC, 
after which they were heat-treated at 80 ºC for 5 min and centrifuged at 21,000 x g for 10 
min to deactivate and precipitate the enzyme. The reactions were then injected onto a C18 
reversed-phase HPLC column and monitored over a range of λ values ranging from 200-
600 nm (7:3 water:MeOH, 0.1 % TFA, over 45 min). A peak with a λmax of 225 and 263 
nm (characteristic of α,β-unsaturated thioesters) that was not observed in control reaction 




PksEI14, respectively. The new peak was collected and subjected to 
1
H NMR and 
LC/MS, confirming its identity as (E)-hex-2-enyl-S-pantetheine (Calc. for C17H31N2O5S 
[M+H]
+




, and 397.2 [M+Na]
+
). 
Reconstitution of enzymatic activity towards (E)-hex-3-enyl-S-NAC was carried out in an 
identical manner to the reaction using (E)-hex-3-enyl-S-pantetheine, only replacing the 2 
mM (E)-hex-3-enyl-S-pantetheine with 2 mM (E)-hex-3-enyl-S-NAC. The 200 mM stock 
solution of (E)-hex-3-enyl-S-NAC was dissolved in 3:1 DMSO:H2O, and therefore the 
final concentration of each component would be: 2 mM (E)-hex-3-enyl-S-NAC, 5% 
glycerol (v/v), 55 mM HEPES (pH 7.5), 275 mM NaCl, 0.75% (v/v) DMSO, and 15 
mg/ml (460 μm) PksEI14. 
PksEI14 isomerase assay conducted in deuterated solvent. 
 To exchange PksEI14 into deuterated solvent, a deuterated isomerase buffer 
(DIB) was first prepared. 10 ml of glycerol, 1.2 g NaCl, and 0.5 g MES were dissolved 
into 10 ml of 99.9% D2O, and the pH/pD set to 7.0 with 5 M NaOH. This mixture was 
then incubated at 60 ˚C for 30 minutes, and dried under vacuum until the mass of the 
container holding the contents no longer decreased after additional drying. An additional 
10 ml of D2O was added, and the mixture was again subjected to incubation at 60 ˚C for 
30 minutes followed by drying under vacuum. This process was repeated an additional 3 
times, after which the dried contents were resuspended in 90 ml D2O to generate DIB 




 Due to the remarkably decreased rate of isomerization catalyzed by PksEI14 in 
D2O, the PksEI14 mutant generated in this study (Tyr185Phe) was chosen for the reaction 
in deuterated solvent for its enhanced catalytic rate (Figure 5-4). This mutation is highly 
unlikely to alter the mechanism for isomerization from the wild-type, as it is already 
present in the Rhizoxin EI domain (Figure 5-3). To exchange PksEI14 (Tyr185Phe) into 
DIB, the hexa-histidine tagged protein was first passed over a column of Ni-NTA agarose 
resin. The bound protein was washed with 10 ml of lysis buffer, and then washed with 10 
ml of DIB. The protein was then eluted from the resin with 5 ml of DIB modified by the 
addition of pure imidazole (150 mM final concentration). To reduce the concentration of 
both imidazole and any remaining solvent protons, the 5 ml of eluted protein solution was 
diluted with 5 ml of DIB to a total volume of 10 ml, followed by concentration to a 
volume of 5 ml using a centrifugal protein concentrator with a 30 kDa MWCO filter 
(Thermo-Scientific). The process of diluting the protein solution with DIB followed by 
concentration was repeated 10 times, effectively reducing the imidazole concentration to 
the low micromolar range. The protein was then concentrated to 2 mM. 
 To initiate the title assay, 10 mg of pure (E)-hex-3-enyl-S-pantetheine was 
dissolved into 2 ml of DIB, to which was added 2 ml of the deuterated PksEI14 
(Tyr185Phe) solution described above, giving a final concentration of each reaction 
component as: 10% glycerol (v/v), 200 mM NaCl, 25 mM MES, 7 mM (E)-hex-3-enyl-S-
pantetheine, 1 mM PksEI14 (Tyr185Phe), <1 mM imidazole, >98% D2O, pD 7.0. As a 
negative control, 10 mg of pure (E)-hex-3-enyl-S-pantetheine was simultaneously 




monitored by HPLC in a similar manner to the activity assay performed in H2O. It was 
noted that the isomerization activity progressively slowed during the time course of the 
reaction, presumably from the background exchange of the substrate α-protons for 
deuterons. After 20-24 h, the rate of isomerization became slower than the rate of 
thioester hydrolysis, leading to the simultaneous stalling of the enzymatic reaction and 
degradation of both substrate and product. The reaction was therefore quenched after 24 h 
by extraction with EtOAc (3 x 10 ml). The extracts were then dried under vacuum and 
resuspended in 1 ml CDCl3 for 
1
H NMR analysis, revealing two points of interest. First, 
the α-proton signal (3.24 ppm) for the unreacted β,γ-unsaturated substrate was absent in 
the spectra and the shifts associated with the substrate olefin protons (5.71-5.63 and 5.51-
5.43) revealed identical splitting patterns as observed for (E)-2,2-dideutero-hex-3-enyl-S-
pantetheine (Figures 5-6 and 5-7). Second, the splitting pattern for the β-proton signal of 
the α,β-unsaturated isomerized product was a doublet of triplets, indicative of a 
protonated γ-carbon. Residual contamination of the reaction with solvent protons is an 
unlikely source for the γ-protons in the isomerized product, since the background 
conversion of (E)-hex-3-enyl-S-pantetheine to (E)-2,2-dideutero-hex-3-enyl-S-
pantetheine confirms that the reaction solvent was greater than 98% D2O.  
PksEI14 catalyzed isomerization of (E)-2,2-dideutero-hex-3-enyl-S-pantetheine. 
 A reaction identical to the assay described above where the isomerase activity of 
PksEI14 was reconstituted in H2O was initiated; however, an α-deuterated version of the 




enyl-S-pantetheine. The reactions were monitored by HPLC as described above, but a 
remarkable decrease in the rate of PksEI14-catalyzed isomerization compounded with the 
background exchange of α-substituted protons (or deuterons) of the β,γ-unsaturated 
thioester with solvent complicated analysis of reaction products (i.e., the small amount of 
isomerized product which did form could have arisen either by 1) the direct enzymatic 
shuttling of an α-deuteron to the γ-position, or 2) the initial background exchange of the 
α-deuteron for a proton, followed by enzyme catalyzed shuttling of that proton to the γ-
position) (Figure 5-7d).  
1
H NMR analysis was performed on a Varian Mercury 400 MHz or a Varian 
DirectDrive 600 MHz instrument. LC-MS was performed on an Agilent Technologies 
1200 Series HPLC with a Gemini C18 column (5 μm, 2 × 50 mm; Phenomenex) coupled 
to an Agilent Technologies 6130 quadrupole mass spectrometer system equipped with an 
electrospray-ionization source. A 5–95% B gradient over 12 min at a flow rate of 
0.7 ml/min was run in which the mobile phases were (A) H2O with 0.1% formic acid and 
(B) acetonitrile with 0.1% formic acid. Reversed-phase HPLC was performed using an 
isocratic flow rate of 1 ml/min through a C18-column, with 34.95% MeOH/64.95% 
H2O/0.1% TFA as the mobile phase, monitoring UV-absorbance at wavelengths ranging 
from 200-600 nm. 
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Figure 5-1. Polyketides with shifted double bonds. (a) Several polyketides with 
isomerized double bonds are highlighted with blue circles. The C3/C4 double bond of 
bacillaene, isomerized by PksEI14, is annotated. (b) The last two PKS subunits 
responsible for the final catalytic steps of bacillaene biosynthesis are PksN and PksR. The 
proposed route involves the installation of β,γ-double bonds by the DH domains of 
modules 11 and 12 (PksDH11 and PksDH12), while the EI domain of module 14 is a 
dedicated isomerase for the α,β-double bond installed by the DH from module 13. The 
KS domain of the terminal module (PksKS15) is not condensationally competent and 
likely acts as a gatekeeper to ensure that the isomerization has taken place before the final 
product is released from the synthase. The small red circles appended to the KS domains 






Figure 5-2. Structure of PksEI14. (a) The monomeric crystal structure of PksEI14 is 
shown in cartoon form, with N- and C-termini labeled with blue and red spheres, 
respectively. Flexible loops that could not be modeled into electron density are shown as 
dashed lines. The catalytic histidine (His18) and active site valine (Val27) are modeled as 
sticks. (b) A structural alignment of PksEI14 (orange) with the DH domain from the 
erythromycin PKS (gray, PDB Code 3EL6) reveals that the highly conserved proline in 
the PKS DH HX8P motif is replaced with a valine, inducing a steric repositioning of the 
catalytic His18 imidazole ring. Asn182 replaces the catalytic aspartic acid of the PKS DH 
domain. The only active site residue that could complete a catalytic dyad is Tyr185; 
however, mutation to phenylalanine did not abolish isomerase activity. (c) Stereodiagram 
of active site 2Fo-Fc electron density contoured at 1.5 Å r.m.s.d. Yellow dashes indicate 













Figure 5-3. PKS DH and EI sequence alignment. Residue numbering is based on the 
structure of PksEI14 (last in the alignment). Asterisks indicate the catalytic dyad of the 
DH domain, and arrows indicate residues that apparently alter the function of the DH 
catalytic dyad in EI domains. In the sequence motif HX8P, His18 is responsible for 
deprotonating the α-carbon during dehydration, and the imidazole ring of this residue 
stacks against Pro27, highly conserved among DH sequences. Pro27 is substituted by 
either valine or leucine in EI sequences, which serves to shift the catalytic imidazole ring 
approximately 1.7 Å relative to its observed position in PKS DH domains. In the 
sequence motif DX3Q/H, Asp182 acts as a general acid during dehydration and is 
activated by a hydrogen-bond network bridged by Gln/His186 (Gay et al., 2013). The 
deterioration of this motif in the EI domain can be seen in the alignment, with Asp182 
replaced with asparagine in three of the four EI domains and Gln/His186 replaced with 
leucine/valine. (Accession codes for sequences in the alignment can be found in the 
Supplementary Information for “A close look at a ketosynthase from a trans-


































Figure 5-4. PksEI14 activity assay. Reversed-phase HPLC chromatograph of 
reconstituted in vitro isomerase activity observed after incubation of the β,γ-unsaturated 
substrate analogue with isolated PksEI14. The black line represents a control reaction that 
did not include any enzyme, revealing a single peak for (E)-hex-3-enyl-S-pantetheine. 
The blue line represents the same reaction with the addition of wild-type PksEI14, 
revealing a new peak with properties consistent with a synthetic standard of (E)-hex-2-
enyl-S-pantetheine, the β,γ → α,β isomerized product. An identical reaction replacing 
wild-type PksEI14 with the Tyr185Phe mutant is shown in red, exhibiting increased 



















Figure 5-5. Characteristics of synthetic substrate and product standards. (a) 
Reversed-phase HPLC analysis of the reaction of PksEI14 with (E)-hex-3-enyl-S-
pantetheine revealed a new peak with a slightly delayed retention time (Figure 5-
4). To confirm that this peak was the isomerized reaction product, synthetic (E)-
hex-2-enyl-S-pantetheine was also analyzed by reversed-phase HPLC. Shown in 
black with a retention time of 18.5 minutes is synthetic (E)-hex-3-enyl-S-
pantetheine, which is the same trace shown in Figure 5-4 (also in black). The 
maximal UV-absorbance for this β,γ-unsaturated thioester is 232 nm (left inset). 
The synthetic α,β-unsaturated thioester (E)-hex-2-enyl-S-pantetheine has a slightly 
delayed retention time of 20.1 minutes, and UV-absorbance maxima of 225 and 
263 nm (shown in red, right inset), which match the PksEI14-catalyzed 
isomerization products. (b) To determine if PksEI14 was active towards NAC-
tethered substrates, (E)-hex-3-enyl-S-NAC was incubated with PksEI14 under 
similar conditions to the assays described for pantetheine-tethered substrates. The 
isomerization activity observed was severely attenuated, indicating that the 
pantetheinyl-moiety is recognized by the enzyme. The identity of the reaction 
product, (E)-hex-2-enyl-S-NAC, was confirmed by the UV-absorbance maxima of 































Figure 5-6. PksEI14-catalyzed isomerization in D2O. To determine whether PksEI14 
shuttles a proton within the substrate or employs water in the catalytic mechanism, (E)-
hex-3-enyl-S-pantetheine (1) was incubated with PksEI14 in D2O, and the reaction was 
analyzed by NMR. The negative control (top spectrum), in which PksEI14 was not 
added, shows only uncatalyzed α-hydrogen exchange. When PksEI14 is supplied (middle 
spectrum), isomerization to (E)-hex-2-enyl-S-pantetheine (2) is observed. If the 
mechanism of isomerization involved a solvent- or enzyme-donated proton, the γ-
position would be monodeuterated, and different splitting patterns would be observed. 
The bottom spectrum is of synthetically prepared (E)-hex-2-enyl-S-pantetheine (2). Each 
of the four possible olefinic proton signals are aligned with the corresponding region of 
the spectrum and denoted with red circles. Pantetheine moieties are represented by 





















Figure 5-7. Background exchange of α-protons in β,γ-unsaturated thioesters. The 
solvent-catalyzed exchange of protons for deuterons at the α-position of β,γ-unsaturated 
thioesters complicates the analysis of isomerase reactions conducted in deuterated 
solvent. In each panel, “R” represents D-pantetheine. (a) The low-field region from a 
1
H-
NMR spectrum of (E)-hex-3-enyl-S-pantetheine reveals a multiplet splitting pattern for 
each olefinic proton. (b) The synthesis of (E)-2,2-dideutero-hex-3-enyl-S-pantetheine 
required the initial synthesis of (E)-2,2-dideutero-hex-3-enoic acid, and the low-field 
1
H-
NMR region of the α-deuterated free acid is shown. The multiplet olefinic signals are 
replaced by peaks with interpretable splitting patterns, which reveal a doublet of triplets 
for the γ-proton, and a broad doublet for the β-proton. (c) During the incubation of 
PksEI14 with (E)-hex-3-enyl-S-pantetheine in D2O, continuous HPLC analysis revealed 
that the reaction had stalled, and it was therefore quenched and subjected to 
1
H-NMR. 
Shown is the low-field region of the spectrum, which indicates that the (E)-hex-3-enyl-S-
pantetheine substrate had nearly completely converted (uncatalyzed) to (E)-2,2-
dideutero-hex-3-enyl-S-pantetheine. The β-proton signal for the isomerized reaction 
product is also visible in the same spectrum (shown in Figure 5-6), and reveals that the 
enzyme-catalyzed isomerization (which must have occurred before the substrate 
underwent uncatalyzed α-deuteration) yielded a γ-protonated product. (d) Due to the 
uncatalyzed background exchange of α-protons in the β,γ-unsaturated substrate mimic, 
analysis of PksEI14 reaction products becomes very complicated. Shown are all the 
competing reactions that occur when (E)-hex-3-enyl-S-pantetheine is incubated with 



























Figure 5-8. Proposed mechanism for double bond migration. Shown in three panels is the 
proposed mechanism for the biological reaction catalyzed by the PKS EI domain. 
Bacillaene carbon atoms are modeled in light blue, “R” represents bacillaene atoms not 
shown in the figure, and “R′” represents the ACP phosphopantetheinyl arm. Each yellow 
dashed line indicates a distance of 2.8 – 3.1 Å, and the red dashed lines indicate a 
distance of 2.2 Å. (a) The substrate modeled contains an α-methyl branch and is 
unsaturated at the α,β and δ,ε positions to resemble the biological intermediate. The 
thioester oxygen atom is modeled in the place of Wat2 (see Figure 5-2C). Catalysis is 
initiated by the abstraction of a γ-proton by the catalytic histidine. (b) The enolate is 
stabilized by the polarization of the thioester carbonyl, which forms interactions with the 
positive dipole of a central α-helix. (c) In the final panel, the proton abstracted from the 




















Table 5-1. Crystallographic data and refinement statistics. Values in parentheses refer to 




Chapter 6. A close look at a ketosynthase from a trans-acyltransferase 
modular polyketide synthase 
 
ABSTRACT 
The recently discovered trans-acyltransferase modular polyketide synthases 
catalyze the biosynthesis of a wide range of bioactive natural products in bacteria. Here 
we report the first structure from a trans-acyltransferase polyketide module – the second 
ketosynthase of the bacillaene synthase. This 1.95 Å-resolution structure provides the 
highest resolution view available of a modular polyketide synthase ketosynthase and 
reveals a flanking subdomain that is homologous to an ordered linker in cis-
acyltransferase modular polyketide synthases. The structure of the cysteine-to-serine 
mutant of the ketosynthase acylated by its natural substrate provides high-resolution 
details of how a native polyketide intermediate is bound and helps explain the basis of 
ketosynthase substrate specificity. The substrate range of the ketosynthase was further 
investigated by mass spectrometry. 
INTRODUCTION 
 The complexity of reduced polyketides is a reflection of the polyketide synthases 
(PKSs) that produce them - a series of multidomain modules that catalyze the elongation 
and processing of polyketide intermediates in assembly-line fashion
 
(Piel, 2010; 
Keatinge-Clay, 2012). While PKS modules are comprised of domains equivalent to those 
of type I fatty acid synthases (FASs), their products are much more functionalized due to 
the processive nature of these assembly lines and the combination of enzymes present 
within their component modules. Since invaluable human medicines such as the 
Chapter 6 was adapted from the following published work: Gay DC, Gay G, Axelrod AJ, Jenner M, 
Kohlhaas C, Kampa A, Oldham NJ, Piel J, and Keatinge-Clay AT. (2014) A close look at a ketosynthase 
from a trans-acyltransferase modular polyketide synthase. Structure 22, 444–451. Each author contributed 




antibacterial erythromycin, the antifungal amphotericin, and the anticancer agent 
epothilone are produced by these biosynthetic machines, it is anticipated that 
understanding their architectures and activities will accelerate the development of new 
medicines. 
 Presently, all of the available structural information for PKS assembly lines is 
from cis-acyltransferase (cis-AT) systems (Keatinge-Clay, 2012), in which AT domains 
are integrated into the assembly line polypeptides C-terminal to ketosynthase (KS) 
domains. Within the modules of cis-AT PKSs, the AT domains are rigidly connected to 
the dimeric KS through an ~100-residue subdomain also present in metazoan FASs
 
(Tang 
et al., 2006; Tang et al., 2007; Maier et al., 2008; Pappenberger et al., 2010). In contrast, 
the AT domains of trans-AT PKSs are not integrated into the assembly lines but 
expressed as free-standing polypeptides
 
(Patel et al., 1995; Calderone et al., 2006; Chen 
et al., 2006, Butcher et al., 2007; Moldenhauer et al., 2007; Reddick et al., 2007; 
Moldenhauer et al., 2010; Jenner et al., 2013) (Figure 6-1). These discrete ATs usually 
transfer malonyl extender units to several acyl carrier protein (ACP) domains within a 
synthase (Cheng et al., 2003); however, some transfer more unusual extender units to 
specific ACPs (Musiol et al., 2011). The first reported trans-AT PKS, which has become 
prototypical for this PKS class, is the bacillaene synthase found within Bacillus subtilis 
and Bacillus amyloliquefaciens (pksX and baeX gene clusters, respectively) (Piel et al., 
2010). Bacillaene (Figure 6-1) is a linear polyene diamide that inhibits prokaryotic 




 The carbon-carbon bond-forming chemistry performed by KSs is at the core of 
polyketide synthesis (Figures 6-1 and 6-2). Catalysis is initiated when a polyketide 
intermediate is transferred through transthioesterification from the ACP of one module to 
the KS of the subsequent module. An extender unit-bound ACP then docks to the 
polyketide-bound KS to enable a decarboxylative condensation, generating a -keto 
intermediate that may be processed at its - and β-carbons through the action of a 
methyltransferase (MT), ketoreductase (KR), dehydratase (DH), enoylreductase (ER), or 
-branching enzyme. Unlike KSs from cis-AT PKSs, KSs from trans-AT PKSs cluster 
into distinct clades that correlate with the chemistries of the - and -positions of the 
accepted polyketide intermediate (Nguyen et al., 2008). Recently it was shown that, at 
least in some cases, this sequence-based correlation manifests in pronounced substrate 
specificity (Jenner et al., 2013; Kohlhaas et al., 2013). An understanding of substrate 
specificity at the structural level is therefore crucial for successful engineering of trans-
AT PKSs.  
 Here we report the 1.95 Å-resolution crystal structure of the KS from the second 
PKS module of the bacillaene synthase (PksKS2), the highest resolution available to date 
of a KS domain from a modular PKS. The structure reveals a flanking subdomain of the 
KS that is equivalent to the KS/AT adapter of cis-AT PKSs and contains two loosely-
connected helices where the AT is incorporated in cis-AT systems. The structure of a 
cysteine-to-serine mutant acylated by both a hexanoyl group and the natural polyketide 
intermediate help elucidate how trans-AT KSs control substrate specificity, identifying 




elaborated through a mass spectrometry-based approach recently developed to investigate 
the substrate specificity of trans-AT KSs (Jenner et al., 2013). 
RESULTS 
Structure determination 
 The boundaries chosen for PksKS2 were based on those used to express KS+AT 
fragments from cis-AT PKSs, beginning six residues N-terminal to the IAIIG motif and 
ending six residues C-terminal to the LPxYPFxxxxxW motif (Tang et al., 2006; Tang et 
al., 2007). The 1.95-Å structure of PksKS2 was solved by molecular replacement using a 
KS from the erythromycin synthase (PDB code: 2QO3) as a search model (Tang et al., 
2007), revealing the KS dimer interface anticipated from related enzymes (Figures 6-3 
and 6-4). Crystal structures of PksKS2(Cys176Ser) bound to the natural substrate and a 
hexanoyl substrate were obtained through soaking and co-crystallization, respectively, of 
substrate analogs (Figure 6-5). 
Comparison of PksKS2 to other type I synthases 
 The architecture of the PksKS2 dimer is highly homologous to the equivalent 
regions of other type I synthases (C r.m.s.d.: 1.7 Å over 470 C with third module of the 
erythromycin PKS and 1.2 Å over 350 C with the human FAS) (Tang et al., 2007; 
Pappenberger et al., 2010). At the C-terminal end of the ~450-residue KS domain is 
incorporated an ~100-residue subdomain with a ------ fold (here referred to as 




PKSs or “ATd” in trans-AT PKSs) (Figures 6-3, 6-4, and 6-6) (Keatinge-Clay, 2012; 
Calderone et al., 2006). In both cis-AT PKSs and the metazoan FAS, the AT domain 
inserts between the final -strand and -helix of the ~100-residue subdomain, while in 
PksKS2, two loosely-connected helices, 17 and 18, insert at this position. The final 
loop of the KS in trans-AT PKSs is essentially identical to that in cis-AT PKSs, with an 
extended LPxYPF peptide mediating the interaction with the flanking subdomain. The 
equivalent peptide in metazoan FASs forms a helical turn. In all type I systems, a 
conserved tryptophan at the end of the final KS loop buries into a pocket near the two-
fold axis of the synthase. 
 Compared to the metazoan FAS KS, the KSs of trans-AT and cis-AT PKSs are 
structurally more similar to one another. Only seven residues were found to consistently 
differ between trans-AT and cis-AT PKSs (Table 6-2). Four of these are within 15 Å of 
one another and together stabilize the position of helix 9. Although oriented by distinct 
networks of residues, this three-turn helix on the KS surface is equivalently located in 
cis-AT and trans-AT PKSs and absent from the KSs of metazoan FASs. Both types of 
PKS KS possess a longer, structured loop between 1 and 2 compared to the KSs of 
metazoan FASs. 
KS specificity 
 The active site of PksKS2 is homologous to the active sites of the KSs from cis-
AT PKS and metazoan FASs, with catalysis mediated by a cysteine and two histidines 




and 6-6) (von Wettstein-Knowles et al., 2006; Zhang et al., 2006). Phylogenetic studies 
of KS domains from trans-AT systems have revealed that, in contrast to the KS domains 
from cis-AT systems, a correlation exists between the biosynthetic intermediate that a KS 
accepts and the primary sequence of that KS (Nguyen et al., 2008). All residues within 15 
Å of the active site cysteine were examined for each of the sixteen defined KS clades 
since sets of these residues are likely responsible for imparting substrate specificity 
(Figure 6-5). 
Crystal structures of PksKS2 bound to substrates were sought in order to help 
elucidate the physical interactions of polyketide intermediates with KS active sites 
(Figures 6-5 and 6-7). A complex structure could not be obtained using crystals of wild-
type PksKS2. However, by mutating the active site cysteine to serine and incubating 
PksKS2(Cys176Ser) with (S)-α-hydroxyisocaproyl--aminobutyryl-S-N-acetylcysteamine 
(NAC), the natural intermediate was observed covalently bound to the active site serine 
(Calderone et al., 2008; Olsen et al., 2001). The ester carbonyl forms a hydrogen bond 
with the Ile433 NH, and a well-ordered water molecule adjacent to the ester (Wat1) is 
coordinated by the catalytic histidines. In unbound PksKS2, this water is only forming a 
hydrogen bond to His311; a similarly-located water has been proposed to participate in 
the condensation reaction (Figure 6-3c) (Zhang et al., 2006). Several functional groups 
of the natural intermediate make favorable interactions with active site residues: its amide 
NH forms a hydrogen bond with the hydroxyl group of Tyr215, its hydroxyl group forms 
a hydrogen bond with the carboxylate of Glu362, and its gem-dimethyl terminus makes 




with the substrate mimic hexanoyl-S-pantetheine, a hexanoyl group was also observed in 
the active site. As with the natural intermediate, the ester carbonyl forms a hydrogen 
bond with the NH of Ile433, and a well-ordered water molecule is coordinated by the 
catalytic histidines. The - and -carbons of the natural substrate and the hexanoyl group 
are closest to the side chains of Tyr237, Glu362, and Ile433. The dihedral angles 
neighboring the - and -carbons of the hexanoyl group and the natural intermediate 
slightly differ due to favorable contacts made between the natural intermediate and active 
site residues. No electron density is observed for either the NAC or pantetheine substrate 
handles, indicating that transesterification liberated the handles into solvent. Mass 
spectrometry suggests complete acylation of PksKS2(Cys176Ser) by the natural 
substrate. 
A time-dependent, mass spectrometry-based method was recently developed to 
examine KS specificity (Jenner et al., 2013). This method was utilized to examine the 
specificity of BaeKS2 with acyl-S-NAC substrates (Figures 6-8 and 6-9). This KS from 
the Bacillus amyloliquefaciens bacillaene synthase is the equivalent of PksKS2 and 
possesses identical residues within 15 Å of the catalytic cysteine. BaeKS2 was most 
rapidly acylated by the short β-ketoacyl-S-NAC 2. The acetamide analog of the natural 
substrate, 3, and the other unbranched acyl-S-NACs 1, 4, and 6 were also accepted. 
BaeKS2 tolerated a methoxy group in the δ- position but not the β-position, as indicated 




The flanking subdomain 
 Most KSs from trans-AT PKSs, including those from clades III and X that do not 
catalyze chain elongation, contain a flanking subdomain (Figure 6-10). Only KSs from 
clades XIV and XV, located within so-called bimodules, consistently do not contain this 
subdomain (Piel, 2010; Nguyen et al., 2008). Some flanking subdomains contain an 
inactive ACP domain, inserted between 14 and 15, lacking the serine residue to which 
the phosphopantetheinyl arm is normally attached (Figure 6-11). 
 The interaction of the AT domain with the KS/AT adapter in cis-AT PKSs is 
primarily mediated by hydrophobic interactions between an -helix structurally 
equivalent to 19 of the flanking subdomain and a groove in the AT domain. While the 
C-terminal helix of some acyltransferases (e.g., Streptomyces coelicolor FabD) is located 
in this groove, discrete ATs from trans-AT PKSs often do not possess this helix 
(Keatinge-Clay et al., 2003; Wong et al., 2011). However, docking an AT to PksKS2 
through 19 results in a clash with 17 and 18 of the flanking subdomain (Figure 6-12) 
(Tang et al., 2007). 
DISCUSSION 
 KS specificity is a central feature in trans-AT PKSs. The primary role of many 
KSs is gatekeeping – they catalyze the specific transfer of intermediates through the 
assembly line but do not catalyze chain elongation. One example from the bacillaene 
synthase is its final KS, which is condensation-incompetent but apparently ensures that a 




allowing it to be off-loaded from the assembly line (Figure 6-2). Condensation-
competent KSs also perform gatekeeping roles, as KSs of the same clade generally 
possess similar specificities (Jenner et al., 2013) (Figure 6-5 and 6-6). PksKS2 belongs 
to Clade V, members of which usually accept ,-unsubstituted substrates and, based on 
the presented crystallographic data, could employ Tyr237 and Glu362 to select against - 
and -branched substrates (-keto substrate 2 may be able to acylate BaeKS2 since it is 
shorter than the natural substrate and possesses more degrees of freedom in the active 
site) (Nguyen et al., 2008) (Figures 6-7 and 6-13). Clade I KSs possess smaller residues 
in these positions (phenylalanine and alanine, respectively) that likely provide more space 
for the variety of branched substrates they accept. The presented KS structures suggest 
that the methionine N-terminal to the catalytic cysteine in ,-olefin-accepting Clade IX 
KSs sterically blocks ,-branched and ,-saturated substrates, which possess greater 
steric bulk around their - and -carbons than ,-olefin substrates (Jenner et al., 2013). 
The asparagine N-terminal to the catalytic cysteine in Clade XVI KSs plays a critical role 
in the acylation of KSs by amide-containing substrates generated by non-ribosomal 
peptide synthetase modules (Kohlhaas et al., 2013). Modeling an asparagine residue in 
the place of Ala175 in PksKS2 reveals that its side chain carbonyl is in position to form a 
hydrogen bond with the amide NH of those intermediates. While it is apparent that 
threading the sequence of a KS through the PksKS2 structure will be beneficial in 
modeling interactions between that KS and its substrate, to determine the precise contacts 




mutating the catalytic cysteine to serine prior to acylation with a small molecule analogue 
yields a highly stable ester adduct, enabling the visualization and analysis of these 
informative complexes. 
 Whether docking sites for discrete ATs exist for trans-AT PKS KSs is unknown. 
No feature of KS correlates with AT docking since no consistent differences are apparent 
between the surfaces of trans-AT KSs and cis-AT KSs. The only consistent difference 
between the flanking subdomain from trans-AT KSs and the equivalent region from other 
type I systems are the two inserted helices (α17 and α18) instead of an AT domain. A 
discrete AT could dock to α19 of PksKS2, through an interaction similar to EryAT3 with 
the equivalent helix of the KS/AT adapter. Such an interaction could be made possible by 
discrete ATs (e.g., PksC in the bacillaene synthase) through the absence of the C-terminal 
helix observed in Streptomyces coelicolor FabD (Keatinge-Clay et al., 2003). However, 
α17 and α18 of the flanking subdomain would need to shift to enable the AT to dock in 
this orientation (Figure 6-12). The length and composition of α17 and α18 are not highly 
conserved (Figure 6-10). 
  Many condensation-incompetent KSs contain flanking subdomains that would 
serve no purpose if their only role was to bind AT. Since such a KS must still interact 
with two ACPs to transfer a polyketide through the assembly line, one could hypothesize 
that the flanking subdomains help form the ACP docking sites. However, even if the 
flanking subdomain facilitates interactions with ACPs, their involvement is not always 
required. KSs in clade XIV catalyze polyketide transfer between two ACPs without this 




subdomain. In the bacterial FAS, the KS equivalents do not possess the subdomain but 
are docked by carrier proteins for transthioesterification and chain elongation reactions. 
 The 1.95-Å structure of PksKS2 reported here represents the first structure from a 
trans-AT PKS module, provides the highest resolution view of a type I KS domain, and 
enables a first glimpse of the mysterious flanking subdomain. The crystallographic 
visualization of a KS bound to its natural intermediate signifies the first snapshot of a 
polyketide intermediate covalently attached to an enzyme from within a PKS module and 
reveals the locations of residues that control substrate specificity. The structure of the KS 
active site correlates with phylogenetic studies of KS specificity that were further 
elucidated in this work by mass spectrometry. Together, the reported structural and 
functional analysis provides much-needed, high-resolution insights into the most central 
enzyme of PKS assembly lines. 
MATERIALS AND METHODS 
Cloning, expression, and purification of PksKS2 
 Domain boundaries for the polypeptide fragment containing PksKS2 were chosen 
based on the crystal structure of Ery(KS+AT)3, six residues N-terminal of the conserved 
IAIXG motif and six residues C-terminal to a LPxYPFxxxxxW motif (Tang et al., 2007). 
The DNA encoding PksKS2 was amplified using primers 5’- 
GCGGCCTGGTGCCGCGCGGCTCTAGCGCTGCCGATTTTGAGCCG-3’ and 5’- 
GTGGTGGTGGTGGTGGTGATGTTAATGTCCCTTTGCCGGTACCC-3’ (ligation-




into pGAY28b, a ligation-independent cloning vector constructed from pET28b. E. coli 
BL21(DE3) transformed with the expression plasmid was inoculated into LB media 
containing 50 mg/L kanamycin at 37 °C, grown to OD600 = 0.4, and induced with 0.5 mM 
IPTG. After 12 h at 15 °C, cells were collected by centrifugation and resuspended in lysis 
buffer (0.5 M NaCl, 10% (v/v) glycerol, 0.1 M HEPES, pH 7.5). Following sonication, 
cell debris was removed by centrifugation (30,000 rcf for 30 min.). The supernatant was 
poured over a column of Nickel-NTA resin (Thermoscientific), which was then washed 
with 50 mL lysis buffer containing 15 mM imidazole and eluted with 5 mL lysis buffer 
containing 150 mM imidazole. PksKS2 was further purified using a Superdex 200 gel 
filtration column (GE Healthcare Life Sciences) equilibrated with 150 mM NaCl, 10 mM 
HEPES, pH 7.5. The eluted protein was concentrated to 9 mg/mL in the equilibration 
buffer and stored at -80 ˚C until needed.  
 The PksKS2(Cys176Ser) expression plasmid was generated by PCR amplification 
from the PksKS2 construct described above using primers 5’-
GAGACGGCCTCGAGCAGTTCTCTTGTAGCCATTCACCGTGCTG-3’ and 5’-
AGAACTGCTCGAGGCCGTCTCTACTGGCTCGCTCGGACCATGAATA-3’ (XhoI 
site underlined). The PCR product was digested with XhoI and ligated. Purification of the 
mutant protein was performed as described for unmutated PksKS2.  
Crystallization and structure determination 
 Crystals of PksKS2 grew in 2-14 d by sitting drop vapor diffusion at 22 °C. Drops 




HEPES, pH 7.5) with 1 µL crystallization buffer (1.1 M ammonium sulfate, 0.2 M 
lithium sulfate, 0.1 M Tris, pH 8.0). Crystals were frozen in liquid nitrogen after a 20-min 
soak in the crystallization buffer modified with 20% (v/v) glycerol. Diffraction data, 
collected at ALS Beamline 5.0.3, were processed by HKL2000 (Otwinowski & Minor, 
1997). The structure was solved to 1.90 Å resolution by molecular replacement with 
PhaserMR (McCoy et al., 2007) in the CCP4 suite (Winn et al., 2011), using a poly-
alanine model (Stein, 2008) of the KS monomer from Ery(KS+AT)3 (PDB code: 2QO3) 
as the search model. The model generated from the molecular replacement solution was 
used to iteratively build into the remaining electron density map with Coot (Emsley et al., 
2010) and was refined with Refmac5 (Murshudov et al., 1997).  
 Crystals of PksKS2(Cys176Ser) bound to a hexanoyl group grew over 2-6 d by 
sitting drop vapor diffusion at 22 °C. Drops were formed by mixing 2 µL protein solution 
(7 mg/mL PksKS2(Cys176Ser), 150 mM NaCl, 10 mM HEPES, pH 7.5, 10 mM 
hexanoyl-S-pantetheine) with 1 µL crystallization buffer (1.3 M ammonium sulfate, 0.1 
M Tris, pH 8.2). Crystals were frozen in liquid nitrogen after a 20-min soak in 
crystallization buffer modified with 20% (v/v) glycerol and 10 mM hexanoyl-S-
pantetheine, and the diffraction data were collected at ALS Beamline 5.0.2. The crystals 
were found to have the same space group and unit cell dimensions as those of unmutated 
PksKS2 and were iteratively refined with Coot and Refmac5.  
 Crystals of PksKS2(Cys176Ser) bound to the natural intermediate could not be 
optimized to diffract beyond 3.6-Å resolution under co-crystallization conditions. Thus a 




of PksKS2(Cys176Ser) grew over 1-2 d by sitting drop vapor diffusion at 22 °C in the 
absence of substrate. Drops were formed by mixing 1.5 µL protein solution (7 mg/mL 
PksKS2(Cys176Ser), 150 mM NaCl, 10 mM HEPES, pH 7.5) with 1 µL crystallization 
buffer (15% (w/v) PEG 3350, 0.18 M tri-ammonium citrate). Crystals were soaked for 2 
h in crystallization buffer modified with 20% (v/v) glycerol and 10 mM (S)-α-
hydroxyisocaproyl--aminobutyryl-S-N-acetylcysteamine before being frozen in liquid 
nitrogen. Diffraction data were collected at ALS Beamline 5.0.2, and the structure was 
solved by molecular replacement with PhaserMR using an unmutated PksKS2 monomer 
as the search model. The structure was iteratively refined with Coot and Refmac5. 
Cloning, expression, and purification of BaeKS2 
The Bacillus amyloliquefaciens FZB42 DNA that encodes BaeKS2 was amplified 
by PCR with Phusion High-Fidelity DNA polymerase (NEB) using the forward primer 
5´-AAAGGATCCGCAAAAGAGCATCCGGGCCGTTT-3´ and the reverse primer 5'-
AAAAAAAAGCGGCCGCTCACCATTGTTTCGTCAGAATACGTTTCATCCG-3´. 
The restriction digest of the PCR amplicon was performed with BamHI and NotI, and the 
product was purified on a TAE agarose gel. The insert was ligated into the BamHI and 
NotI sites of pHis8 (Jez et al., 2000).
 
The ligation product was then transformed into 
electrocompetent E. coli BL21(DE3) cells. Positive clones were grown overnight in LB 
medium at 37 °C. The plasmid DNA was isolated and sequenced. A positive colony was 




A 10 mL overnight culture of E. coli BL21(DE3) transformed with the BaeKS2 
plasmid (pAK6) were transferred into 1 L LB medium with 50 µg/mL kanamycin. After 
3-4 h incubation at 37 °C and growth to OD600 = 0.7, overexpression was induced by 
addition of 1 mM IPTG, and the culture was grown overnight at 16 °C. Cells were 
centrifuged, and the supernatant was removed. The cell material was resuspended in lysis 
buffer (25 mM Tris, 0.5 M NaCl, 10% (v/v) glycerol, 10 mM imidazole, pH 7.6), 
sonicated, and centrifuged again. BaeKS2 was purified via its N-terminal His8-tag by 
adding Ni-NTA agarose to the supernatant and incubating 1 h on ice while shaking. The 
suspension was loaded on a column and washed with lysis buffer with an increasing 
imidazole gradient (40-300 mM). Fractions containing BaeKS2 were frozen in liquid 
nitrogen and stored at -80 °C. 
Mass spectrometry analysis of KS acylation 
Acylation assays. Acylation reactions were conducted in storage buffer (25 mM 
Tris, 0.5 M NaCl, 10% (v/v) glycerol, pH 7.6). NAC thioesters were incubated with KS 
domains at a final concentration of 2 mM. BaeKS2 was maintained at 12 M for 
acylation assays. To ensure the NAC thioesters remained in solution, the concentration of 
DMSO was adjusted to 5% (v/v). Acylation reactions were allowed to run 0-20 min at 25 
°C before quenching with 0.1% TFA. 
 
Sample preparation for mass spectrometry analysis. C4 ZipTips
TM
 (Merck 




with two 10 L aspirations of H2O/0.1% TFA solution. The protein sample was then 
loaded onto the ZipTip column by 15-20 10-L aspirations of the sample, each time 
injecting back into the sample vial. The loaded protein sample was then desalted by 
15x10-L aspirations of H2O/5% MeOH/0.1% TFA, followed by elution of the sample 
into 5 L H2O/80% MeCN/0.1% TFA. 
 
Data analysis. Denatured KS spectra obtained from acylation experiments were 
subjected to minimal smoothing and noise reduction. The spectra were deconvoluted 
using the transform function of Mass Lynx
TM
, taking an average of all charge states. 
Relevant peak intensities were recorded and converted into the concentration of 
unacylated KS and acylated KS. Data was recorded in triplicate, and an average taken for 
kinetic plots. 
 





, a hybrid quadrupole-ion mobility-orthogonal acceleration TOF 
instrument (oa-TOF) produced by Waters
TM
 (Milford, MA). This instrument has multiple 
ionization capabilities of which nanoESI was utilized during this study. Parameters 
employed: cone voltage, 20 V; capillary voltage, 1.5 kV; trap CE, 10 V; transfer CE, 5 V; 
backing pressure, ~4 mbar; trap pressure, 2.3 x 10
-3
; TOF pressure: 1.6 x 10
-6
 mbar. A 
quadrupole profile was applied that gave optimal transmission between 1000-3000 m/z. 
Spectra were acquired between 1000-4000 m/z. Mass Lynx
TM
 4.1 software was used to 




Mass spectrometry analysis of PksKS2 acylation 
Acylation assays. Acylation reactions were conducted in storage buffer (10 mM 
HEPES, 0.15 M NaCl, pH 7.5). The NAC thioester of the natural substrate was incubated 
with Cys176Ser PksKS2 at a final concentration of 10 mM, while the protein was 
maintained at 100 μM. To ensure the NAC thioester remained in solution, the 
concentration of DMSO was adjusted to 0.5% (v/v). The reaction was allowed to run for 
60 min at 25 °C before quenching with 0.1% TFA. Protein molecular weight 
determination was provided by the University of Texas at Austin Proteomics Facility on 
the 4000 QTrap (AB Sciex). 
Synthesis of ligands for crystallographic analysis of KS acylation 
 
 
To a stirred solution of (S)-(-)-2-hydroxyisocaproic acid (500 mg, 3.8 mmol, 1.0 eq.) in 
DMF (2.0 mL) at 23 °C was added imidazole (1.24 g, 18.2 mmol, 4.8 eq.) followed by 
TBSCl (1.37 g, 9.1 mmol, 2.4 eq.). The pale yellow solution was stirred for 18 h and then 
diluted with 100 mL of 1:1 hexanes:EtOAc. The solution was washed with 10% aqueous 
citric acid (30 mL), saturated NaHCO3 (50 mL), water (50 mL) and then brine (50 mL). 




was dissolved in MeOH (40 mL), cooled to 0
 
°C and both K2CO3 (1.3 g, 9.5 mmol, 2.5 
eq.) and water (12 mL) were added. The resulting mixture was stirred 4 h at 23 °C, and 
the solvent was removed in vacuo. The residue was dissolved in water (20 mL), cooled to 
0
 
°C, and acidified to pH = 4 through the addition of 10% aqueous citric acid solution. 
The aqueous solution was washed with EtOAc (50 mL), and the organic layer was 
separated. The aqueous layer was washed with EtOAc (50 mL), and the combined 
organic layers were dried over sodium sulfate and concentrated in vacuo. The crude 
product was chromatographed on silica gel eluting with 2:1 EtOAc:hexanes to afford the 
title compound (68%, 640 mg) as a pale, clear oil. 
 
1
H NMR: 400 MHz (CDCl3) = 4.27 (dd, J = 7.2 Hz, J = 5.1 Hz, 1H), 1.82 (m, 1H), 
1.67-1.56 (m, 2H), 0.95 (d, J = 6.6 Hz, 3H), 0.94 (s, 9H), 0.94 (d, J = 6.6 Hz, 3H), 0.14 
(s, 3H), 0.13 (s, 3H). 
13
C NMR: 100 MHz (CDCl3) = 179.8, 70.4, 44.0, 25.7, 24.0, 23.2, 21.7, 18.2, -4.9, -
5.3. 










To a stirred solution of protected carboxylic acid (140 mg, 0.57 mmol, 1.0 eq.) in DMF 
(2.9 mL) at 23 °C was added N,N-diisopropylethylamine (0.36 mL, 2 mmol, 3.5 eq.) 
followed by HBTU (259 mg, 0.68 mmol, 1.2 eq.). After 5 min, -aminobutyric acid 
methylester hydrochloride (107 mg, 0.68 mol, 1.2 eq.) was added in one portion. After 12 
h, the reaction was diluted with 1:1 hexanes:EtOAc (100 mL) and washed with saturated 
aq. LiCl solution (3 x 50 mL). The organic layer was dried over sodium sulfate and 
concentrated in vacuo to furnish the title compound (150 mg, 76%) as a tan oil that did 
not require further purification. For analytical purposes, the material was 
chromatographed on silica gel eluting with 1:1 hexanes:EtOAc. 
 
Rf = 0.5 (2:1 hexanes:EtOAc) 
1
H NMR: 400 MHz (CDCl3) = 6.64 (bs, 1H), 4.12 (dd, J = 7.2 Hz, J = 4.8 Hz, 1H), 
3.68 (s, 3H), 3.29 (qd, J = 7.2 Hz, J = 3.1 Hz, 2H) 2.36 (t, J = 7.5 Hz, J = 7.2 Hz, 2H), 
1.88-1.74 (m, 3H), 1.56 (m, 2H), 0.93 (s, 9H), 0.92 (d, J = 6.5 Hz, 3H), 0.91 (d, J = 6.8 
Hz, 3H), 0.09 (s, 3H), 0.06 (s, 3H). 
13
C NMR: 100 MHz (CDCl3) = 177.2, 175.2, 72.3, 44.7, 38.1, 31.3, 25.7, 24.8, 23.9, 







) 3426, 2969, 1745, 1675, 1519. 
HRMS: ESI calc. for C17H36NO4Si [M+H]
+




To a stirred solution of the methyl ester (150 mg, 0.43 mmol, 1.0 eq.) in THF (2.1 mL) at 
0 °C was added a solution of aqueous NaOH (1.0 M, 1.29 mL, 1.29 mmol, 2.0 eq.), and 
upon complete addition the reaction was allowed to warm to 23 °C. At 5 h, the reaction 
was cooled to 0 °C and was treated with 1.0 M HCl (aqueous) (1.4 mL). The reaction was 
diluted with EtOAc (100 mL), and the aqueous layer was separated. The organic layer 
was dried over sodium sulfate and concentrated in vacuo to furnish the title compound 




H NMR: 400 MHz (CDCl3) = 6.74 (bs, 1H), 4.15 (dd, J = 7.2 Hz, J = 4.8 Hz, 1H), 
3.35 (m, 2H) 2.39 (t, J = 7.2 Hz, 2H), 1.91-1.74 (m, 3H), 1.56 (m, 2H), 0.93 (s, 9H), 0.93 
(d, J = 6.5 Hz, 3H), 0.91 (d, J = 6.8 Hz, 3H), 0.11 (s, 3H), 0.07 (s, 3H). 
13
C NMR: 100 MHz (CDCl3) = 174.4, 173.4, 75.9, 72.5, 51.6, 44.8, 38.0, 31.2, 25.7, 
24.9, 23.9, 23.4, 22.3, 17.9, -4.9, -5.2. 
IR: (film, cm
-1
) 3411, 2965, 2934, 1729, 1640, 1535. 
HRMS: ESI calc. for C16H34NO4Si [M+H]
+








To a stirred solution of carboxylic acid (162 mg, 0.49 mmol, 1.0 eq.) in DMF (2.5 mL) at 
23 °C was added N,N-diisopropylethylamine (0.36 mL, 2.0 mmol, 4.0 eq.) followed by 
HBTU (224 mg, 0.59 mmol, 1.2 eq.). After 5 min, N-acetylcysteamine (0.06 mL, 0.59 
mmol, 1.2 equiv.) was added in one portion. After 12 h, the reaction was diluted with 1:1 
hexanes:EtOAc and washed with sat. aqueous LiCl (3 x 50 mL). The organic layer was 
dried over sodium sulfate and concentrated in vacuo. The crude material was 
chromatographed on silica gel eluting with 1:2 hexanes:EtOAc to afford the title 
compound (128 mg, 60%) as a pale oil. 
 
Rf = 0.19 (1:2 hexanes:EtOAc) 
1
H NMR: 400 MHz (CDCl3) = 6.63 (bs, 1H), 6.33 (bs, 1H) 4.13 (dd, J = 6.8 Hz, J = 
4.8 Hz, 1H), 3.44 (q, J = 12.3 Hz, J = 6.2 Hz, 2H), 3.29 (qd, J = 6.8 Hz, J = 2.1 Hz, 2H) 
3.04 (t, J = 6.2 Hz, J = 5.8 Hz, 2H), 2.61 (t, J = 7.2 Hz, 2H), 1.97 (s, 3H), 1.87 (p, J = 7.2 
Hz, 2H), 1.78 (m, 1H), 1.56 (m, 1H), 0.94 (s, 9H), 0.92 (d, J = 6.5 Hz, 3H), 0.91 (d, J = 
6.8 Hz, 3H), 0.11 (s, 3H), 0.08 (s, 3H). 
13
C NMR: 100 MHz (CDCl3) = 198.6, 174.4, 170.5, 72.4, 44.7, 40.6, 38.9, 37.2, 28.6, 







) 3326, 2954, 1694, 1659, 1551, 1519. 
HRMS: ESI calc. for C20H41N2O4SSi [M+H]
+





To a stirred solution of TBS-protected thioester (153 mg, 0.37 mmol, 1.0 eq.) in DCM 
(3.7 mL) at 23 °C was added neat TFA (84 L, 1.1 mmol, 3.0 eq.) in one portion. At 6 h, 
the reaction was concentrated in vacuo. The crude material was chromatographed on 
silica gel eluting with 3% MeOH in DCM to 4:1 DCM:MeOH to afford the title 
compound (93 mg, 82%) as a clear oil. 
 
Rf = 0.25 (3% MeOH in DCM) 
1
H NMR: 400 MHz (CDCl3) = 6.67 (bs, 1H), 6.20 (bs, 1H), 4.14 (dd, J = 9.9 Hz, J = 
3.1 Hz, 1H), 3.45 (q, J = 12 Hz, J = 5.8 Hz, 2H), 3.33 (qd, J = 6.8 Hz, J = 2.7 Hz, 2H), 
3.03 (m, 2H), 2.63 (t, J = 6.8 Hz, 2H), 1.97 (s, 3H), 1.92 (dt, J = 6.8 Hz, J = 2.7 Hz, 1H), 
1.84 (m, 1H), 1.66 (m, 2H), 1.53 (m, 2H), 0.97 (d, J = 6.5 Hz, 3H), 0.96 (d, J = 6.5 Hz, 
3H). 
13
C NMR: 100 MHz (CDCl3) = 199.2, 175.2, 170.9, 70.6, 43.7, 40.8, 39.1, 37.7, 28.8, 
25.2, 24.4, 23.5, 23.0, 21.3. 
IR: (film, cm
-1




HRMS: ESI calc. for C14H27N2O4S [M+H]
+







To a stirred solution of D-pantetheine (111 mg, 0.40 mmol, 1 eq.) dissolved in 8 mL THF 
and 2 mL Et3N, DMAP was added (20 mg, 0.16 mmol, 0.4 eq.), and the solution was 
brought to 4 °C. Hexanoyl chloride (100 mg, 0.74 mmol, 1.9 eq.) was dissolved in 2 mL 
THF and added dropwise over 2 min to the stirring D-pantetheine solution. The solution 
was stirred 1 h at 4 °C and then 1 h at 22 °C. Solvent was removed in vacuo, and the 
remaining material was resuspended in acetone and filtered. The acetone was removed in 
vacuo, and the clear oil was chromatographed on silica gel eluting with 1:1 
EtOAc:acetone to afford the title compound (105 mg, 70%) as a clear oil. 
 
 
Rf = 0.3 (1:1 EtOAc:acetone) 
1
H NMR: 400 MHz (CDCl3) = 7.35 (t, J = 5.3 Hz, 1H), 6.18 (t, J = 5.3 Hz, 1H), 3.99 
(s, 1H), 3.59-3.32 (m, 6H), 3.08-2.95 (m, 2H), 2.56 (t, J = 8.0 Hz, 2H), 2.41 (t, J = 5.8 
Hz, 2H), 1.65 (p, J = 7.6 Hz, 2H), 1.34-1.23 (m, 4H), 1.02 (s, 3H), 0.92 (s, 3H), 0.89 (t, J 




HRMS: ESI calc. for C17H33N2O5S [M+H]
+





Synthesis of ligands for mass spectrometry analysis of KS acylation 
All chemicals were purchased from commercial sources and were used without 
further purification. Solvents were dried as described (Hünig et al., 2006). All reactions 
were carried out under an atmosphere of argon unless otherwise noted. 
1
H NMR and 
13
C 
NMR were recorded on a Bruker dpx 400 (400 MHz/100 MHz) or Bruker dpx 300 
(300 MHz/75 MHz) spectrometer at room temperature. Chemical shifts were reported in 
parts per million (ppm) and the residual solvent peak was used as internal reference: 
1
H-
NMR (CHCl3: 7.26 ppm), 
13
C-NMR (CDCl3: 77.16 ppm). High resolution mass spectra 
(HRMS) were recorded with a Bruker micrOTOF-Q mass spectrometer. IR was recorded 
on a Thermo Smart Orbit Nicolet 380 FT-IR spectrometer. TLC was performed on silica 
gel plates (Merck Silica gel 60 F254) and visualized with Seebach reagent (12.5 g 
phosphomolybdic acid, 5.0 g cerium(IV) sulphate tetrahydrate, 16.0 mL water, 450.0 mL 
concentrated sulfuric acid). Flash column chromatography was performed on silica gel 
(Merck-Kieselgel 60, 40–60 mesh). Abbreviations used: CDI, carbonyldiimidazole; 























(E)-Hex-4-enoic acid (8b) (Smith et al., 1997) 
LiOH (4.26 g, 177.87 mmol, 25 eq.) was added to a stirred solution of (E)-ethyl hex-4-
enoate (Noack & Göttlich, 2002) (8a) (1.00 g, 7.03 mmol) in THF/MeOH/H2O (290 mL, 
2:2:1) at r.t., and the mixture was stirred at r.t. overnight. The organic solvents were 
removed under reduced pressure, and the aqueous phase was acidified with aqueous 
0.1 M NaHSO4 to pH = 2. The aqueous phase was extracted with EtOAc (3 x 50 mL), 
and the combined organic phases were washed with brine (20 mL). The organic phase 
was dried over Na2SO4, filtered, and concentrated under reduced pressure. The acid 8b 
(0.74 g, 92%) was obtained as a colorless oil and used without further purification. 
 
1
H NMR: (400 MHz, CDCl3) (Jefford & Wang, 1987) δ 1.56 – 1.60 (m, 3H), 2.20 - 2.28 
(m, 2H), 2.31 – 2.37 (m, 2H), 5.29 – 5.50 (m, 2H). 
(E)-S-(2-Acetamidoethyl) hex-4-enethioate (6) (Deska et al., 2011) 
CDI (1.74 g, 10.74 mmol, 1.2 eq.) was added to a stirred solution of (E)-hex-4-enoic acid 
8b (1.02 g, 8.95 mmol) in anhydrous CH2Cl2 (30 mL) at room temperature. After 10 min, 
N-acetylcysteamine (1.14 mL, 1.28 g, 10.74 mmol, 1.2 eq.) was added, and the reaction 
mixture was stirred at room temperature overnight. The solvent was removed under 




was washed with water (3 x 5 mL) and brine (2 x 5 mL). The organic phase was dried 
(Na2SO4), and the solvent was removed under reduced pressure. Purification by column 




H NMR: (400 MHz, CDCl3) δ 1.61 (dd, J = 6.3, 1.4 Hz, 3H), 1.94 (s, 3H), 2.27 – 2.35 
(m, 2H), 2.60 (t, J = 6.9 Hz, 2H), 3.00 (t, J = 6.4 Hz, 2H), 3.36 - 3.44 (m, 2H), 5.30 - 5.40 
(m, 1H), 5.41 - 5.52 (m, 1H), 6.03 (brs, 1H) 
13
C NMR: (75 MHz, CDCl3) δ 18.0 (CH3), 23.3 (CH3), 28.53 (CH2), 28.54 (CH2) 39.8 
(CH2), 44.0 (CH2), 126.8 (CH), 128.5 (CH), 170.4 (C), 199.6 (C); 
IR: (neat) νmax 598, 963, 1036, 1287, 1372, 1435, 1545, 1650, 1688, 2933, 3272 cm
-1
; 






































(E)-Ethyl 5-methoxyhex-2-enoate (10) (Brückner et al., 2008) 
Ethyl 2-(triphenylphosphoranylidene)acetate (1.28 g, 3.67 mmol) was added to a solution 
of 3-methoxybutanal (Münster et al., 2012) (9) (0.34 g, 3.67 mmol) in anhydrous toluene 




under reduced pressure, and the residue was suspended in c-hexane (50 mL). The 
suspension was filtered through a plug of Celite® 545, and the filtrate was concentrated 
under reduced pressure. Purification by column chromatography (SiO2, EtOAc/c-hexane, 
1/3, Rf = 0.55) gave the ester 10 (0.45 g, 75%) as a colorless oil. 
 
1
H NMR: (400 MHz, CDCl3) δ .15 (d, J = 6.2 Hz, 3H), 1.27 (t, J = 7.1 Hz, 3H), 2.22 – 
2.52 (m, 2H), 3.32 (s, 3H), 3.38 – 3.50 (m, 1H), 4.17 (q, 
3
J= 7.1 Hz, 2H), 5.85 (dt, J = 
15.7, 1.5 Hz, 1H), 6.93 (dt, J = 15.7, 7.3 Hz, 1H) 
13
C NMR: (75 MHz, CDCl3) δ 14.4 (CH3), 19.2 (CH3), 39.0 (CH2), 56.3 (CH3), 60.3 
(CH2), 75.7 (CH), 123.5 (CH), 145.3 (CH), 166.5 (C) 
IR: (neat) νmax 1040, 1090, 1172, 1264, 1716, 2357, 2977 cm
-1
 
HRMS: m/z 195.0990 (calcd. for C9H16O3Na 195.0992). 
 
 
Ethyl 5-methoxyhexanoate (11a) 
A suspension of the unsaturated (E)-ethyl 5-methoxyhex-2-enoate (10) (0.84 g, 
4.94 mmol) and Pd/C (0.09 g, 10 mol%) in anhydrous methanol (8 mL) was stirred under 
hydrogen atmosphere (1 bar) at room temperature for 16 h. The suspension was filtered 
through a plug of Celite®545 and rinsed with EtOAc (20 mL). The solvents of the 
combined organic fractions were removed under reduced pressure, yielding the desired 






H NMR: (400 MHz, CDCl3) δ 1.12 (d, J = 6.1 Hz, 3H), 1.24 (t, J = 7.1 Hz, 3H), 1.37 – 
1.58 (m, 2H), 1.58 – 1.78 (m, 2H), 2.30 (t, J = 7.4 Hz, 2H), 3.14 – 3.41 (m, 4H), 4.12 (q, 
J = 7.1 Hz, 2H) 
13
C NMR (75 MHz, CDCl3) δ 14.4 (CH3), 19.1 (CH3), 21.1 (CH2), 35.5 (CH2), 35.8 
(CH2), 56.1 (CH3), 60.4 (CH2), 76.5 (CH), 173.8 (C) 
IR: (neat) νmax 1082, 1164, 1372, 1732, 2359, 2970 cm
-1
 
HRMS: m/z 197.1146 (calcd. for C9H18O3Na 197.1148). 
5-Methoxyhexanoic acid (11b) 
Acid 11b (0.57 g, 98%) was obtained from ethyl 5-methoxyhexanoate (11a) (0.67 g, 
3.86 mmol), according the procedure described for acid 8b, as a colorless oil 
1
H NMR: (400 MHz, CDCl3) δ 1.14 (d, J = 6.1 Hz, 3H), 1.29 – 1.83 (m, 4H), 2.37 (t, J = 
7.3 Hz, 2H), 3.25 – 3.48 (m, 4H), 10.59 (br s, 1H, H-8) 
13
C NMR: (75 MHz, CDCl3) δ 19.0 (CH3), 20.8 (CH2), 34.1 (CH2), 35.7 (CH2), 56.1 
(CH3), 76.6 (CH), 177.6 (C) 
IR: (neat) νmax 1078, 1135, 1169, 1706, 2970 cm
-1
 
HRMS: m/z 145.0831 (calcd. for C7H14O3 145.0835). 
 
S-(2-acetamidoethyl) 5-methoxyhexanethioate (5) 
Thioester 5 was prepared from 5-methoxyhexanoic acid (11b) (0.57 g, 3.89 mmol) 








H NMR: (400 MHz, CDCl3) δ 1.11 (d, J = 6.1 Hz, 3H), 1.29 – 1.58 (m, 2H), 1.59 – 1.88 
(m, 2H), 1.95 (s, 3H), 2.58 (t, J = 7.4 Hz, 2H), 3.01 (t, J = 6.4 Hz, 2H), 3.19 – 3.35 (m, 
4H), 3.37 – 3.46 (m, 2H), 5.91 (br s, 1H) 
13
C NMR: (75 MHz, CDCl3) δ 19.0 (CH3), 21.8 (CH3), 23.3 (CH2), 28.6 (CH2), 35.6 
(CH2), 39.8 (CH2), 56.1 (CH3), 76.4 (CH), 170.4 (C), 200.1 (C) 
IR: (neat) νmax 598, 1087, 1135, 1286, 1372, 1543, 1651, 1686, 2930, 3290 cm
-1
 


















(R)-3-methoxybutanoic acid (12b) 
Acid 12b was prepared from (R)-methyl 3-methoxybutanoate (Page et al., 2004) (12a) 
(0.94 g, 7.11 mmol) according the procedure described for acid 8b. The acid 12b (0.55 g, 
65%) was obtained as a colorless oil and used without further purification. 
 
1
H NMR: (400 MHz, CDCl3) (Zhu & Burgess, 2008) δ 1.23 (d, J = 6.0 Hz, 3H), 2.45 
(dd, J = 15.4, 5.4 Hz, 1H), 2.59 (dd, J = 15.4, 7.2 Hz, 1H), 3.35 (s, 3H), 3.78 (ddd, J = 





C NMR: (75 MHz, CDCl3) δ 19.1 (CH3), 41.6 (CH2), 56.5 (CH3), 73.6 (CH), 176.9 (C-
5). 
 
(R)-S-(2-acetamidoethyl) 3-methoxybutanethioate (7) 
Thioester 7 was prepared from (R)-3-methoxybutanoic acid (12b) (0.55 g, 4.67 mmol) 
according to the procedure described for thioester 6. Anhydrous THF (10 mL) was used 
instead of CH2Cl2. Purification by column chromatography (SiO2, EtOAc, Rf = 0.34) gave 
thioester 7 (0.58 g, 57%) as a white, waxy solid. 
 
1
H NMR: (400 MHz, CDCl3) δ 1.19 (d, J = 6.1 Hz, 3H), 1.93 (s, 3H), 2.58 (dd, J = 15.1, 
5.7 Hz, 1H), 2.81 (dd, J = 15.1, 7.2 Hz, 1H), 3.01 (t,
 
J = 6.5 Hz, 2H), 3.29 (s, 3H), 3.37 – 
3.44 (m, 2H), 3.77 (ddd, J = 7.2, 6.1, 5.7 Hz, 1H), 6.05 (br s, 1H) 
13
C NMR: (75 MHz, CDCl3) δ 19.2 (CH3), 23.2 (CH3), 28.7 (CH2), 39.6 (CH2), 50.8 
(CH2), 56.5 (CH3), 73.8 (CH), 170.4 (C), 197.8 (C) 
IR: (neat) νmax 997, 1086, 1284, 1373, 1544, 1651, 2360, 2931, 3283 cm
-1
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Figure 6-1. A bacillaene synthase ketosynthase. PksKS2 is in PksJ, the first subunit of a 
hybrid trans-AT polyketide synthase/nonribosomal peptide synthetase (PKS/NRPS) from 
Bacillus subtilis. Discrete polypeptides containing ATs and an ER (PksC, PksD, and 
PksE) cooperate in trans with the assembly line polypeptides (PksJ, PksL, PksM, PksN, 
and PksR) in the construction of bacillaene. In the catalytic cycle of PksKS2, an 
intermediate is transferred from an ACP of the previous module before the malonyl-



























Figure 6-2. KS gatekeeping. The last KS of bacillaene synthase is condensation-
incompetent and apparently plays a gatekeeping role to select for the intermediate that 





















Figure 6-3. PksKS2 architecture. (a) Like ~90% of trans-AT KSs, PksKS2 possesses a 
flanking subdomain equivalent to the KS/AT adapter in cis-AT PKSs. One active site is 
indicated with an asterisk. (b) The flanking subdomain contains two loosely-connected 
helices, 17 and 18, in the position that AT is inserted in cis-AT PKSs. The interaction 
between the body of the KS and the flanking subdomain is primarily mediated by the 
LPxYPF motif; nine unstructured residues link the body of the KS to the flanking 
subdomain as indicated by the circles. (c) The 1.95-Å resolution 2Fo-Fc electron density 
maps, contoured at 1.5 r.m.s.d., show the highest-resolution view yet available for a KS 
from a type I PKS. Transfer of the polyketide intermediate to Cys176 is aided by His360. 
That condensation-incompetent KSs usually lack the histidine equivalent to His311 





Figure 6-4. Secondary structure assignment. The secondary structure features of PksKS2 
















Figure 6-5. PksKS2 bound to substrates. (a) To crystallographically observe the natural 
substrate covalently bound at high occupancy, mutation of the catalytic cysteine to serine 
was necessary (crystals were soaked with the N-acetylcysteamine thioester of the natural 
substrate). The expected mass shift for the acyl group was observed by mass 
spectrometry. (b) A stereodiagram shows the Fo-Fc omit map (contoured at 3.0 r.m.s.d.; 
substrate atoms, represented in salmon, were omitted prior to map calculation) for the 
natural substrate of PksKS2. The ester carbonyl forms a hydrogen bond with Ile433. The 
side chains of Met220, Glu362, Ile433, and Tyr237 are nearest to the α- and β-carbons of 
the polyketide and may help confer specificity. Hydrogen bonds, indicated with yellow 
dashes, are each 2.9–3.1 Å. (c) Residues within 15 Å of the PksKS2 reactive cysteine that 
vary between the sixteen KS clades were identified. The most highly represented residues 



































Figure 6-6. KS alignment. The KSs described in “Biosynthesis of polyketides by trans-
AT polyketide synthases” (Piel, 2010) were aligned, and sequences were taken from the 
supplementary information found within “Exploiting the mosaic structure of trans-
acyltransferase polyketide synthases for natural product discovery and pathway 
dissection” (Nguyen et al., 2008). The secondary structure is from the crystal structure of 
PksKS2. Catalytic residues are indicated with asterisks. Residues consistently different 
from cis-AT PKSs are labeled grey. Residues within 15 Å of the catalytic cysteine and 
that vary between clades are labeled black. KS clades and their associated substrates are 







































Figure 6-7. Interactions between PksKS2 active site residues and its natural substrate. 
Shown in cartoon form are the interactions made between the natural substrate for 
PksKS2 and each active site residue. Due to the large number of interactions, two angles 
are presented. Red dashes indicate steric interactions and blue dashes indicate hydrogen 









Figure 6-8. Examining KS specificity by mass spectrometry. Acyl-S-NACs 1-7 were 
incubated with BaeKS2. The formation of the acyl-enzyme intermediate was monitored 
through mass spectrometry. Early time points are reported in the subpanel. The 
specificity of BaeKS2 is quite broad; however, it does not tolerate a methoxy group at the 


































Figure 6-9. KS acylation measured by mass spectrometry. (a) Nano-ESI mass spectrum 
of BaeKS2 sprayed from 80:20 MeCN:H2O 0.1% TFA, resulting in a measured mass of 
77,407 Da. (b) The 58
+
 charge state of BaeKS2 not incubated with substrate. (c) The 58
+
 
charge state of BaeKS2 following incubation with 2 mM thioester 4, clearly showing a 
mass shift corresponding to acylated BaeKS2. (d) ESI-mass spectrum (Figure insert) and 
mass reconstruction of Cys176Ser PksKS2. The mass observed corresponds to an N-
terminal methionine cleavage, in addition to an anomalous glycosylation (+ 180 Da). No 
sugar moieties were visible in the high-resolution crystal structure, indicating that the site 
of glycosylation was either highly disordered, or was excluded from the crystals due to 
unfavorable crystal packing. (e) ESI-mass spectrum (Figure insert) and mass 
reconstruction of Cys176Ser PksKS2 after a 1 hour incubation with 10 mM of the natural 




































Figure 6-10. Flanking subdomain alignment. The flanking subdomains from KSs 
described in “Biosynthesis of polyketides by trans-AT polyketide synthases” (Piel, 2010) 
were aligned, and sequences were taken from the supplementary information found 
within “Exploiting the mosaic structure of trans-acyltransferase polyketide synthases for 














Figure 6-11. Flanking subdomains containing an inactive ACP. An alignment shows the 





































Figure 6-12. Clashes from AT docking. If a discrete AT, such as the disorazole AT 
(DszAT, PDB Code: 3RGI), were to dock to PksKS2 in an equivalent position to what 
has been observed for cis-AT PKSs, such as Ery(KS+AT)3 (PDB Code: 2QO3) and the 
metazoan FAS, the AT would clash with α17 and α18 of the flanking subdomain; 
however, these loosely-connected helices could shift. Sequence alignments of several 
trans-AT domains reveal the absence of a helix equivalent to the final helix of 









































Figure 6-13. Location of substrate binding relative to proposed ACP docking site. 
Monomer A of PksKS2 is colored blue, monomer B is colored grey, and the covalently 
bound substrates are colored salmon (electron density was clearly defined for the 
substrate in both monomers of the complex structure). The proposed docking location for 

















Table 6-2. Residues that consistently differ between cis- and trans-AT PKSs. These 
residues were found to be highly conserved within either cis- or trans-AT PKSs, but not 



































Chapter 7. The LINKS motif zippers trans-acyltransferase polyketide 
synthase assembly lines into a biosynthetic megacomplex 
ABSTRACT 
Polyketides such as the clinically-valuable antibacterial agent mupirocin are 
constructed by architecturally-sophisticated assembly lines known as trans-
acyltransferase polyketide synthases. Organelle-sized megacomplexes composed of 
several copies of trans-acyltransferase polyketide synthase assembly lines have been 
observed by others through transmission electron microscopy to be located at the Bacillus 
subtilis plasma membrane, where the synthesis and export of the antibacterial polyketide 
bacillaene takes place. In this work we analyze ten crystal structures of trans-
acyltransferase polyketide synthases ketosynthase domains, seven of which are reported 
here for the first time, to characterize a motif capable of zippering assembly lines into a 
megacomplex. While each of the three-helix LINKS (Localization INducing 
Ketosynthase Sequence) motifs is observed to similarly dock with a spatially-reversed 
copy of itself through hydrophobic and ionic interactions, the amino acid sequences of 
this motif are not conserved. Such a code is appropriate for mediating homotypic contacts 
between assembly lines to ensure the ordered self-assembly of a noncovalent, yet tightly-
knit, enzymatic network. LINKS-mediated lateral interactions would also have the effect 
of bolstering the vertical association of the polypeptides that comprise a polyketide 





 Complex polyketides are a class of secondary metabolites that provide a 
competitive advantage for a wide spectrum of bacteria and fungi, often by targeting vital 
processes within competing organisms (Hertweck, 2009; Piel, 2010). The polyketide 
synthases (PKSs) responsible for their production are inherently modular, enabling PKS-
harboring organisms to explore vast regions of chemical space through the reorganization 
of enzymatic domains. While the clinical value of the antibiotics erythromycin and 
mupirocin allude to the potential of polyketides in drug discovery, harnessing the 
biosynthetic capabilities of PKSs has been hindered by the complexity of their higher-
order architecture (Walsh, 2008; Keatinge-Clay, 2012; Dutta et al., 2014). 
 An enzymatic juggernaut of the subcellular milieu, a PKS typically contains 
upwards of 50 independently-folded domains, each responsible for one step in the 
biosynthesis of a polyketide. The enzymatic modules of PKSs work together in assembly-
line fashion to extend and process a growing polyketide chain (Khosla et al., 2014), each 
module containing a set of domains responsible for the incorporation and tailoring of a 
selected -carboxylated extender unit. The domains employed by Type I PKSs are 
homologous to those responsible for fatty acid biosynthesis (Smith & Tsai, 2007), 
including acyltransferases (ATs) that select extender units, ketosynthases (KSs) that 
condense extender units with growing polyketides in a decarboxylative thio-Claisen 
condensation, ketoreductases (KRs) that stereospecifically reduce newly incorporated β-
keto groups, dehydratases (DHs) that eliminate water to form α,β-olefins, enoylreductases 




shuttle polyketide intermediates between the domains within a module as well as the 
following module. Thus, modules containing different sets of KR, DH, or ER domains 
yield different functional groups and stereochemistries. A thioesterase (TE) downstream 
of the final module commonly off-loads the polyketide product via hydrolysis or 
cyclization.  
 Modular PKSs are divided into two architecturally-distinct classes: cis-AT and 
trans-AT (Piel, 2010). While cis-AT PKSs harbor ATs that are integrated into the multi-
domain polypeptide, trans-AT systems rely on discretely-encoded AT domains that 
noncovalently interact with the megasynthase (Figure 7-1). Each of the independently-
folded domains from cis-AT PKSs has been structurally characterized (Keatinge-Clay, 
2012), and although structural information has recently become available for domains 
from trans-AT PKSs, if and how the eponymous trans-AT domains dock to the 
megasynthase to charge ACPs with extender units remains to be determined 
(Bretschneider et al., 2013; Gay et al., 2014; Piasecki et al., 2014). A conserved ~100-
residue region C-terminal to KS was hypothesized to facilitate the docking of trans-ATs 
to megasynthases and was named the AT-docking domain, or ATd (Tang et al., 2004). 
The KS/AT adapters, observed in the crystal structures of KS+AT didomains from the 
erythromycin PKS and the mammalian fatty acid synthase (FAS), are homologous to 
ATd on a sequence level and seem to validate this functional assignment (Tang et al., 
2007; Maier et al., 2008). However, in vitro experiments examining extender unit transfer 




catalytic efficiency of acyl transfer compared to constructs that did not include ATd 
(Aron et al., 2007).  
 The first-discovered, and prototypical, trans-AT PKS is encoded within the 
Bacillus subtilis and Bacillus amyloliquefaciens genomes (pksX and bae, respectively) 
(Piel, 2010). This hybrid PKS/non-ribosomal peptide synthetase (NRPS) produces 
bacillaene, a linear polyene diamide that interferes with prokaryotic protein synthesis 
(Figure 7-1) (Patel et al., 1995). Transmission electron micrographs of B. subtilis cells 
have revealed dense masses associated with the plasma membrane, each comprised of 
several copies of the PksX megasynthase (Butcher et al., 2007; Straight et al., 2007). 
This organelle-sized structure, with an approximate mass of 10-100 MDa, includes the 
five multidomain polypeptides PksJ, PksL, PksM, PksN, and PksR. At the time of this 
discovery megacomplex formation was a complete mystery since trans-AT PKS 
polypeptides lack the N- and C-terminal docking domains that linearly organize cis-AT 
PKSs and no PKS architectural scaffolding proteins were known; however, ATd was 
hypothesized to help stabilize the observed structure (Figure 7-1) (Broadhurst et al., 
2008). Membrane localization of PKS enzymes has been observed for the mycolactone 
and actinorhodin pathways, and the biosynthetic machinery for the siderophore 
pyoverdine is known to accrete into a dense, membrane-bound mass termed the 
“siderosome”; the co-localization of large enzymatic complexes at the bacterial plasma 
membrane is emerging as a theme in the biosynthesis of natural products (Xu et al., 2008; 





 The first ATd to be structurally observed, from a didomain comprised of a KS and 
a β-branching enzyme (KS+B) from the rhizoxin PKS, revealed that ATd is structurally 
related to the KS/AT adapter of cis-AT PKSs (Bretschneider et al., 2013). Where the AT 
domain branches from the KS/AT adapter in cis-AT PKSs, only a short loop is present. 
The second structure of an ATd, from the second KS domain of the B. subtilis PksX 
synthase (PksKS2), showed two additional α-helices where the AT domain branches 
from the KS/AT adapter in cis-AT PKSs (Gay et al., 2014). Modeling a trans-AT docked 
to the ATd based on the location of AT within cis-AT PKSs indicated that significant 
restructuring of these helices would be required for docking. Since neither functional nor 
structural studies supported the role of ATd as a trans-AT docking site, it was renamed 
the “flanking subdomain”.  
 Here, we present seven crystal structures of trans-AT KS domains that 
provide evidence that the flanking subdomain plays a role in the assembly of PKS 
megacomplexes. At first considered to be a serendipitous crystal contact, the clearly 
defined self-association of flanking subdomains published here and elsewhere appears in 
ten crystal structures (five different KS domains from three different microbial species 
harboring trans-AT PKSs;
 
seven structures reported here, two structures reported in 
reference 9, and one deposited but not published structure, PDB: 4TL2). We introduce 
the term Localization INducing Ketosynthase Sequences (LINKS) to distinguish the 
three helices that form the observed interaction from the remainder of the flanking 
subdomain. Bioinformatic analysis of LINKS regions reveals that each is unique to the 




megacomplexes are zippered together by LINKS-containing KSs that possess higher 
affinity for copies of themselves than other LINKS-containing KSs within the assembly 
line. These findings suggest an unprecedented mechanism for the assembly of several 
copies of a PKS megasynthase into a megacomplex. 
RESULTS 
Structure of the LINKS interaction 
 Three of the trans-AT KS domains deposited into the Protein Data Bank (PDB) 
contain the LINKS region: one from the bacillaene PKS (PksKS2, PDBs 4NA1 and 
4NA2) and two from the migrastatin PKS (MgsKS5 and MgsKS7, PDBs 4TL2 and 
4TKT, respectively). The LINKS interaction between homodimeric KSs, not apparent 
from the asymmetric units of wild-type PksKS2 (PDB 4NA1) and MgsKS5 (PDB 4TL2), 
can be observed by generating the crystallographic symmetry mates. This is opposite in 
crystals of PksKS2(Cys176Ser) (PDB: 4NA2), in which the asymmetric unit shows two 
KS monomers associated via the LINKS interaction and the KS dimer is visualized by 
generating crystallographic symmetry mates. Here we report seven additional crystal 
structures in which LINKS interactions are observed, including one of PksKS2 in its 
monomeric form, one of PksKS6, two of PksKS6(Cys169Ser), one of Pks(ACP5+KS6), 
one of BaeKS1, and one of BaeKS5 (Table 7-1). To date, only one crystal structure of a 
LINKS-containing trans-AT KS has been reported that does not show this interaction 




 The LINKS motif is comprised of ~40 residues (α17-α19) that project from the 
flanking subdomain as a triangular flap (see reference 9 for secondary structure 
assignments) (Figure 7-2). While α19 is structurally equivalent to a helix in the KS/AT 
adapter of cis-AT PKSs and the mammalian FAS, α17 and α18 take the place of the AT 
domain in these synthases. Helices α17 and α18 do not make interactions with 
neighboring secondary structural elements and thus are not rigidly oriented with respect 
to the flanking subdomain. In the LINKS interaction α18 of one flanking subdomain 
makes contact with a spatially-reversed α18 of the neighboring flanking subdomain, and 
α17 of one flanking subdomain makes contact with α19 of the neighboring flanking 
subdomain. 
 The observed LINKS interactions form through the burial of hydrophobic 
residues and exhibit a high degree of shape complementarity (~700 Å
2
). In the LINKS 
motif of PksKS2 (the structure possessing the highest-resolution and lowest B-factors for 
the LINKS region) these hydrophobic residues include I552, F553, M559, L563, W566, 
and L578 (Figures 7-2b-d and Table 7-2). The LINKS interactions observed from 
bacillaene synthases (PksKS2, PksKS6, BaeKS1, and BaeKS5) show contact between 
clusters of charged residues that cap the poles of α18. The N-terminal end of this helix 
contains ~3 negatively-charged residues, and the C-terminal end contains ~3 positively-
charged residues. Two copies of α18 are oriented in an antiparallel fashion, and the 
negatively-charged N-terminal end of α18 from one flanking subdomain forms salt 
bridges with the positively-charged C-terminal end of α18 from the neighboring flanking 




center of each LINKS triangular flap and the clustering of complementary ionic 
interactions at both termini of α18 form a lock-and-key fit uniquely adapted to each 
LINKS interaction (Figure 7-4). 
The LINKS motifs connect neighboring KS dimers in crystals of MgsKS5 (PDB: 
4TL2); however, instead of the twofold axes of these KS dimers being parallel as in each 
of the other observed LINKS-mediated associations of KS dimers, they are nearly 
orthogonal (Figure 7-2a). The MgsKS5 LINKS interaction is distorted relative to all the 
other crystallographically-observed LINKS interactions - α17 and α18 are skewed, and 
several ionic interactions potentially made in vivo are not formed (e.g., Asp1121/Arg1133 
and Glu1122/Arg1129) (Figure 7-5). The only intact salt bridge, formed by Lys1120 and 
Asp1138, may provide an example of covariation within the LINKS motif, as both of 
these residues generally carry the opposite charge in sequence alignments (Figure 7-6 
and Table 7-3).  
The seven crystal structures reported here show the LINKS interaction in seven 
different contexts. In one crystal form, PksKS2 monomers that do not make the 
traditional KS homodimer interaction were observed. Remarkably, even though ~5300 Å
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is not buried through the formation of the traditional KS homodimer, the LINKS 
interaction is maintained (Figure 7-2a). The construct Pks(ACP5+KS6), generated to 
investigate the interaction between KS and ACP, also yielded crystals in which the 
LINKS interaction was observed. Although the crystals could not be optimized to diffract 
beyond 4.0-Å resolution and the ACP domain could not be located in the electron density 




monomers in the asymmetric unit (Figure 7-7). In addition to the 2.0 Å-resolution 
structure of PksKS6(Cys169Ser), a construct generated to visualize bound intermediates 
(Gay et al., 2014), two additional crystal forms of PksKS6 were observed that contain the 
LINKS interaction (wild-type PksKS6, 3.10-Å resolution; PksKS6(Cys169Ser), 2.16-Å 
resolution) (Table 7-1). Two crystal structures of KSs from the B. amyloliquefaciens 
bacillaene PKS, BaeKS1 (2.93 Å) and BaeKS5 (4.20 Å), were also determined. While 
locally-elevated temperature factors prevented the complete modeling of α17-α19 in 
BaeKS1 (Figure 7-8), the relative positioning of KSs indicates that each of the flanking 
subdomains form LINKS interactions. 
Bioinformatic analysis of LINKS 
  The lack of sequence conservation of α17-α19 is a hallmark of the LINKS motif. 
While the LINKS motifs shown in Figure 7-6 are each quite hydrophobic and contain 
charged residues at the poles of α18, individual LINKS residues are highly variable 
(Figures 7-6 and 7-9). To further investigate this variability the sequence conservation of 
LINKS-containing KSs was mapped onto a model of a trans-AT KS domain (Figure 7-
10). An alignment of 152 trans-AT KS sequences was generated, and the degree of 
conservation of each residue was assessed. A moving average calculation was used to 
determine the mean conservation for short stretches of sequence, such that the value for 
the conservation of residue n is equal to the average value of conservation for the 11 
residues ranging from n-5 to n+5. A template KS structure was then colored based on this 




While the active site region of KS appears blue and the remainder of the KS body varies 
between green and yellow, the longest stretch of red (46 residues) is the LINKS region. 
The next longest stretch of red sequence is only 17 residues and is located on the face of 
KS that would be adjacent to processing domains such as DH, KR, and MT. Classes of 
LINKS motifs other than the one shown in the sequence alignment of Figure 7-6 likely 
exist; several LINKS motifs that did not align well with those in Figure 7-6 are displayed 
in Figure 7-9. 
LINKS interactions are homotypic 
 With the exception of MgsKS5, the relative orientation of trans-AT KS dimers 
connected through a LINKS interaction is essentially identical for all of the crystal 
structures available to date (Figure 7-2a). We investigated whether heterotypic LINKS 
interactions were complementary between KSs from different modules. The six LINKS 
helices (three helices from each KS monomer) were isolated from the observed LINKS 
interactions (using the structure with the best-resolved LINKS motif for each KS), each 
of these were superposed, and new coordinate files were created for the heterodimeric 
LINKS interactions (i.e., PksKS2 with BaeKS1, PksKS6, or MgsKS5). The simulated 
interactions were investigated to assess the interfacial contacts. In general, heterotypic 
LINKS interactions were significantly less favorable than homotypic LINKS interactions, 






 The docking site of trans-ATs had been hypothesized to be generated by an ~100-
residue subdomain, formerly termed ATd and now referred to as the “flanking 
subdomain”, that is associated with the majority of KSs within trans-AT PKSs. That an 
AT domain is integrated into the equivalent subdomain of the mammalian FAS and cis-
AT PKSs appears to support this role; however, this subdomain is common to each of 
these synthases and was most likely present within an ancestral PKS before cis- and 
trans-AT PKSs diverged (Nguyen, et al., 2008). Thus, the docking site to which trans-
ATs dock in trans-AT PKSs should not be expected to be equivalent to where ATs are 
integrated in cis-AT PKSs. A ~40-residue LINKS motif is usually found in trans-AT 
PKSs where the AT domain is integrated in cis-AT PKSs. In 10 out of 11 crystal 
structures of constructs containing the LINKS motif it is found mediating a LINKS-
interaction, and in 8 of the 10 structures it associates neighboring KS dimers in a parallel 
orientation (the exceptions being MgsKS5 and the monomeric form of PksKS2). We 
propose that the LINKS motif makes lateral interactions that help construct 
megacomplexes like those observed in B. subtilis cells (Figure 7-12; based on the 
measured dimensions, one bacillaene megacomplex is comprised of 10-20 homodimeric 
bacillaene PKS assembly lines).  
 The LINKS hypothesis excludes the site that AT is observed in cis-AT PKSs as 
the docking site for a trans-AT. While trans-ATs could dock with another region of the 
flanking subdomain or the KS body, they may only interact with the ACP domains to 




trans-AT in the PksX bacillaene pathway, is present in concentrations 10–100 fold 
greater than the assembly line polypeptides (Straight et al., 2007). Additionally, 
superstoichiometric trans-AT concentrations have a large effect on the rate of polyketide 
production by the virginiamycin trans-AT PKS (Pulsawat et al., 2007). If trans-ATs were 
stably associated with each trans-AT PKS module, increased trans-AT expression would 
have little effect. Several condensation-incompetent trans-AT KSs harbor flanking 
subdomains yet have no need to interact with a trans-AT (e.g., BTKS10, ChiKS18, 
DszKS10, and OnnKS4). Similarly, several trans-AT KSs that catalyze polyketide chain 
elongation do not contain a flanking subdomain, yet the corresponding ACPs from these 
modules must interact with a trans-AT (e.g., ChiKS16, LnmKS3, MlnKS8, and 
DifKS10). Studies have shown that trans-ATs are capable of charging ACP domains in 
the absence of a KS or flanking subdomain and that a trans-AT from the kirromycin PKS 
(KirCII) is quite specific for its cognate ACP (Aron et al., 2007; Ye et al., 2014; Wong et 
al., 2011; Lopanik et al., 2008; Musiol et al., 2011). This degree of trans-AT specificity 
for an ACP is surprising if the flanking subdomain or KS body is selective for docking 
with a particular trans-AT.  
 The structure of the homodimeric KS+B didomain from the rhizoxin trans-AT 
PKS shows that the longest dimension of the B dimer is rotated 90˚ relative to the longest 
dimension of the KS dimer (Bretschneider et al., 2013). This orientation, also anticipated 
for the trans-AT KS+DH didomain based on the structural homology of the B and DH 
domains, would be compatible with the higher-order architecture of a PKS megacomplex 




KS and B dimers from a trans-AT PKS fix their relative orientation, the KS and DH 
dimers of the mammalian FAS rotate freely relative to one another (Maier et al., 2008; 
Brignole et al., 2009). The crystal structure of the mammalian FAS shows no contact 
between the two dimers (Figure 7-13), and cryo-electron microscopy studies also report 
flexibility between the KS and DH dimers. 
 Even if LINKS motifs do not make high affinity interactions, significant avidity 
could be generated through the several LINKS motifs interacting along the length of the 
synthase (Figure 7-14). Within the megacomplex, the lateral LINKS interactions would 
have the effect of bolstering vertical interactions, thought to be mediated by the N- and 
C-terminal regions of trans-AT PKS polypeptides. The flexibility of the LINKS 
interaction, illustrated by the MgsKS5 crystal structure, could aid megacomplex 
formation and maintenance. Many trans-AT PKS assembly lines harbor several LINKS 
motifs (e.g., the bacillaene PKS contains 12, the chivosazol PKS contains 9, the 
mupirocin PKS contains 7), such that the dissociation of a single LINKS interaction 
would have little effect on the stability of the entire megacomplex. LINKS interactions 
may be difficult to biophysically characterize using methods other than x-ray 
crystallography. If the dissociation constant for an individual LINKS interaction is in the 
millimolar range, it may not be observable through techniques such as small-angle x-ray 
scattering (SAXS) or analytical ultracentrifugation (Davison et al., 2014). To accurately 
determine the dissociation constant of the LINKS interaction, the natural KS dimerization 
interface may need to be disrupted by site-directed mutagenesis such that only the 




Several structures of trans-AT PKS KS domains have been deposited in the PDB 
that do not contain a LINKS motif, including the KS+B didomain from the rhizoxin PKS 
(Bretschneider et al., 2013). However, only one reported crystal structure of a LINKS-
containing KS does not display the LINKS interaction (MgsKS7). Favorable crystal 
contacts made elsewhere may preclude this interaction in the same manner that LINKS-
mediated crystal contacts within the monomeric crystal structure of PksKS2 are favored 
over natural homodimer interactions. 
 The mode through which LINKS interactions stabilize trans-AT PKS 
megacomplexes has not been observed in the architectures of other biosynthetic 
assemblies. The crystal structures presented here reveal a defined binding interface 
formed by hydrophobic and ionic interactions mediated by three helices on the surface of 
the flanking subdomain. Bioinformatic analysis suggests that the LINKS interaction is 
unique for each KS, such that the in-register, homotypic, lateral interactions made by 
them also confer stability to the vertical interactions between the assembly lines of the 
megacomplex through avidity. While trans-AT systems represent an excellent template 
for the rational engineering of synthetic PKSs for the exploration of new medicines, it 
may be necessary to consider the implications of modifying the LINKS network when 
genetically relocating modules or domains within a trans-AT PKS megasynthase.  
MATERIALS AND METHODS 
 All protein structures described in this work were cloned, purified, and the 




for PksKS2 (Gay et al., 2014). Therefore, only the primers used for gene amplification of 
new constructs, crystallization conditions, phasing methods, and any other modifications 
will be reported here.  
 Crystals of PksKS2 in which the KS domains did not crystallize in the native 
dimeric form grew over a period of 5-7 days by sitting drop vapor diffusion at 4 ˚C. 
Drops were formed by mixing 2 µL protein solution (4.5 mg/ml PksKS2, 150 mM NaCl, 
10% glycerol, 10 mM HEPES, pH 7.5) with 1 µL crystallization buffer (30% PEG 400 
(v/v), 0.2 M MgCl2, 0.1 M HEPES, pH 7.5). Crystals were frozen in liquid nitrogen after 
a 20 min soak in crystallization buffer modified with 20% glycerol, and the diffraction 
data collected at ALS Beamline 5.0.3. The structure was solved to 3.0 Å resolution by 
molecular replacement with PhaserMR in the CCP4 suite, using a single chain of the 
dimeric structure of PksKS2 (PDB: 4NA1) as the search model.  
 The DNA encoding PksKS6 was amplified using primers: 5′-
GCGGCCTGGTGCCGCGCGGCTCTAGCGACCGCCCGGAGGATGCGATAG-3′ and 
5′-GTGGTGGTGGTGGTGGTGATGTTAGCCTTCTTGAGTTGGCAGCCAG-3′ (LIC 
cloning regions underlined for insertion into the plasmid pGAY28 (Gay et al., 2014)). 
The eluted protein was concentrated to 15 mg/mL in the equilibration buffer and stored at 
-80  C until needed. Crystals of PksKS6 grew in 1-6 days by sitting drop vapor diffusion 
at 22 ˚C. Drops were formed by mixing 2 μL protein solution (15 mg/mL PksKS6, 150 
mM NaCl, 10 mM HEPES, pH 7.5) with 1 μL crystallization buffer (150 mM (NH4)2SO4
-
2
, 15% PEG 4000 (v/v), 100 mM MES, pH 6.0). Crystals were frozen in liquid nitrogen 




Diffraction data, collected at ALS Beamline 5.0.3, were processed by HKL2000. The 
structure was solved to 3.00 Å resolution by molecular replacement using the KS2 
monomer from the PksX synthase of B. subtilis as the search model (PDB: 4NA1). 
The PksKS6(Cys169Ser) expression plasmid was generated by PCR amplification 




AAATACGG-3′ (XhoI site underlined). The PCR product was digested with XhoI and 
ligated. Crystals of PksKS6(Cys169Ser) grew over 2-10 days by sitting drop vapor 
diffusion at 22 ˚C. Drops were formed by mixing 2 μL protein solution (15 mg/mL 
PksKS6(Cys169Ser), 150 mM NaCl, 10 mM HEPES, pH 7.5) with 1 μL crystallization 
buffer (1.7 M LiSO4, 100 mM Tris, pH 8.0) (both crystal forms grew in the same 
crystallization condition). Crystals were frozen in liquid nitrogen after a 20 min soak in 
crystallization buffer modified with 10% (v/v) ethylene glycol and the diffraction data 
were collected at APS Beamline 23-ID-D. The structure was solved by molecular 
replacement using a single chain of the dimeric structure of PksKS2 (PDB: 4NA1) as the 
search model. 
 Bacillus amyloliquefaciens FZB42 genomic DNA was used as template DNA to 






and the reverse primer 5′- 
GTGGTGGTGGTGGTGGTGATGTTAGTTCTTTTCTGCTTTTTTCGGCG-3′ 
(pGAY28 LIC cloning regions underlined). The eluted protein was concentrated to 14 
mg/mL in the equilibration buffer and stored at -80  C until needed. Crystals of BaeKS1 
grew over 4-15 days by sitting drop vapor diffusion at 22 ˚C. Drops were formed by 
mixing 2 μL protein solution (14 mg/mL BaeKS1, 150 mM NaCl, 10 mM HEPES, pH 
7.5) with 1 μL crystallization buffer (32% PEG 400 (v/v), 0.2 M MgCl2, 100 mM 
HEPES, pH 7.5). Crystals were frozen in liquid nitrogen after a 20 min soak in 
crystallization buffer modified with 40% PEG 400 (v/v) and the diffraction data were 
collected at APS Beamline 23-ID-D. The structure was solved by molecular replacement 
using a single chain of the dimeric structure of PksKS2 (PDB: 4NA1) as the search 
model. 
 The gene corresponding to Pks(ACP5+KS6) was PCR amplified using primers 5′-
GCGGCCTGGTGCCGCGCGGCTCTAGCGCTGAAGAAACGATTCAATATGC-3′ 
and 5′-GTGGTGGTGGTGGTGGTGATGTTAGCCTTCTTGAGTTGGCAGC-3′ 
(pGAY28 LIC cloning regions underlined). Crystals grew over a period of 2-4 days by 
sitting drop vapor diffusion at 22 ˚C. Drops were formed by mixing 2 µL protein solution 
(25 mg/ml Pks(ACP5+KS6), 150 mM NaCl, 10% glycerol, 10 mM HEPES, pH 7.5) with 
1 µL crystallization buffer (30% PEG 4000 (v/v), 0.2 M sodium acetate, 0.1 M Tris, pH 




modified with 20% glycerol, and the diffraction data collected at ALS Beamline 5.0.2. 
Phases were obtained by molecular replacement using PksKS6 (wild-type) as a search 
model. The structure was solved to 4.0 Å resolution by molecular replacement using a 
single chain from the dimeric structure of PksKS6 as the search model. Electron density 
for the eight ACPs in the asymmetric unit could not be located despite exhaustive 
inspection of the map.  
 The DNA encoding BaeKS5 was amplified using primers: 5′- 
GCGGCCTGGTGCCGCGCGGCTCTAGCCAGCAGCTGACAGAGCGTG-3′ and 5′-
GTGGTGGTGGTGGTGGTGATGTTAATCAGCTGATGTGTCGATCCAATAAC -3′ 
(pGAY28 LIC cloning regions underlined). The eluted protein was concentrated to 9.9 
mg/mL in the equilibration buffer. Crystals of BaeKS5 grew in 2 days by sitting drop 
vapor diffusion at 22 ˚C. Drops were formed by mixing 1.75 μL protein solution (9.9 
mg/mL BaeKS5, 150 mM NaCl, 15 mM HEPES, pH 7.5) with 0.5 μL crystallization 
buffer (1.1 M LiSO4, 0.1 M Tris, pH 8.0). Crystals were frozen in liquid nitrogen after a 
20 min soak in the crystallization buffer modified with 10% (v/v) glycerol. Diffraction 
data, collected at APS Beamline 23-ID-B, were processed by HKL2000. The structure 
was solved to 4.20 Å resolution by molecular replacement using the KS2 monomer from 
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Figure 7-1. Trans-AT vs. cis-AT PKS architecture. The modular assembly for the 
archetypal trans-AT (PksX) and cis-AT (6-dEBS) PKSs are shown, responsible for the 
biosynthesis of bacillaene and erythromycin, respectively. For each system, the fourth 
PKS module has been magnified to reveal the organization of domains. Although much 
of the higher-order architecture remains unknown, the schematics represent hypothetical 
models based on available crystal structures (Ery(KS+AT)3 (PDB: 2QO3), EryDH4 
(PDB: 3EL6), Spn(KR+ER)2 (PDB: 3SLK), PksKS2 (PDB: 4NA1), and Rhi(KS+B)11 
(PDB: 4KC5). The presence of a LINKS contact is shown as lateral red extensions for 
each of the modules in PksX that harbor this region. N- and C-terminal docking domains 
for 6-dEBS are shown as vertical blue extensions. ACP, acyl carrier protein; AL, acyl-
CoA ligase; AT, acyltransferase; DH, dehydratase; ECH, enoyl-CoA hydratase; ER, 
enoylreductase; FSD, flanking subdomain; HCS, HMG-CoA synthase; HYD, hydrolase; 
KS, ketosynthase; KR, ketoreductase; LD, loading didomain; M, module; NRPS, non-






































Figure 7-2. The LINKS interaction. The LINKS interaction that forms between trans-AT 
KS domains is mediated by three α-helices (α17-α19) that bind to a spatially-reversed 
copy of the same structure. (a) A model for the LINKS interaction between two KS 
homodimers is magnified, revealing the orientation of the LINKS helices. The angle 
above the structures indicates the relative angle between KS monomers forming the 
interaction (Figure 7-5). Each individual LINKS sequence is colored blue at the N-
terminal end of α17 and red at the C-terminal end of α19, and the N-terminal end of α17 
always forms favorable interactions with the C-terminal end of α19 from the neighboring 
KS (α19′). The coloring scheme used for the cartoon model has been repeated in each of 
the displayed structures to highlight the conservation of the LINKS interface. The 
structure shown for PksKS2 (monomeric form) reveals two KS monomers that do not 
form the traditional homodimer interaction; however, the LINKS interaction is 
crystallographically maintained. The relatively high thermal factors for the LINKS 
helices in BaeKS1 (3.0 Å) did not permit the complete construction of α17-α19 for each 
of the KS monomers, but the relative orientation of the KS bodies indicates that the 
LINKS interaction is conserved. (b) The three helices forming the LINKS interaction for 
PksKS2 are shown in cartoon format (green), and the remainder of this PksKS2 monomer 
has been hidden for clarity. The neighboring KS forming the complementary LINKS 
interaction is represented with a transparent surface (cyan). The angle of the image is set 
from the interior of the flanking subdomain, to reveal the collection of centrally-located 
hydrophobic residues that would be surface-exposed in the absence of the LINKS 
interaction. (c) A 90˚ rotation of the viewing angle shown in panel B reveals the series of 
ionic interactions formed at the poles of α18. The aspartate and glutamate residues at the 
N-terminal end of α18 form well-defined ionic interactions with the lysine residues at the 
C-terminal end of α18 from the neighboring structure. Met559 of the blue monomer can 
be observed in the center of the image, extending into the hydrophobic cavity of the green 
monomer (Figure 7-3a). (d) The three LINKS helices for PksKS2 have been modeled 
linearly to reduce the complexity of the image. LINKS contacts between residues ranging 
from 2.0 - 3.0 Å are shown as black dots, and those ranging from 3.1 – 4.0 Å are shown 
as grey dots. The corresponding sequence for the region is also shown, and residues 
represented by grey letters have been hidden from the cartoon and do not directly 




















Figure 7-3. Electron density for PksKS2 LINKS interaction. A 2Fo-Fc map contoured at 
1.0 r.m.s.d. is shown for the PksKS2 LINKS interaction, which represents the highest-
resolution view available of this region. (a) M559 from the blue monomer inserts into the 
hydrophobic core of the opposite KS monomer (green). This interaction is mirrored 
several angstroms away, employing the same residues from the alternate KS. (b) The N-
terminus of α18 (blue) forms well-defined ionic interactions with the C-terminus of α18 
(green) from the complementary KS. This interaction is repeated on the opposite end of 
α18 for both helices, albeit with the correspondingly-exchanged residues. For specific 








































Figure 7-4. Shape complementarity of LINKS interaction. The hydrophobic core of the 
LINKS interaction exhibits a high degree of shape complementarity, maximizing the van 
der Waals forces that stabilize the contact. A crystallographically-observed LINKS 
interaction is shown (PksKS2), cut by five planes (A-E). Each resulting cross-section 
reveals that cavities or alcoves present in one KS are complemented by protrusions and 



















Figure 7-5. Angle of MgsKS5 LINKS interaction relative to PksKS2. Shown in green is 
PksKS2 with corresponding LINKS highlighted yellow, and shown in cyan is MgsKS5 
with corresponding LINKS highlighted orange. Both structures were generated from the 
associated crystallographic symmetry operators. Structurally aligning both LINKS 
interactions reveals the flexibility of α17-α19, indicating that α18 is able to swing at least 
~50˚ from the FSD to form the LINKS interaction. The angle for PksKS2 is 180˚, 
because a straight line can be drawn through the center of α17-α19 for each of the four 
monomers displayed. It is expected that 180˚ represents the lowest energy angle for the 
interaction, and deviations from this can arise from favorable contacts made elsewhere in 



















Figure 7-6. Sequence alignment of the LINKS region. Over 100 trans-AT KS sequences 
were aligned, and a subset of the alignment is shown. Residues in the alignment have 
been colored according to the following scheme: red for acidic residues, blue for basic 
residues, and yellow for hydrophobic residues. Helices α17-α19 (grey) delineate the 
boundaries of the LINKS region. If a KS in the alignment has been structurally 
characterized, the associated PDB identifier is shown in parentheses (XXXX: reported in 
this work, to be deposited). Although strict conservation of the LINKS region is poor, the 
conservation of LINKS attributes are generally maintained (i.e., charged poles of α18 
flanked by hydrophobic residues). For those KSs that do not contain LINKS (e.g., 
RhiKS11 and OzmKS9, bottom of alignment), the available structures do not reveal any 
crystallographic homotypic interactions mediated by this region. The only structure 
available that contains LINKS but does not exhibit the crystallographic interaction 
observed in all other trans-AT KS structures is of MgsKS7. The structure of MgsKS5 
reveals the LINKS interaction, yet the LINKS attributes differ from what has been 
observed in other structures. A seemingly anomalous basic residue at the N-terminal end 
of α18 (Lys1120) forms an ionic interaction with an acidic residue at the N-terminal end 
of α19 (Asp1138) that is almost invariably basic in the other sequences (both residue 
positions are marked with asterisks). (A 22-residue region from MgsKS5 that is 
composed of alternating aspartate and serine residues has been deleted from the image for 



























Figure 7-7. 2Fo-Fc electron density for Pks(ACP5+KS6). The 2Fo-Fc electron density 
(contoured to 1.0 r.m.s.d.) for the Pks(ACP5+KS6) structure is shown in blue, and the 
backbone traces of PksKS6 that could be fit to the density are shown in yellow. Despite 
the extremely high thermal factors for protein atoms in the structure (157.3 Å
2
), the 
backbone KS atoms fit the density very well. The eight ACPs in the asymmetric unit 













Figure 7-8. Fo-Fc omit map of α17-α19 for BaeKS1. High local B-factors and relatively-
poor resolution (3.0 Å) made the construction of α17-α19 for BaeKS1 very challenging. 
To confirm that the helices have been correctly placed, an Fo-Fc omit map for the region 
was generated. (a) The Fo-Fc omit map contoured at 3.0 r.m.s.d. is shown for a generous 
portion of the unit cell. The atoms omitted from phasing to produce the map were all 
those contained in α17-α19. (b) To orient the viewer, the model of BaeKS1 has been 














Figure 7-9. Sequence alignment of LINKS region with uncharacterized binding 
interactions. For approximately half of the sequences used in the alignment of over 100 
trans-AT KSs, the LINKS region does not reveal the conserved attributes observed in 
Figure 7-6. It is expected that a structurally-uncharacterized form of LINKS interaction 
occurs in these KSs, but it is not clear from the sequence alignment how this interface 


















































Figure 7-10. Simple moving average calculation of sequence conservation. To determine 
which regions of trans-AT KSs are the most susceptible to sequence variation, a simple 
moving average (SMA) calculation was performed based on sequence conservation and 
residues were colored according to the corresponding quartiles. The five regions that 
received the highest SMA conservation scores all map to the active site of the KS body 
(blue), while the lowest scoring region corresponds to the LINKS helices (red). A 
representative KS structure is shown colored accordingly. N- and C-termini are depicted 









































Figure 7-11. Homotypic LINKS interactions are favored over heterotypic. In the top 
panel, a region of the LINKS interaction for PksKS2 is shown. In the middle panel, the 
same region of the PksKS6 LINKS interaction is also shown. Modeling a pseudo-LINKS 
interaction between PksKS6 and PksKS2 reveals several clashes, and two are shown in 
the bottom panel (black arrows). Both W543 and K551 from PksKS6 are within clashing 
distance of M559 from PksKS2, responsible for a key hydrophobic contact in the PksKS2 














Figure 7-12. Vertical and lateral interactions stabilize the PKS megacomplex. The 
electron micrographs observed by Straight et al. revealed a dense mass associated with 
the membrane of B. subtilis cells, identified to consist of numerous copies of the PksX 
megasynthase (Straight et al., 2007). An image from that work is reprinted here, 
revealing that the observed superstructure measures approximately 150 × 150 nm. The 
arrow points to the cell membrane, and the arrowhead points to gold nanoparticles 
engineered to target PksX proteins. For visualizing how this mass of proteins may self-
associate, a diagram shows the assembly line subunits (PksJ, PksL, PksM, PksN, and 
PksR) interacting vertically through domain-domain interactions, and laterally through 
the LINKS network. The estimations for megacomplex dimensions that flank the cartoon 
are calculated based on available crystal structures of individual PKS domains. In the 
vertical dimension, 175 nm is represented by 15 PKS modules and 2.5 NRPS modules 
(10 nm each). In the lateral dimension, 160 nm is estimated by the total length of 15 KS 


































Figure 7-13. Relative orientation of mammalian fatty acid synthase(KS+DH) and 
Rhi11(KS+B). Shown in cyan and orange are the mammalian fatty acid synthase KS and 
DH domains, respectively (PDB: 2VZ8). Shown in green and yellow are the trans-AT 
KS and B domains, respectively (PDB: 4KC5). The relative positioning of the DH and B 
domains respective to their cognate KS domains differs by 35˚. The orientation of the 
KS+B didomain may indicate the processing domains of trans-AT PKSs have adopted 
this architecture to accommodate lateral LINKS interactions, which would form a 








































Figure 7-14. Protein density of the megacomplex. To reveal the density of the trans-AT 
PKS megacomplex, a simulation of nine modules in megacomplex formation was 
generated. The modules are based on the crystal structure of Rhi(KS+B)11, PDB: 4KC5 
(the B domain is structurally identical to the DH domain). RhiKS11 does not contain 
LINKS, and was replaced with PksKS2 in each module (red). The flanking subdomains 
are shown in salmon, the DH domains are shown in yellow, and the ACPs are shown in 
purple (PDB: 2JU2). (a) The nine modules are forming six LINKS interactions. Panels 
(b) and (c) represent a 30˚ and 180˚ rotation of the view in panel (a), respectively. Based 
on the structure of Rhi(KS+B)11, DH domains dimerize orthogonal to KS domains and 
do not inhibit the LINKS interaction (Figure 7-13). The ACP domains appear to have 
sufficient freedom to visit the condensation and processing domains of the respective 
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Chapter 8. Conclusions and Future Perspectives 
 This work examined the structure and function of several enzymes involved in 
polyketide biosynthesis, and unveiled a motif that forms the structural foundation of the 
PKS megacomplex. The findings have revealed that harnessing PKS enzymes to generate 
designer molecules will soon become a reality, as more details regarding their 
architecture, function, and substrate promiscuity emerge. Whether by reengineering entire 
synthases to build novel natural products in vivo or isolating PKS domains to catalyze 
valuable reactions in vitro, the future of natural product biocatalysis only awaits our own 
determination and creativity.  
 In Chapter 2, the structure and function of a PKS KR+ER didomain revealed that 
the PKS and FAS architectures diverged early in evolution, and that analogies may be 
more difficult to form between the two systems than previously hypothesized. It will not 
be possible to rationally engineer a man-made PKS without understanding the large-scale 
ramifications of domain- and module-swapping, and the structure of a complete module 
would undoubtedly solve many of the outstanding questions. In Chapter 3, the 
stereoselectivity of a PKS DH domain was completely reversed by exchanging the 
thioester handle attached to the substrate for dehydration. Only the cognate ACP for this 
DH domain was able to deliver a substrate for dehydration that matches the expected 
biological selectivity, a finding that reveals potential complications for rational PKS 
design. In Chapter 4, homologous recombination in S. cerevisiae was used to generate a 
new LIC-cloning plasmid, pGAY-28. This plasmid is much more efficient for cloning 
large PKS genes compared to the more traditional pET-28 series of vectors, demonstrated 
by the successful incorporation of a 10.3 kb insert. Although the massive size of PKS 




purification, the modularity that accompanies the size of these systems is exactly what 
will be taken advantage of for biocatalytic engineering. In Chapter 5, the structure and 
mechanism of the newly identified enoyl-isomerase domain uncovered a unique 
mechanism for polyketide double bond migration. The structure revealed a single 
histidine mediates catalysis unaided by other active site residues or water, shuttling a 
proton from the γ- position of the enoyl thioester to the α-position. Double bonds control 
the topography and structural configuration of macrocycles more than any other 
functional group, and this domain may potentially be employed in biocatalytic reactions 
to catalyze the migration of double bonds in conjugation with a thioester. In Chapter 6, 
the structure of a PKS KS domain covalently bound to its natural polyketide intermediate 
answered many questions regarding how polyketides bind in the active site of this 
domain. The gatekeeping functionality of KS domains may very well be the primary 
barricade to rational PKS engineering, and experiments using the techniques presented in 
Chapter 6 to determine how other KS clades select for substrates should be performed. In 
Chapter 7, the LINKS motif of trans-AT PKS KS domains was found to mediate the 
formation of the organelle-sized PKS megacomplex observed by others through cryo-
electron microscopy. This motif binds in a homotypic fashion to a spatially-reversed copy 
of itself, creating a horizontal network that stabilizes the vertical assembly of the PKS 
megasynthase. While trans-AT systems embody an excellent template for the 
engineering of synthetic PKSs for the exploration of new medicines, it may be necessary 
to consider the consequences of modifying the LINKS network when relocating modules 
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